DUPONT DE NEMOURS, INC., 10-K filed on 2/14/2025
Annual Report
v3.25.0.1
Cover - USD ($)
$ in Billions
 12 Months Ended
Dec. 31, 2024
Feb. 12, 2025
Jun. 30, 2024
Cover [Abstract]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Dec. 31, 2024    
Current Fiscal Year End Date --12-31    
Document Transition Report false    
Entity File Number 001-38196    
Entity Registrant Name DUPONT DE NEMOURS, INC.    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 81-1224539    
Entity Address, Address Line One 974 Centre Road    
Entity Address, Address Line Two Building 730    
Entity Address, City or Town Wilmington    
Entity Address, State or Province DE    
Entity Address, Postal Zip Code 19805    
City Area Code 302    
Local Phone Number 295-5783    
Title of 12(b) Security Common Stock, par value $0.01 per share    
Trading Symbol DD    
Security Exchange Name NYSE    
Entity Well-known Seasoned Issuer Yes    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Large Accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag true    
Document Financial Statement Error Correction false    
Entity Shell Company false    
Entity Public Float     $ 34
Entity Common Stock, Shares Outstanding   418,049,127  
Documents Incorporated by Reference
Part III: Proxy Statement for the 2025 Annual Meeting of Stockholders to be filed not later than 120 days after the end of the fiscal year covered by this Form 10-K.
    
Entity Central Index Key 0001666700    
Amendment Flag false    
Document Fiscal Year Focus 2024    
Document Fiscal Period Focus FY    
v3.25.0.1
Audit Information
 12 Months Ended
Dec. 31, 2024
Audit Information [Abstract]  
Auditor Name PricewaterhouseCoopers LLP
Auditor Location Philadelphia, Pennsylvania
Auditor Firm ID 238
v3.25.0.1
Consolidated Statements of Operations - USD ($)
shares in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]      
Net sales $ 12,386,000,000 $ 12,068,000,000 $ 13,017,000,000
Cost of sales 7,879,000,000 7,835,000,000 8,402,000,000
Research and development expenses 531,000,000 508,000,000 536,000,000
Selling, general and administrative expenses 1,552,000,000 1,408,000,000 1,467,000,000
Amortization of intangibles 595,000,000 600,000,000 590,000,000
Restructuring and asset related charges - net 87,000,000 146,000,000 155,000,000
Goodwill impairment charge 0 804,000,000 0
Acquisition, integration and separation costs 168,000,000 20,000,000 193,000,000
Equity in earnings of nonconsolidated affiliates 60,000,000 51,000,000 75,000,000
Sundry income (expense) - net (76,000,000) 102,000,000 191,000,000
Interest expense 366,000,000 396,000,000 492,000,000
Income from continuing operations before income taxes 1,192,000,000 504,000,000 1,448,000,000
Provision for (benefit from) income taxes on continuing operations 414,000,000 (29,000,000) 387,000,000
Income from continuing operations, net of tax 778,000,000 533,000,000 1,061,000,000
(Loss) income from discontinued operations, net of tax (40,000,000) (71,000,000) 4,856,000,000
Net income 738,000,000 462,000,000 5,917,000,000
Net income attributable to noncontrolling interests 35,000,000 39,000,000 49,000,000
Net income available for DuPont common stockholders $ 703,000,000 $ 423,000,000 $ 5,868,000,000
Per common share data:      
Earnings per common share from continuing operations - basic (in USD per share) $ 1.77 $ 1.10 $ 2.02
(Loss) earnings per common share from discontinued operations - basic (in USD per share) (0.10) (0.16) 9.75
Earnings per common share - basic (in USD per share) 1.68 0.94 11.77
Earnings per common share from continuing operations - diluted (in USD per share) 1.77 1.09 2.02
(Loss) earnings per common share from discontinued operations - diluted (in USD per share) (0.10) (0.16) 9.73
Earnings per common share - diluted (in USD per share) $ 1.67 $ 0.94 $ 11.75
Weighted-average common shares outstanding - basic (in shares) 419.2 449.9 498.5
Weighted-average common shares outstanding - diluted (in shares) 420.6 451.2 499.4
v3.25.0.1
Consolidated Statements of Comprehensive Income - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Statement of Comprehensive Income [Abstract]      
Net income $ 738 $ 462 $ 5,917
Other comprehensive (loss) income, net of tax      
Cumulative translation adjustments (575) 38 (1,119)
Pension and other post-employment benefit plans (60) (92) 41
Derivative instruments 32 (41) 61
Separation of M&M Divestitures 0 (32) 167
Total other comprehensive loss (603) (127) (850)
Comprehensive income 135 335 5,067
Comprehensive income attributable to noncontrolling interests, net of tax 22 31 31
Comprehensive income attributable to DuPont $ 113 $ 304 $ 5,036
v3.25.0.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2024
Dec. 31, 2023
Current Assets    
Cash and cash equivalents $ 1,850 $ 2,392
Restricted cash and cash equivalents 6 411
Accounts and notes receivable - net 2,199 2,370
Inventories 2,130 2,147
Prepaid and other current assets 179 194
Total current assets 6,364 7,514
Property    
Property, plant and equipment 10,956 10,725
Less: Accumulated depreciation 5,188 4,841
Total property, plant and equipment - net 5,768 5,884
Other Assets    
Goodwill 16,567 16,720
Other intangible assets 5,370 5,814
Restricted cash and cash equivalents - noncurrent 36 0
Investments and noncurrent receivables 1,081 1,071
Deferred income tax assets 246 312
Deferred charges and other assets 1,204 1,237
Total other assets 24,504 25,154
Total Assets 36,636 38,552
Current Liabilities    
Short-term borrowings 1,848 0
Accounts payable 1,720 1,675
Income taxes payable 202 154
Accrued and other current liabilities 1,031 1,269
Total current liabilities 4,801 3,098
Long-Term Debt 5,323 7,800
Other Noncurrent Liabilities    
Deferred income tax liabilities 915 1,130
Pension and other post-employment benefits - noncurrent 523 565
Other noncurrent obligations 1,281 1,234
Total other noncurrent liabilities 2,719 2,929
Total Liabilities 12,843 13,827
Commitments and contingent liabilities
Stockholders' Equity    
Common stock (authorized 1,666,666,667 shares of $0.01 par value each; issued 2024: 417,994,343 shares; 2023: 430,110,140 shares) 4 4
Additional paid-in capital 47,922 48,059
Accumulated deficit (23,076) (22,874)
Accumulated other comprehensive loss (1,500) (910)
Total DuPont stockholders' equity 23,350 24,279
Noncontrolling interests 443 446
Total equity 23,793 24,725
Total Liabilities and Equity $ 36,636 $ 38,552
v3.25.0.1
Consolidated Balance Sheets (Parenthetical) - $ / shares
Dec. 31, 2024
Dec. 31, 2023
Statement of Financial Position [Abstract]    
Shares authorized (in shares) 1,666,666,667 1,666,666,667
Par value (in USD per share) $ 0.01 $ 0.01
Shares issued (in shares) 417,994,343 430,110,140
v3.25.0.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Operating Activities      
Net income $ 738,000,000 $ 462,000,000 $ 5,917,000,000
(Loss) income from discontinued operations (40,000,000) (71,000,000) 4,856,000,000
Net income from continuing operations 778,000,000 533,000,000 1,061,000,000
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 1,194,000,000 1,147,000,000 1,135,000,000
Credit for deferred income tax and other tax related items (163,000,000) (381,000,000) (157,000,000)
Earnings of nonconsolidated affiliates less than dividends received 13,000,000 20,000,000 36,000,000
Net periodic pension benefit (credit) cost (1,000,000) 31,000,000 2,000,000
Periodic benefit plan contributions (51,000,000) (63,000,000) (66,000,000)
Net gain on sales, businesses and investments (20,000,000) (19,000,000) (78,000,000)
Restructuring and asset related charges - net 87,000,000 146,000,000 155,000,000
Stock based compensation 77,000,000 74,000,000 75,000,000
Goodwill impairment charge 0 804,000,000 0
Loss on debt extinguishment 74,000,000 0 0
Interest rate swap loss 138,000,000 0 0
Other net (income) loss (27,000,000) 54,000,000 (59,000,000)
Changes in assets and liabilities, net of effects of acquired and divested companies:      
Accounts and notes receivable (135,000,000) 202,000,000 (79,000,000)
Inventories (7,000,000) 227,000,000 (215,000,000)
Accounts payable 77,000,000 (310,000,000) (138,000,000)
Other assets and liabilities, net 287,000,000 (274,000,000) (423,000,000)
Cash provided by operating activities - continuing operations 2,321,000,000 2,191,000,000 1,249,000,000
Investing Activities      
Capital expenditures (579,000,000) (619,000,000) (662,000,000)
Proceeds from sales of property, businesses, and ownership interests in nonconsolidated affiliates, net of cash divested 8,000,000 1,244,000,000 10,951,000,000
Acquisitions of property and businesses, net of cash acquired (321,000,000) (1,761,000,000) 5,000,000
Purchases of investments 0 (32,000,000) (1,317,000,000)
Proceeds from sales and maturities of investments 0 1,334,000,000 15,000,000
Other investing activities, net 43,000,000 6,000,000 12,000,000
Cash (used for) provided by investing activities - continuing operations (849,000,000) 172,000,000 9,004,000,000
Financing Activities      
Changes in short-term borrowings 0 0 (150,000,000)
Proceeds from credit facility 0 0 600,000,000
Repayment of credit facility 0 0 (600,000,000)
Payments on long-term debt (687,000,000) (300,000,000) (2,500,000,000)
Purchases of common stock and forward contracts (500,000,000) (2,000,000,000) (4,375,000,000)
Proceeds from issuance of Company stock 50,000,000 27,000,000 88,000,000
Employee taxes paid for share-based payment arrangements (27,000,000) (27,000,000) (27,000,000)
Distributions to noncontrolling interests (26,000,000) (37,000,000) (26,000,000)
Dividends paid to stockholders (635,000,000) (651,000,000) (652,000,000)
Payment of excise tax on purchase of treasury stock (21,000,000) 0 0
Other financing activities, net (1,000,000) (1,000,000) (4,000,000)
Cash used for financing activities - continuing operations (1,847,000,000) (2,989,000,000) (7,646,000,000)
Cash Flows from Discontinued Operations      
Cash used for operations - discontinued operations (474,000,000) (273,000,000) (661,000,000)
Cash used for investing activities - discontinued operations 0 (33,000,000) (81,000,000)
Cash used for financing activities - discontinued operations 0 0 (21,000,000)
Cash used in discontinued operations (474,000,000) (306,000,000) (763,000,000)
Effect of exchange rate changes on cash, cash equivalents and restricted cash (62,000,000) (37,000,000) (148,000,000)
(Decrease) increase in cash, cash equivalents and restricted cash (911,000,000) (969,000,000) 1,696,000,000
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations [Abstract]      
Cash, cash equivalents and restricted cash from continuing operations, beginning of period 2,803,000,000 3,772,000,000 2,037,000,000
Cash, cash equivalents and restricted cash from discontinued operations, beginning of period 0 0 39,000,000
Cash, cash equivalents and restricted cash at beginning of period 2,803,000,000 3,772,000,000 2,076,000,000
Cash, cash equivalents and restricted cash from continuing operations, end of period 1,892,000,000 2,803,000,000 3,772,000,000
Cash, cash equivalents and restricted cash from discontinued operations, end of period 0 0 0
Cash, cash equivalents and restricted cash from discontinued operations, end of period 1,892,000,000 2,803,000,000 3,772,000,000
Supplemental cash flow information      
Interest, net of amounts capitalized - from continuing operations 394,000,000 408,000,000 494,000,000
Income taxes, net of refunds - from continuing operations 363,000,000 360,000,000 642,000,000
Interest, net of amounts capitalized - from discontinued operations 0 0 0
Income taxes, net of refunds - from discontinued operations $ (47,000,000) $ 34,000,000 $ 202,000,000
v3.25.0.1
Consolidated Statements of Equity - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-in Capital
Retained Earnings (Accumulated Deficit)
Accumulated Other Comp (Loss) Income
Treasury Stock
Non-controlling Interests
Beginning balance at Dec. 31, 2021 $ 27,050 $ 5 $ 49,574 $ (23,187) $ 41 $ 0 $ 617
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 5,917     5,868     49
Other comprehensive loss (850)       (832)   (18)
Dividends (652)   (652)        
Common stock issued/sold 88   88        
Stock-based compensation 57   57        
Contributions from non-controlling interests 2           2
Distributions to non-controlling interests (36)           (36)
Purchases of treasury stock (3,725)         (3,725)  
Retirement of treasury stock 0     (3,725)   3,725  
Forward contracts for share repurchase (650)   (650)        
M&M Divestiture (167)           (167)
Other (17)   3 (21)     1
Ending balance at Dec. 31, 2022 27,017 5 48,420 (21,065) (791) 0 448
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 462     423     39
Other comprehensive loss (127)       (119)   (8)
Dividends (651)   (651)        
Common stock issued/sold 27   27        
Stock-based compensation 51   51        
Distributions to non-controlling interests (37)           (37)
Purchases of treasury stock (1,600)         (1,600)  
Excise tax on purchases of treasury stock (21)     (21)      
Retirement of treasury stock 0 (1)   (2,212)   2,213  
Forward contracts for share repurchase (400)   (400)        
Settlement of forward contracts for share repurchase 0   613     (613)  
Other 4   (1) 1     4
Ending balance at Dec. 31, 2023 24,725 4 48,059 (22,874) (910) 0 446
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 738     703     35
Other comprehensive loss (603)       (590)   (13)
Dividends (635)   (635)        
Common stock issued/sold 50   50        
Stock-based compensation 50   50        
Distributions to non-controlling interests (26)           (26)
Purchases of treasury stock (400)         (400)  
Excise tax on purchases of treasury stock (8)     (8)      
Retirement of treasury stock 0     (898)   898  
Forward contracts for share repurchase (100)   (100)        
Settlement of forward contracts for share repurchase 0   498     (498)  
Other 2     1     1
Ending balance at Dec. 31, 2024 $ 23,793 $ 4 $ 47,922 $ (23,076) $ (1,500) $ 0 $ 443
v3.25.0.1
Consolidated Statements of Equity (Parenthetical) - $ / shares
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Statement of Stockholders' Equity [Abstract]      
Dividends declared (in USD per share) $ 1.52 $ 1.44 $ 1.32
v3.25.0.1
Schedule II—Valuation and Qualifying Accounts
 12 Months Ended
Dec. 31, 2024
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]  
Schedule II—Valuation and Qualifying Accounts
Schedule II—Valuation and Qualifying Accounts
(In millions) for the years ended December 31,202420232022
Accounts Receivable—Allowance for Doubtful Receivables   
Balance at beginning of period$40 $38 $28 
Additions charged to expenses17 12 11 
Deductions from reserves 1
(31)(10)(1)
Balance at end of period$26 $40 $38 
Inventory—Obsolescence Reserve
Balance at beginning of period$8 $4 $6 
Additions charged to expenses41 14 18 
Deductions from reserves 2
(14)(10)(20)
Balance at end of period$35 $8 $4 
Deferred Tax Assets—Valuation Allowance   
Balance at beginning of period$738 $703 $700 
Additions 3
122 47 125 
Deductions from reserves 3
(88)(12)(122)
Balance at end of period$772 $738 $703 
1.Deductions include write-offs, recoveries and currency translation adjustments.
2.Deductions include disposals and currency translation adjustments.
3.Additions and Deductions include currency translation adjustments.
v3.25.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 12 Months Ended
Dec. 31, 2024
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Principles of Consolidation and Basis of Presentation
The accompanying Consolidated Financial Statements of DuPont de Nemours, Inc. ("DuPont” or the "Company”) were prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The significant accounting policies described below, together with the other notes that follow, are an integral part of the Consolidated Financial Statements.

The Consolidated Financial Statements include the accounts of the Company and subsidiaries in which a controlling interest is maintained. The Consolidated Financial Statements also include the accounts of joint ventures that are variable interest entities ("VIEs") in which the Company is the primary beneficiary due to the Company's power to direct the VIEs significant activities. For those consolidated subsidiaries in which the Company's ownership is less than 100 percent, the outside stockholders' interests are shown as noncontrolling interests. Investments in affiliates over which the Company has the ability to exercise significant influence but does not have a controlling interest are accounted for under the equity method.

The Company is also involved with certain joint ventures accounted for under the equity method of accounting that are VIEs. The Company is not the primary beneficiary, as the nature of the Company's involvement with the VIEs does not provide it the power to direct the VIEs significant activities. Future events may require these VIEs to be consolidated if the Company becomes the primary beneficiary. At December 31, 2024 and 2023, the maximum exposure to loss related to the nonconsolidated VIEs is not considered material to the Consolidated Financial Statements.

DWDP Distributions
Effective August 31, 2017, E. I. du Pont de Nemours and Company ("EID") and The Dow Chemical Company ("TDCC") each merged with subsidiaries of DowDuPont Inc. (n/k/a "DuPont”) and, as a result, EID and TDCC became subsidiaries of the Company. On April 1, 2019, the Company completed the separation of the materials science business through the spin-off of Dow Inc., (“Dow”) including Dow’s subsidiary TDCC (the “Dow Distribution”). On June 1, 2019, the Company completed the separation of the agriculture business through the spin-off of Corteva, Inc. (“Corteva”) including Corteva’s subsidiary EID (subsequently renamed EIDP, Inc. (n/k/a "EIDP")), (the “Corteva Distribution" and together with the Dow Distribution, the “DWDP Distributions”). Following the Corteva Distribution, DuPont holds the specialty products business as continuing operations. DowDuPont Inc. changed its registered name to DuPont de Nemours, Inc. (“DuPont”) (for certain events prior to June 1, 2019, the Company may be referred to as DowDuPont). Beginning on June 3, 2019, the Company's common stock is traded on the New York Stock Exchange under the ticker symbol "DD."

Intended Electronics Separation
On May 22, 2024, DuPont announced a plan to separate each of its Electronics and Water businesses in a tax-free manner to its shareholders, (the “Previously Intended Business Separations”). On January 15, 2025, DuPont announced it is targeting November 1, 2025, for the completion of the intended separation of the Electronics business (the “Intended Electronics Separation”). DuPont also announced that it would retain the Water business. The Intended Electronics Separation will not require a shareholder vote and is subject to satisfaction of customary conditions, including final approval by DuPont's Board of Directors, receipt of tax opinion from counsel, the filing and effectiveness of a Form 10 registration statement with the U.S. Securities and Exchange Commission, applicable regulatory approvals and satisfactory completion of financing.

M&M Transactions
On November 1, 2022, DuPont completed the previously announced divestiture of the majority of its historic Mobility & Materials segment, including the Engineering Polymers business line and select product lines within the Advanced Solutions and Performance Resins business lines (the “M&M Divestiture”), to Celanese Corporation (“Celanese”) for cash proceeds of $11.0 billion. On November 1, 2023, the Company closed the sale of the Delrin® business to TJC LP ("TJC"), (the “Delrin® Divestiture”). The Delrin® Divestiture and together with the M&M Divestiture, collectively the "M&M Divestitures” and the businesses in scope of the M&M Divestitures collectively the "M&M Businesses". See Note 4 for more information.

The results of operations for the year ended December 31, 2023, present the financial results of Delrin® as discontinued operations through November 1, 2023. The results of operations for the year ended December 31, 2022, present the financial results of the M&M Businesses as discontinued operations. For the year ended December 31, 2023, the Consolidated Statements of Cash Flows present the cash flows of the Delrin® Divestiture as discontinued operations for activity. The Consolidated Statements of Cash Flows for the year ended December 31, 2022, present the cash flows from the M&M Businesses as discontinued operations. The comprehensive income of the M&M Businesses has not been segregated and is included in the Consolidated Statements of Comprehensive Income for all periods presented. Unless otherwise indicated, the information in the notes to the Consolidated Financial Statements refer only to DuPont's continuing operations and do not include discussion of balances or activity of the M&M Businesses.
Use of Estimates in Financial Statement Preparation
The preparation of financial statements in accordance with U.S. GAAP requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. The Company’s Consolidated Financial Statements include amounts that are based on management’s best estimates and judgments. Actual results could differ from those estimates.

Cash and Cash Equivalents
Cash equivalents represent investments with maturities of three months or less from time of purchase. They are carried at cost plus accrued interest, which approximates fair value.

Restricted Cash and Cash Equivalents
Restricted cash and cash equivalents represents trust assets, cash held in escrow and cash within qualified settlement funds. These funds are restricted as to withdrawal or use under the terms of certain contractual agreements. Restricted cash is classified as a current or non-current asset based on the timing and nature of when or how the cash is expected to be used. See Note 7 and 16 for further information.

Marketable Securities
Marketable securities represent investments in fixed and floating rate financial instruments with maturities greater than three months and up to twelve months at time of purchase. Investments classified as held-to-maturity are recorded at amortized cost. The carrying value approximates fair value due to the short-term nature of the investments.

Fair Value Measurements
Under the accounting guidance for fair value measurements and disclosures, a fair value hierarchy was established that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). A financial instrument's level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.

The Company uses the following valuation techniques to measure fair value for its assets and liabilities:
Level 1–Quoted market prices in active markets for identical assets or liabilities;
Level 2–Significant other observable inputs (e.g. quoted prices for similar items in active markets, quoted prices for identical or similar items in markets that are not active, inputs other than quoted prices that are observable such as interest rate and yield curves, and market-corroborated inputs);
Level 3–Unobservable inputs for the asset or liability, which are valued based on management's estimates of assumptions that market participants would use in pricing the asset or liability.

Foreign Currency Translation
The Company's worldwide operations utilize the U.S. dollar ("USD") or local currency as the functional currency, where applicable. The Company identifies its separate and distinct foreign entities and groups the foreign entities into two categories: 1) extension of the parent or foreign subsidiaries operating in a hyper-inflationary environment (USD functional currency) and 2) self-contained (local functional currency). If a foreign entity does not align with either category, factors are evaluated and a judgment is made to determine the functional currency.

For foreign entities where the USD is the functional currency, all foreign currency-denominated asset and liability amounts are re-measured into USD at end-of-period exchange rates, except for inventories, prepaid expenses, property, plant and equipment, goodwill, other intangible assets and other non-monetary items, which are re-measured at historical rates. Foreign currency income and expenses are re-measured at average exchange rates in effect during the year, except for expenses related to balance sheet amounts re-measured at historical exchange rates. Exchange gains and losses arising from re-measurement of foreign currency-denominated monetary assets and liabilities are included in income in the period in which they occur.

For foreign entities where the local currency is the functional currency, assets and liabilities denominated in local currencies are translated into USD at end-of-period exchange rates and the resultant translation adjustments are reported, net of their related tax effects, as a component of accumulated other comprehensive loss in equity. Assets and liabilities denominated in other than the local currency are re-measured into the local currency prior to translation into USD and the resultant exchange gains or
losses are included in income in the period in which they occur. Income and expenses are translated into USD at average exchange rates in effect during the period.

The Company changes the functional currency of its separate and distinct foreign entities only when significant changes in economic facts and circumstances indicate clearly that the functional currency has changed.

Interest Rate Swap Agreements
The Company has entered into a fixed-to-floating interest rate swap agreement to hedge changes in the fair value of the Company’s long-term debt due to interest rate movements. Under the terms of the agreement, the Company agrees to exchange, at specified intervals, fixed for floating interest amounts based on the agreed upon notional principal amount. The interest rate swaps are designated and carried as fair value hedges. Fair value hedge accounting has been applied and thus, changes in the fair value of these swaps and changes in the fair value of the related hedged portion of long-term debt will be presented and will net to zero in Sundry income (expense) – net in the Consolidated Statements of Operations.

In 2024, the Company issued a notice of partial redemption concerning the associated long-term debt linked to this hedging relationship. As a result, the Company dedesignated the hedging relationship, and fair value hedge accounting is no longer applied to these swaps. After dedesignation, changes in fair value of these swaps are recognized directly in earnings in “Sundry income (expense) – net” in the Consolidated Statements of Operations, resulting in gains or losses that are separate from the hedged item.

In addition, the Company has entered into two forward-starting fixed-to-floating interest rate swap agreements to hedge changes in the fair value of the Company’s long-term debt resulting from interest rate movements. These new derivatives convert fixed interest rate payments to floating rate payments. The Company employs both the dedesignated fixed-to-floating interest rate swaps and the forward-starting fixed-to-floating interest rate swaps as economic hedges of its fixed-rate debt. Changes in the fair value of the economic hedges, and any gains or losses from net interest settlements associated with the dedesignated swaps, are recorded in “Sundry income (expense) – net” in the Consolidated Statements of Operations.

Cash payments or receipts associated with interest rate swaps are classified as operating activities in the Consolidated Statements of Cash Flows.

Net Foreign Investment Hedge
The Company has fixed-for-fixed cross currency swaps which are designated as a net investment hedge and has made an accounting policy election to account for the net investment hedge using the spot method. The Company has also elected to amortize the excluded components in interest expense in the related quarterly accounting period that such interest is accrued. The cross-currency swap is marked to market at each reporting date and any unrealized gains or losses are included in unrealized currency translation adjustments within "Accumulated other comprehensive loss" ("AOCL"), net of amounts associated with excluded components which are recognized in interest expense in the Consolidated Statements of Operations.

Inventories
The Company's inventories are valued at the lower of cost or net realizable value. Elements of cost in inventories include raw materials, direct labor and manufacturing overhead. Stores and supplies are valued at cost or net realizable value, whichever is lower; cost is generally determined by the average cost method. The Company's inventories are generally accounted for under the average cost method. The Company establishes allowances for obsolescence of inventory based upon quality considerations and assumptions about future demand and market conditions.

In periods of abnormally low production, certain fixed costs normally absorbed into inventory are recorded directly to cost of sales in the period incurred.

Property, Plant and Equipment
Property, plant and equipment are carried at cost less accumulated depreciation. Depreciation is based on the estimated service lives of depreciable assets and is calculated using the straight-line method. Fully depreciated assets are retained in property and accumulated depreciation accounts until they are removed from service. When assets are surrendered, retired, sold, or otherwise disposed of, their gross carrying values and related accumulated depreciation are removed from the Consolidated Balance Sheets and included in determining gain or loss on such disposals.
Goodwill and Other Intangible Assets
The Company records goodwill when the purchase price of a business acquisition exceeds the estimated fair value of net identified tangible and intangible assets acquired. Goodwill is tested for impairment at the reporting unit level annually during the fourth quarter, or more frequently when events or changes in circumstances indicate that the fair value of a reporting unit has more likely than not declined below its carrying value.

When testing goodwill for impairment, the Company has the option to first perform qualitative testing to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value. If the Company chooses not to complete a qualitative assessment for a given reporting unit or if the initial assessment indicates that it is more likely than not that the carrying value of a reporting unit exceeds its estimated fair value, additional quantitative testing is required. If the carrying value of a reporting unit exceeds its fair value, an impairment loss is recognized in the amount by which the carrying value of the reporting unit exceeds its fair value, limited to the amount of goodwill at the reporting unit. The Company determines fair values for each of the reporting units using a combination of the income approach and/or market approach. Under the income approach, fair value is determined based on the net present value of estimated future cash flows, discounted at an appropriate risk-adjusted rate. Under the market approach, the Company selects peer sets based on close competitors and reviews the EBITDA multiples to determine the fair value. When applicable, third-party purchase offers may be utilized to measure fair value. The Company applies a weighting to the market approach and income approach to determine the fair value. See Note 14 for further information on goodwill.

Indefinite-lived intangible assets are tested for impairment at least annually during the fourth quarter; however, these tests are performed more frequently when events or changes in circumstances indicate that the asset may be impaired. When testing indefinite-lived intangible assets for impairment, the Company has the option to first perform qualitative testing to determine whether it is more likely than not that the fair value of indefinite-lived intangible assets is less than carrying value. If the Company chooses not to complete a qualitative assessment for indefinite-lived intangible assets or if the initial assessment indicates that it is more likely than not that the carrying value of indefinite-lived intangible assets exceeds the fair value, additional quantitative testing is required. Impairment exists when carrying value exceeds fair value. The Company's fair value methodology is primarily based on discounted cash flow techniques.

Definite-lived intangible assets are amortized over their estimated useful lives, generally on a straight-line basis for periods ranging primarily from 1 to 20 years. The Company continually evaluates the reasonableness of the useful lives of these assets.

Impairment and Disposals of Long-Lived Assets
The Company evaluates the carrying value of long-lived assets to be held and used when events or changes in circumstances indicate the carrying value may not be recoverable. The carrying value of a long-lived asset group is considered for impairment when the total projected undiscounted cash flows from the assets are separately identifiable and are less than its carrying value. In that event, a loss would be recognized based on the amount by which the carrying value exceeds the fair value of the long-lived asset group. The Company's fair value methodology is an estimate of fair market value which is made based on prices of similar assets or other valuation methodologies, including present value techniques. Long-lived assets to be disposed of by sale, if material, are classified as held for sale and reported at the lower of carrying amount or fair value less cost to sell, and depreciation is ceased. Long-lived assets to be disposed of other than by sale are classified as held and used until they are disposed. Depreciation is recognized over the remaining useful life of the assets.

Acquisitions
In accordance with ASC 805, Business Combinations, acquisitions are recorded using the acquisition method of accounting. The Company includes the operating results of acquired entities from their respective dates of acquisition. The Company recognizes and measures the identifiable assets acquired and liabilities assumed as of the acquisition date fair value, where applicable. The excess, if any, of total consideration transferred in a business combination over the fair value of identifiable assets acquired and liabilities assumed is recognized as goodwill. Costs incurred as a result of a business combination other than costs related to the issuance of debt or equity securities are recorded in the period the costs are incurred.

Leases
The Company determines whether an arrangement is a lease at the inception of the arrangement based on the terms and conditions in the contract, in accordance with ASC 842, Leases. A contract contains a lease if there is an identified asset and the Company has the right to control the asset. Operating lease right-of-use ("ROU") assets are included in "Deferred charges and other assets" on the Consolidated Balance Sheets. Operating lease liabilities are included in "Accrued and other current liabilities" and "Other noncurrent obligations" on the Consolidated Balance Sheets. Finance lease ROU assets are included in "Property, plant and equipment - net" and the corresponding lease liabilities are included in "Long-term debt" or "Short-term borrowings" on the Consolidated Balance Sheets.
ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. As most of the Company’s leases do not provide the lessor's implicit rate, the Company uses its incremental borrowing rate at the commencement date in determining the present value of lease payments. Lease terms include options to extend the lease when it is reasonably certain those options will be exercised. Leases with an initial term of 12 months or less are not recorded on the balance sheet, and lease expense is recognized on a straight-line basis over the lease term.

The Company has lease agreements with lease and non-lease components, which are accounted for as a single lease component for all asset classes. Additionally, for certain equipment leases, the portfolio approach is applied to account for the operating lease ROU assets and lease liabilities. In the Consolidated Statements of Operations, lease expense for operating lease payments is recognized on a straight-line basis over the lease term. For finance leases, interest expense is recognized on the lease liability and the ROU asset is amortized over the lease term.

The Company has leases in which it is the lessor, these leases are classified as operating leases and lessor revenue and related expenses are not significant to the Company’s Consolidated Balance Sheets or Consolidated Statement of Operations. Lease income is recorded in "Selling, general, and administrative expenses" and "Research and development expenses". See Note 17 for additional information regarding the Company's leases.

Derivative Instruments
Derivative instruments are reported in the Consolidated Balance Sheets at their fair values. The Company utilizes derivatives to manage exposures to foreign currency exchange rates and commodity prices. Changes in the fair values of derivative instruments that are not designated as hedges are recorded in current period earnings. For derivative instruments designated as cash flow hedges, the gain or loss is reported in AOCL until it is cleared to earnings during the same period in which the hedged item affects earnings.

In the event that a derivative designated as a hedge of a firm commitment or an anticipated transaction is terminated prior to the maturation of the hedged transaction, the net gain or loss in AOCL generally remains in AOCL until the item that was hedged affects earnings. If a hedged transaction matures, or is sold, extinguished, or terminated prior to the maturity of a derivative designated as a hedge of such transaction, gains or losses associated with the derivative through the date the transaction matured are included in the measurement of the hedged transaction and the derivative is reclassified as for trading purposes. Derivatives designated as hedges of anticipated transactions are reclassified as for trading purposes if the anticipated transaction is no longer probable.

For derivative instruments designated as net investment hedges, the gain or loss is reported as a component of Other comprehensive income (loss) and recorded in AOCL. The gain or loss will be subsequently reclassified into net earnings when the hedged net investment is either sold or substantially liquidated.

Environmental Matters
Accruals for environmental matters are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated. These accruals are adjusted periodically as assessment and remediation efforts progress or as additional technical or legal information becomes available. Accruals for environmental liabilities are included in the Consolidated Balance Sheets in "Accrued and other current liabilities" and "Other noncurrent obligations" at undiscounted amounts. Accruals for related insurance or other third-party recoveries for environmental liabilities are recorded when it is probable that a recovery will be realized and are included in the Consolidated Balance Sheets as "Accounts and notes receivable - net."

Environmental costs are capitalized if the costs extend the life of the property, increase its capacity, and/or mitigate or prevent contamination from future operations. Environmental costs are also capitalized in recognition of legal asset retirement obligations resulting from the acquisition, construction and/or normal operation of a long-lived asset. Costs related to environmental contamination treatment and cleanup are charged to expense. Estimated future incremental operations, maintenance and management costs directly related to remediation are accrued when such costs are probable and reasonably estimable.
Revenue Recognition
The Company recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration which the Company expects to receive in exchange for those goods or services. To determine revenue recognition for the arrangements that the Company determines are within the scope of Revenue from Contracts with Customers (Topic 606), the Company performs the following five steps: (1) identify the contract(s) with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when (or as) the entity satisfies a performance obligation. See Note 5 for additional information on revenue recognition.

Cost of Sales
Cost of sales primarily includes the cost of manufacture and delivery, ingredients or raw materials, direct salaries, wages and benefits and overhead, non-capitalizable costs associated with capital projects and other operational expenses. No amortization of intangibles is included within costs of sales.

Research and Development
Research and development costs are expensed as incurred. Research and development expense includes costs (primarily consisting of employee costs, materials, contract services, research agreements, and other external spend) relating to the discovery and development of new products, and enhancement of existing products.

Selling, General and Administrative Expenses
Selling, general and administrative expenses primarily include selling and marketing expenses, commissions, functional costs, and business management expenses.

Acquisition, Integration and Separation Costs
Acquisition, integration and separation costs primarily consist of financial advisory, information technology, legal, accounting, consulting, other professional advisory fees and other contractual transaction payments associated with the preparation and execution of activities related to strategic initiatives.

Litigation
Accruals for legal matters are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated. Legal costs, such as outside counsel fees and expenses, are charged to expense in the period incurred.

Restructuring and Asset Related Charges
Charges for restructuring programs generally include targeted actions involving employee severance and related benefit costs, contract termination charges, and asset related charges, which include impairments or accelerated depreciation/amortization of long-lived assets associated with such actions. Employee severance and related benefit costs are provided to employees under the Company’s ongoing benefit arrangements. These charges are accrued during the period when management commits to a plan of termination and it becomes probable that employees will be entitled to benefits at amounts that can be reasonably estimated. Contract termination charges primarily reflect costs to terminate a contract before the end of its term or costs that will continue to be incurred under the contract for its remaining term without economic benefit to the Company. Asset related charges reflect impairments to long-lived assets and indefinite-lived intangible assets no longer deemed recoverable and depreciation/amortization of long-lived assets, which is accelerated over their remaining economic lives.

Income Taxes
The Company accounts for income taxes using the asset and liability method. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences of temporary differences between the carrying amounts and tax bases of assets and liabilities using enacted tax rates. The effect of a change in tax rates on deferred tax assets or liabilities is recognized in income in the period that includes the enactment date.

The Company recognizes the financial statement effects of an uncertain income tax position when it is more likely than not, based on the technical merits, that the position will be sustained upon examination. The Company accrues for other tax contingencies, such as indemnifications, when it is probable that a liability to a taxing authority has been incurred and the amount of the contingency can be reasonably estimated. The current portion of uncertain income tax positions is included in "Income taxes payable" and the long-term portion is included in "Other noncurrent obligations" in the Consolidated Balance Sheets.
v3.25.0.1
RECENT ACCOUNTING GUIDANCE
 12 Months Ended
Dec. 31, 2024
Accounting Changes and Error Corrections [Abstract]  
RECENT ACCOUNTING GUIDANCE RECENT ACCOUNTING GUIDANCE
Recently Adopted Accounting Guidance
In September 2022, the FASB issued Accounting Standards Update No. 2022-04, "Liabilities-Supplier Finance Programs (Subtopic 405-50)" ("ASU 2022-04") to enhance transparency about the use of supplier finance programs. The new guidance requires that a buyer in a supplier finance program provides additional qualitative and quantitative disclosures about its program including the nature of the program, activity during the period, changes from period to period, and the potential magnitude of the program. The amendments in ASU 2022-04 are effective for fiscal years beginning after December 15, 2022 on a retrospective basis, including interim periods within those fiscal years, except for the amendment on rollforward information which is effective prospectively for fiscal years beginning after December 15, 2023. The Company implemented the new disclosures, other than the rollforward information, as required in the first quarter of 2023. The rollforward information disclosures have been implemented as required for the year ended December 31, 2024. See Note 15 for more information.

In November 2023, the FASB issued Accounting Standards Update No. 2023-07, "Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures" ("ASU 2023-07") to improve disclosure requirements about reportable segments and address requests from investors for additional, more detailed information about a reportable segment’s expenses. The new guidance requires disclosures of significant segment expenses regularly provided to the Chief Operating Decision Maker ("CODM") and included in reported measures of segment profit and loss. Disclosure of the title and position of the CODM is required. The guidance requires interim and annual disclosures about a reportable segment's profit or loss and assets. Additionally, the guidance requires disclosure of other segment items by reportable segment including a description of its composition. The amendments in ASU 2023-07 are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, on a retrospective basis. The disclosures have been implemented as required for the year ended December 31, 2024. See Note 23 for more information.

Accounting Guidance Issued But Not Adopted at December 31, 2024
In December 2023, the FASB issued Accounting Standards Update No. 2023-09, "Income Taxes (Topic 740): Improvements to Income Tax Disclosures" ("ASU 2023-09") to improve transparency and disclosure requirements for the rate reconciliation, income taxes paid and other tax disclosures. The amendments in ASU 2023-09 are effective for fiscal years beginning after December 15, 2024, on a prospective basis. The disclosures will be implemented as required for the Company's 2025 annual report. The Company is currently evaluating the impact of adopting this guidance.

In March 2024, the U.S. Securities and Exchange Commission ("SEC") adopted rules under SEC Release No. 33-11275, "The Enhancement and Standardization of Climate-Related Disclosures for Investors", which require a registrant to disclose information in annual reports and registration statements about climate-related risks that are reasonably likely to have a material impact on its business, results of operations, or financial condition. The information would include disclosure of a registrant's greenhouse gas emissions. In addition, certain disclosures related to severe weather events and other natural conditions will be required in a registrant’s audited financial statements. Certain annual disclosure requirements would be effective as early as the fiscal year beginning January 1, 2025. However, in April 2024, the SEC voluntarily stayed the final rules pending certain legal challenges. The Company is currently evaluating the impact of these rules on its disclosures.

In November 2024, the FASB issued Accounting Standards Update No. 2024-03, "Income Statement: Reporting Comprehensive Income (Topic 220): Expense Disaggregation Disclosures" ("ASU 2024-03") to improve disclosures about the nature of expenses within line items on the statements of operations. The amendments in ASU 2024-03 are effective for the Company's 2028 annual report and subsequent interim periods; however, early adoption is permitted. The amendments can be applied prospectively or retrospectively to all periods presented. The Company is currently evaluating the impact of adopting this guidance.
v3.25.0.1
ACQUISITIONS
 12 Months Ended
Dec. 31, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]  
ACQUISITIONS ACQUISITIONS
Donatelle Plastics Acquisition
On July 28, 2024, DuPont completed the acquisition of Donatelle Plastics, LLC ("Donatelle Plastics"), for a net purchase price of $365 million (the "Donatelle Plastics Acquisition"), which includes immaterial adjustments for acquired cash and net working capital. The net purchase price also includes the estimated fair value for a contingent earn-out liability of $40 million, further discussed below. Donatelle Plastics is a medical device company specializing in the design, development and manufacture of medical components and devices. Donatelle Plastics is being integrated into Industrial Solutions within the Electronics & Industrial segment.

The purchase accounting and purchase price allocation for Donatelle Plastics are substantially complete. However, the Company continues to refine the preliminary valuation of certain acquired assets and liabilities assumed, including income tax related amounts, which could impact the amount of residual goodwill recorded. The Company will finalize the amounts recognized as it obtains the information necessary to complete the analysis, but no later than one year from the date of the acquisition.

The provisional fair values allocated to the assets acquired and liabilities assumed on July 28, 2024 include total assets of $268 million and total liabilities of $17 million. The goodwill acquired as part of the Donatelle Plastics Acquisition was $114 million resulting in total consideration of $365 million. The fair value of total assets acquired primarily includes $201 million of other intangible assets and $36 million of property, plant and equipment. The remaining assets acquired primarily include cash and cash equivalents and inventory. Final determination of the fair values may result in further adjustments to these values.

The significant fair value estimates included in the provisional allocation of purchase price are discussed below.

Other Intangible Assets
Other intangible assets with definite lives primarily include provisional customer relationships of $151 million and developed technology of $47 million. Customer relationships and developed technology have useful lives of 20 years and 15 years, respectively. The customer-related intangible assets' estimated fair value was determined using the multi-period excess earnings method while the developed technology fair values were determined utilizing the relief from royalty method.

Goodwill
The excess of the consideration for Donatelle Plastics over the preliminary net fair value of assets acquired and liabilities assumed resulted in the provisional recognition of $114 million of goodwill, which has been assigned to the Electronics & Industrial segment. Goodwill is primarily attributable to the optimization of the combined Electronics & Industrial segment and Donatelle Plastics businesses’ global activities across sales and manufacturing, as well as expected future customer relationships. Donatelle Plastics goodwill will be deductible for U.S. tax purposes.

Contingent Earn-out Liability
The purchase agreement includes annual contingent earn-out payments based upon customer specific revenue generated through December 31, 2029, with total accumulated earn-out payments of up to $85 million. The contingent earn-out liability was measured using a Monte Carlo simulation and the primary assumption used is the estimated likelihood the customer specific revenue is earned. The contingent earn-out liability estimate represents a recurring fair value measurement with significant unobservable inputs, considered to be Level 3 measurements under the fair value hierarchy. The fair value of the contingent earn-out liability at the acquisition date was $40 million.

The fair value of the contingent earn-out liability is sensitive to changes in the interest rates, discount rates and the timing of the future payments, which are based upon estimates of future achievement of the customer specific revenue. Changes in the fair value of the contingent earn-out liability will be recognized in "Sundry income (expense), net" in the Consolidated Statements of Operations. As of December 31, 2024, the fair value of the contingent earn-out liability was $40 million, reflected in “Other noncurrent obligations” on the Consolidated Balance Sheets.

The Company evaluated the disclosure requirements under ASC 805, Business Combinations and determined Donatelle Plastics was not considered a material business combination for purposes of disclosing either the earnings of Donatelle Plastics since the date of acquisition or supplemental pro forma information.
Spectrum Acquisition
On August 1, 2023, the Company completed the previously announced acquisition of Spectrum Plastics Group (“Spectrum”) from AEA Investors (the “Spectrum Acquisition”). Spectrum manufactures flexible packaging products, plastic and silicone extrusions, and components for the global industrial, food and medical business sectors. Spectrum is part of the Electronics & Industrial segment. The net purchase price was approximately $1,781 million, including a net upward adjustment of approximately $43 million for acquired cash and net working capital, among other items. The Company accounted for the acquisition in accordance with ASC 805, which requires the assets acquired and liabilities assumed to be recognized on the balance sheet at their fair values as of the acquisition date.

The purchase accounting and purchase price allocation for Spectrum are complete as of December 31, 2024. In the third quarter 2024, the Company finalized the working capital settlements for an immaterial amount which impacted the residual goodwill recorded. The Company has finalized the fair values allocated to the assets acquired and liabilities assumed and the purchase allocation is considered final. Final determination of the fair values are presented in the following table:
Spectrum Assets Acquired and Liabilities Assumed on August 1, 2023
In millions
Fair value of assets acquired
Cash and cash equivalents$31 
Accounts and notes receivable68 
Inventories52 
Property, plant and equipment125 
Other intangible assets916 
Deferred charges and other assets34 
Total Assets Acquired$1,226 
Fair value of liabilities assumed
Accounts payable$21 
Income taxes payable17 
Deferred income tax liabilities177 
Other noncurrent liabilities44 
Total Liabilities Assumed$259 
Goodwill814 
Total Consideration$1,781 

The significant fair value adjustments included in the allocation of purchase price are discussed below.

Other Intangible Assets
Other intangible assets with definite lives include acquired customer-related intangible assets of $772 million, developed technology of $126 million and trademark/tradename of $18 million. Acquired customer-related intangible assets, developed technology, and trademark/tradename have useful lives of 20 years, 15 years, and 5 years, respectively. The customer-related intangible assets' fair value was determined using the multi-period excess earnings method while the developed technology and trademark/tradename fair values were determined utilizing the relief from royalty method. The determination and allocation of fair value of other intangibles assets assumed is based on various assumptions and valuation methodologies requiring considerable management judgment, including estimates based on historical information, current market data and future expectations.

Goodwill
The excess of the consideration for Spectrum over the net fair value of assets acquired and liabilities assumed resulted in the recognition of $814 million of goodwill, which has been assigned to the Electronics & Industrial segment. Goodwill is primarily attributable to the optimization of the combined Electronics & Industrial segment and Spectrum businesses’ global activities across sales and manufacturing, as well as expected future customer relationships. Spectrum goodwill will not be deductible for U.S. tax purposes.

The Company evaluated the disclosure requirements under ASC 805 and determined Spectrum was not considered a material business combination for purposes of disclosing the earnings of Spectrum since the date of acquisition or supplemental pro forma information.
Terminated Intended Rogers Corporation Acquisition
On November 1, 2022, the Company announced the termination of the agreement to acquire all the outstanding shares of Rogers Corporation (“Rogers”) for about $5.2 billion, as DuPont and Rogers were unable to obtain timely clearance from all the required regulators ("Terminated Intended Rogers Corporation Acquisition"). DuPont paid Rogers a termination fee of $162.5 million in accordance with the agreement on November 2, 2022. The termination fee was recognized as a charge in the fourth quarter of 2022 and recorded in the "Acquisition, integration and separation costs" within the Consolidated Statements of Operations.

Acquisition, Integration and Separation Costs
Acquisition, integration and separation costs primarily consist of financial advisory, information technology, legal, accounting, consulting, other professional advisory fees and other contractual transaction payments. For the year ended December 31, 2024, these costs were primarily related to the Previously Intended Business Separations and the Intended Electronics Separation. For the year ended December 31, 2023, these costs were primarily related to the Spectrum Acquisition. Comparatively, for the year ended December 31, 2022, these costs were associated with the Terminated Intended Rogers Corporation Acquisition, including the $162.5 million termination fee, the divestiture of the Biomaterials business unit and the prior year acquisition of Laird PM.

These costs are recorded within "Acquisition, integration and separation costs" within the Consolidated Statements of Operations.
(In millions) For the years ended December 31, 202420232022
Acquisition, integration and separation costs$168 $20 $193 
v3.25.0.1
DIVESTITURES
 12 Months Ended
Dec. 31, 2024
Discontinued Operations and Disposal Groups [Abstract]  
DIVESTITURES DIVESTITURES
Mobility & Materials Divestitures
On November 1, 2022, (the "Transaction Date") DuPont completed the previously announced divestiture of the majority of the historic Mobility & Materials segment, including the Engineering Polymers business line and select product lines within the Advanced Solutions and Performance Resins business lines (the “M&M Divestiture”). The Company had previously entered into a Transaction Agreement (the "Transaction Agreement") with Celanese Corporation ("Celanese") on February 17, 2022, for consideration of $11.0 billion. Cash received on the Transaction Date, as adjusted for preliminary and other adjustments, was $11.0 billion. These adjustments include approximately $500 million of cash transferred with the M&M Divestiture business for which DuPont was reimbursed at closing resulting in net proceeds of $10.5 billion.

The Company also announced on February 18, 2022, that its Board of Directors approved the divestiture of the Delrin® acetal homopolymer (H-POM) business, subject to entry into a definitive agreement and satisfaction of customary closing conditions, (the Delrin® business together with the M&M Divestiture businesses, the "M&M Businesses”). On November 1, 2023, the Company closed the sale of the Delrin® business to TJC LP ("TJC"), (the “Delrin® Divestiture”). DuPont received cash proceeds of approximately $1.28 billion, which includes certain customary transaction adjustments, a note receivable in the amount of $350 million and acquired a 19.9 percent non-controlling equity interest in Derby Group Holdings LLC, (“Derby”). The customary transaction adjustments primarily relate to $27 million of cash transferred with the Delrin® Divestiture for which DuPont was reimbursed at closing resulting in net cash proceeds of $1.25 billion. TJC, through its subsidiaries, holds the 80.1 percent controlling interest in Derby. The Company accounts for its equity interest in Derby as an equity method investment based upon its non-controlling equity interest, its $350 million intra-entity note receivable owed by an indirect, wholly owned subsidiary of Derby and its representation on the Derby board of directors. The note receivable has a maturity date of November 2031. The Company has limited continuing involvement with Derby including short term transition service agreements and insignificant sales to the Delrin® business.

As a result of the Delrin® Divestiture, and included as part of the $419 million gain on the sale, the Company initially recognized the 19.9 percent equity interest and the $350 million note receivable at fair values of $121 million and $224 million, respectively, which are recorded in "Investments and noncurrent receivables" in the Consolidated Balance Sheets. The fair value of the equity interest was determined using the enterprise value based on sales proceeds and a market approach primarily based on restricted stock studies. The fair value of the note receivable was determined using a market approach primarily based on current market interest rates for similar credit facilities and the duration of the note.

The Company determined the sales of the M&M Businesses represent a strategic shift that has a major effect on the Company’s operations and results. For the years ended December 31, 2023 and 2022 the Company recognized an after-tax gain of $480 million and $5 billion, respectively, recorded in "(Loss) income from discontinued operations, net of tax" in the Company's Consolidated Statement Operations. For the year ended December 31, 2023, $419 million is related to the gain on the sale of Delrin®, which is included in the Consolidated Statements of Cash Flows. The results of operations of the M&M Businesses are presented as discontinued operations as summarized below for all periods. The M&M Divestiture is reflected through the Transaction Date and the Delrin® Divestiture is reflected through November 1, 2023:
For the Years Ended December 31,
In millions20232022
Net sales$460 $3,532 
Cost of sales295 2,712 
Research and development expenses3 46 
Selling, general and administrative expenses2 127 
Amortization of intangibles— 28 
Acquisition, integration and separation costs 1
195 555 
Equity in earnings of nonconsolidated affiliates— (9)
Sundry income (expense) - net9 4 
(Loss) income from discontinued operations before income taxes$(26)$59 
Provision for income taxes on discontinued operations31 128 
(Loss) income from discontinued operations, net of tax$(57)$(69)
Net (loss) income from discontinued operations attributable to noncontrolling interests— (4)
Gain on sale, net of tax 2
480 5,024 
Income from discontinued operations attributable to DuPont stockholders, net of tax$423 $4,959 
1. Includes costs related to the M&M Divestitures for all periods presented.
2. Gain includes purchase price adjustments related to the M&M Divestitures in 2023.
During the first quarter of 2022 after meeting the criteria to be classified as held for sale, the Company performed impairment analyses and allocated goodwill to the M&M Divestiture and Delrin® disposal groups and no impairments were identified. Refer to Note 14 for additional information. During each reporting period that the M&M Divestiture and Delrin® disposal groups were classified as held for sale, the Company assessed whether the fair value less cost to sell were less than the carrying value of each disposal group.

Pursuant to the Transaction Agreement, liabilities and assets related to the M&M Divestiture could not be directly assumed by Celanese and as a result, transferred by way of indemnification between both parties. In addition, pursuant to the Transaction Agreement, DuPont indemnifies Celanese against certain litigation, environmental, workers' compensation and other liabilities that arose prior to the transaction.

Other Discontinued Operations Activity
The Company recorded a loss from discontinued operations, net of tax, of $40 million and $71 million for the years ended December 31, 2024 and 2023, respectively, and income from discontinued operations of $4,856 million for the year ended December 31, 2022.

Discontinued operations activity consists of the following:
For the Years Ended December 31,
In millions202420232022
M&M Divestitures 1
$(27)$423 $4,955 
MOU Activity 2
(36)(426)(74)
Indemnification activity - environmental and legal 3
(24)(50)— 
Tax related matters 4
57 — — 
Other(10)(18)(25)
(Loss) income from discontinued operations, net of tax$(40)$(71)$4,856 
1.The year ended December 31, 2024 primarily includes separation costs and purchase price adjustments.
2.Includes the activity subject to the binding Memorandum of Understanding (“MOU”) between Chemours, Corteva Inc ("Corteva"), E. I. du Pont de Nemours and Company ("EIDP") and the Company. The year ended December 31, 2023 includes a charge related to the Water District Settlement Agreement, as defined in Note 16.
3.Primarily related to the DWDP Separation and Distribution Agreement and Letter Agreement between Corteva and EIDP. For additional information on these matters, refer to Note 16.
4.The year ended December 31, 2024 includes tax indemnification activity associated with divested businesses.

Biomaterials
In May 2022, the Company completed the sale of its Biomaterials business unit, which included the Company's equity method investment in DuPont Tate & Lyle Bio Products, to the Huafon Group. Total consideration received related to the sale was approximately $240 million. For the year ended December 31, 2022, a pre-tax gain of $26 million ($21 million net of tax) was recorded in "Sundry income (expense) - net" in the Company's Consolidated Statements of Operations. For the year ended December 31, 2022, the results of operations of the Biomaterials business unit are reported in Corporate & Other.
v3.25.0.1
REVENUE
 12 Months Ended
Dec. 31, 2024
Revenue from Contract with Customer [Abstract]  
REVENUE REVENUE
Revenue Recognition
Products
Substantially all of DuPont's revenue is derived from product sales. Product sales consist of sales of DuPont's products to supply manufacturers and distributors. DuPont considers purchase orders, which in some cases are governed by master supply agreements, to be a contract with a customer. Contracts with customers are considered to be short-term when the time between order confirmation and satisfaction of the performance obligations is equal to or less than one year.

Revenue from product sales is recognized when the customer obtains control of the Company’s product, which occurs at a point in time, usually upon shipment, with payment terms typically in the range of 30 to 60 days after invoicing depending on business and geographic region. The Company elected the practical expedient to not adjust the amount of consideration for the effects of a significant financing component for all instances in which the period between payment and transfer of the goods will be one year or less. When the Company performs shipping and handling activities after the transfer of control to the customer (e.g., when control transfers prior to shipment), these are considered fulfillment activities, and accordingly, the costs are accrued when the related revenue is recognized. Taxes collected from customers relating to product sales and remitted to governmental authorities are excluded from revenues. The Company elected to use the practical expedient to expense cash and non-cash sales incentives as the amortization period for the costs to obtain the contract would have been one year or less.
The transaction price includes estimates for reductions in revenue from customer rebates and rights of return on product sales. These amounts are estimated based upon the most likely amount of consideration to which the customer will be entitled. All estimates are based on historical experience, anticipated performance, and the Company’s best judgment at the time to the extent it is probable, that a significant reversal of revenue recognized will not occur. All estimates for variable consideration are reassessed periodically.

For contracts with multiple performance obligations, the Company allocates the transaction price to each performance obligation based on the relative standalone selling price. The standalone selling price is the observable price which depicts the price as if sold to a similar customer in similar circumstances.

Disaggregation of Revenue
The Company disaggregates its revenue from contracts with customers by segment and business or major product line and geographic region, as the Company believes it best depicts the nature, amount, timing and uncertainty of its revenue and cash flows. Refer to Note 23 for the breakout of net sales by geographic region.

Effective as of January 1, 2024, Electronics & Industrial realigned certain product lines that comprise its business units (Industrial Solutions, Interconnect Solutions and Semiconductor Technologies) that are intended to optimize business operations across the segment leading to enhanced value for customers and cost savings. The Net Trade Revenue table below has been recast for all periods presented to reflect the new structure. There was no change to total Electronics & Industrial segment net sales.
Net Trade Revenue202420232022
(In millions) For the years ended December 31,
Industrial Solutions$1,922 $1,756 $1,633 
Interconnect Solutions1,822 1,688 2,045 
Semiconductor Technologies2,186 1,893 2,239 
Electronics & Industrial$5,930 $5,337 $5,917 
Safety Solutions$2,375 $2,519 $2,649 
Shelter Solutions1,640 1,655 1,815 
Water Solutions1,408 1,459 1,493 
Water & Protection$5,423 $5,633 $5,957 
Retained Businesses 1
$1,033 $1,098 $1,067 
Other 2
— — 76 
Corporate & Other$1,033 $1,098 $1,143 
Total$12,386 $12,068 $13,017 
1.Net sales reflected in Retained Businesses includes the Auto Adhesives & Fluids, MultibaseTM and Tedlar® businesses.
2.Net sales reflected in Other includes activity of the previously divested Biomaterials business.

Contract Balances
From time to time, the Company enters into arrangements in which it receives payments from customers based upon contractual billing schedules. The Company records accounts receivables when the right to consideration becomes unconditional. Contract liabilities primarily reflect deferred revenue from advance payment for product that the Company has received from customers. The Company classifies deferred revenue as current or noncurrent based on the timing of when the Company expects to recognize revenue.

Revenue recognized for the years ended December 31, 2024 and 2023 from amounts included in contract liabilities at the beginning of the period was insignificant. The Company did not recognize any asset impairment charges related to contract assets during the period.
Contract BalancesDecember 31, 2024December 31, 2023
In millions
Accounts receivable - trade 1
$1,561 $1,543 
Deferred revenue - current 2
$2 $1 
Deferred revenue - non-current 3
$36 $22 
1.Included in "Accounts and notes receivable - net" in the Consolidated Balance Sheets.
2.Included in "Accrued and other current liabilities" in the Consolidated Balance Sheets.
3.Included in "Other noncurrent obligations" in the Consolidated Balance Sheets.
v3.25.0.1
RESTRUCTURING AND ASSET RELATED CHARGES - NET
 12 Months Ended
Dec. 31, 2024
Restructuring and Related Activities [Abstract]  
RESTRUCTURING AND ASSET RELATED CHARGES - NET RESTRUCTURING AND ASSET RELATED CHARGES - NET
The Company records restructuring liabilities that represent nonrecurring charges in connection with simplifying certain organizational structures and operations, including operations related to transformational projects such as divestitures and acquisitions. Charges for restructuring programs and asset related charges, which includes asset impairments, were $87 million, $146 million and $155 million for the years ended December 31, 2024, 2023 and 2022, respectively. These charges were recorded in "Restructuring and asset related charges - net" in the Consolidated Statements of Operations. The total liability related to restructuring programs was $48 million and $107 million at December 31, 2024 and December 31, 2023, respectively, recorded in "Accrued and other current liabilities" in the Consolidated Balance Sheets. Inventory write-offs associated with restructuring programs are recorded to "Cost of Sales” in the Consolidated Statements of Operations. Restructuring activity consists of the following programs:

2023-2024 Restructuring Program
In December 2023, the Company approved targeted restructuring actions to capture near-term cost reductions due to macroeconomic factors as well as to further simplify certain organizational structures following the Spectrum acquisition and Delrin® Divestiture (the "2023-2024 Restructuring Program"). DuPont recorded a pre-tax charge related to the 2023-2024 Restructuring Program in the amount of $199 million, inception to date, comprised of $114 million of severance and related benefit costs and asset related charges of $85 million. In connection with the 2023-2024 Restructuring Program, the Company recorded $25 million of net inventory write-offs in “Cost of Sales” within the Consolidated Statements of Operations for the year ended December 31, 2024. The inventory write-offs are related to plant line closures within the Water & Protection segment. A raw material was written down to salvage value as it was only utilizable on the closed lines which were based on outdated technology and has a limited third party resale market. Refer to Note 23 for significant items by segment.

The following table summarizes the charges incurred by segment related to the 2023-2024 Restructuring Program:
2023-2024 Restructuring Program Charges by Segment20242023
(In millions) For the Year Ended December 31,
Electronics & Industrial$2 $21 
Water & Protection50 57 
Corporate & Other37 32 
Total$89 $110 
The following table summarizes the activities related to the 2023-2024 Restructuring Program:
2023-2024 Restructuring ProgramSeverance and Related Benefit CostAsset Related ChargesTotal
In millions
Reserve balance at December 31, 2022$— $— $— 
Restructuring charges80 30 110 
Reductions against the reserve(1)(30)(31)
Reserve balance at December 31, 2023$79 $— $79 
Restructuring charges34 55 89 
Reductions against the reserve(3)(55)(58)
Cash payments(63)— (63)
Reserve balance at December 31, 2024$47 $— $47 

At December 31, 2024 and 2023, total liabilities related to the 2023-2024 Restructuring Program were $47 million and $79 million, respectively, for severance and related benefit costs, recognized in "Accrued and other current liabilities" in the Consolidated Balance Sheets. Actions related to the 2023-2024 Restructuring Program are substantially complete.

2022 Restructuring Program
In October 2022, the Company approved targeted restructuring actions to capture near-term cost reductions and to further simplify certain organizational structures following the M&M Divestitures (the "2022 Restructuring Program"). The Company recorded a pre-tax charge related to the 2022 Restructuring Program in the amount of $94 million inception-to-date, comprised of $80 million of severance and related benefit costs and asset related charges of $14 million. The Company recorded pre-tax restructuring benefits of $2 million and charges of $35 million for the years ended December 31, 2024 and 2023, respectively.
The following table summarizes the charges incurred by segment related to the 2022 Restructuring Program:
2022 Restructuring Program Charges by Segment202420232022
(In millions) For the years ended December 31,
Electronics & Industrial$3 $29 $23 
Water & Protection— (2)16 
Corporate & Other(5)8 22 
Total$(2)$35 $61 
At December 31, 2024 and 2023, total liabilities related to the 2022 Restructuring Program were $1 million and $27 million for severance and related benefit costs, recognized in "Accrued and other current liabilities" in the Consolidated Balance Sheets. Actions related to the 2022 Restructuring Program are substantially complete.

Equity Method Investment Impairment Related Charges
In connection with the M&M Divestitures, in the first quarter of 2022 a portion of an equity method investment was reclassified to “Assets of discontinued operations” within the Consolidated Balance Sheets. The reclassification served as a triggering event requiring the Company to perform an impairment analysis on the retained portion of the equity method investment held within “Investments and noncurrent receivables” on the Consolidated Balance Sheets. The fair value of the retained equity method investment was estimated using a discounted cash flow model (a form of the income approach). The Company's assumptions in estimating fair value utilize Level 3 inputs and include projected revenue growth, gross margins, EBITDA margins, weighted average costs of capital, and terminal growth rates. The Company determined the fair value of the retained equity method investment was below the carrying value and had no expectation the fair value would recover in the short-term due to the current economic environment. As a result, the Company concluded the impairment was other-than-temporary and, in March 2022, recorded a pre-tax impairment charge of $94 million ($65 million net of tax) in “Restructuring and asset related charges - net” in the Consolidated Statements of Operations for the year ended December 31, 2022 related to the Electronics & Industrial segment. No impairment was required to be recorded for the portion of the equity method investment previously included within “Assets of discontinued operations.”
v3.25.0.1
SUPPLEMENTARY INFORMATION
 12 Months Ended
Dec. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
SUPPLEMENTARY INFORMATION SUPPLEMENTARY INFORMATION
Sundry Income (Expense) - Net
(In millions) For the years ended December 31,202420232022
Non-operating pension and other post-employment benefit ("OPEB") credits (costs)$18 $(9)$28 
Interest income 1, 2
73 155 50 
Net gain on divestiture and sales of other assets and investments 3, 4, 5
20 19 78 
Foreign exchange gains (losses), net3 (73)15 
Loss on debt extinguishment 6
(74)— — 
Interest rate swap mark-to-market loss 7
(138)— — 
Miscellaneous income (expenses) - net22 10 20 
Sundry income (expense) - net$(76)$102 $191 
1.The years ended December 31, 2024 and 2023 include non-cash interest income of $26 million and $4 million, respectively, related to the $350 million Delrin® related party note receivable. Refer to Note 4 for additional information.
2.The year ended December 31, 2023 includes interest on cash and marketable securities. Fluctuations in interest income are due to changes in cash balances and/or changes in interest rates.
3.The year ended December 31, 2024 primarily reflects income related to gains on sale of intellectual property.
4.The year ended December 31, 2023 primarily reflects income related to a land sale within the Water & Protection segment and gain adjustments from previously divested businesses.
5.The year ended December 31, 2022 primarily reflects income of $26 million related to the gain on sale of the Biomaterials business unit and income of $37 million related to the sale of a land use right within the Water & Protection segment.
6.Reflects the loss on the partial redemption of an aggregate principal amount of the 2038 Notes. Refer to Note 15 for further details.
7.Includes the mark-to-market loss related to the 2022 Swaps and 2024 Swaps. Refer to Note 21 for further details.

Cash, Cash Equivalents and Restricted Cash
At December 31, 2024 and 2023, the Company had restricted cash of $6 million and $411 million, respectively, within “Restricted cash and cash equivalents” in the Consolidated Balance Sheets. At December 31, 2024, the Company also had $36 million, within "Restricted cash and cash equivalents - noncurrent", which is related to the MOU escrow account deposits. During the second quarter 2024, the judgment related to the Water District Settlement Fund became final and therefore $408 million was removed from "Restricted cash and cash equivalents”. Additional information can be found in Note 16.

Accrued and Other Current Liabilities
"Accrued and other current liabilities" in the Consolidated Balance Sheets were $1,031 million at December 31, 2024 and $1,269 million at December 31, 2023. "Accrued and other current liabilities" at December 31, 2023 includes approximately $405 million related to a settlement agreement further discussed in Note 16. Accrued payroll, which is a component of "Accrued and other current liabilities" was $383 million at December 31, 2024 and $250 million at December 31, 2023. No other component of "Accrued and other current liabilities" was more than five percent of total current liabilities at December 31, 2024 and 2023.
v3.25.0.1
INCOME TAXES
 12 Months Ended
Dec. 31, 2024
Income Tax Disclosure [Abstract]  
INCOME TAXES INCOME TAXES
Geographic Allocation of Income (Loss) and Provision for (Benefit from) Income Taxes 202420232022
(In millions) For the years ended December 31,
(Loss) income from continuing operations before income taxes
Domestic$(505)$(695)$(308)
Foreign1,697 1,199 1,756 
Income from continuing operations before income taxes$1,192 $504 $1,448 
Current tax expense
Federal$148 $80 $211 
State and local16 9 7 
Foreign 389 246 373 
Total current tax expense$553 $335 $591 
Deferred tax (benefit) expense
Federal $(141)$(24)$(191)
State and local(31)(27)(16)
Foreign 33 (313)3 
Total deferred tax benefit$(139)$(364)$(204)
Provision for (benefit from) income taxes on continuing operations414 (29)387 
Net income from continuing operations$778 $533 $1,061 

Reconciliation to U.S. Statutory Rate202420232022
(In millions) For the years ended December 31,
Statutory U.S. federal income tax rate21.0 %21.0 %21.0 %
Equity earning effect(0.4)(1.2)0.2 
Foreign income taxed at rates other than the statutory U.S. federal income tax rate2.8 4.9 (3.9)
U.S. tax effect of foreign earnings and dividends4.6 13.0 5.0 
Unrecognized tax benefits(0.1)(0.1)1.0 
Acquisitions, divestitures and ownership restructuring activities 1
9.0 (64.4)2.5 
Exchange gains/losses 2
1.5 (1.1)0.4 
State and local income taxes(0.6)(2.8)0.2 
Change in valuation allowance0.5 — — 
Goodwill impairments — 33.5 — 
Stock-based compensation0.2 (1.0)(0.2)
Foreign-derived intangible income (FDII)(1.9)(6.0)(2.0)
Other - net(1.9)(1.6)2.5 
Effective tax rate34.7 %(5.8)%26.7 %
1.Includes a tax expense of $103 million and a tax benefit of $324 million in connection with internal restructurings involving foreign subsidiaries for the years ended December 31, 2024 and 2023, respectively.
2. Principally reflects the impact of foreign exchange gains and losses on net monetary assets for which no corresponding tax impact is realized.
Deferred Tax Balances at December 31,20242023
(In millions)
Deferred tax assets:
Tax losses and credit carryforwards 1
$800 $870 
Lease liability 98 116 
Pension and postretirement benefit obligations98 46 
Other accruals and reserves124 131 
Research and development268 218 
Inventory7 16 
Other – net254 202 
Gross deferred tax assets$1,649 $1,599 
Valuation allowances 1
(772)(738)
Total deferred tax assets$877 $861 
Deferred tax liabilities:
Investments(176)(204)
Unrealized exchange losses, net(36)(17)
Operating lease asset(98)(116)
Property(360)(343)
Intangibles(876)(999)
Total deferred tax liabilities$(1,546)$(1,679)
Total net deferred tax liability$(669)$(818)
1.Primarily related to recorded tax benefits and the non-realizability of tax losses and credit carryforwards from operations in the United States, Europe and Asia Pacific.

Included in the 2024 and 2023 deferred tax asset and liability amounts above is $356 million and $410 million, respectively, of a net deferred tax liability related to the Company’s investment in DuPont Specialty Products USA, LLC, which is a partnership for U.S. federal income tax purposes. The Company and its subsidiaries own in aggregate 100 percent of DuPont Specialty Products USA, LLC and the assets and liabilities of DuPont Specialty Products USA, LLC are included in the Consolidated Financial Statements of the Company.
Operating Loss and Tax Credit CarryforwardsDeferred Tax Asset
(In millions) As of December 31,20242023
Operating loss carryforwards
Expire within 5 years$5 $40 
Expire after 5 years or indefinite expiration617 624 
Total operating loss carryforwards$622 $664 
Tax credit carryforwards
Expire within 5 years$40 $37 
Expire after 5 years or indefinite expiration138 169 
Total tax credit carryforwards$178 $206 
Total Operating Loss and Tax Credit Carryforwards$800 $870 
Total Gross Unrecognized Tax Benefits202420232022
(In millions)
Total unrecognized tax benefits at January 1,$473 $470 $351 
Decreases related to positions taken on items from prior years(32)(4)(4)
Increases related to positions taken on items from prior years17 3 4 
Increases related to positions taken in the current year5 18 164 
Settlement of uncertain tax positions with tax authorities(21)(10)(10)
Decreases due to expiration of statutes of limitations(5)(9)— 
Exchange (gain) loss(9)5 (9)
Divestiture of M&M— — (26)
Total unrecognized tax benefits at December 31, 1
$428 $473 $470 
Total unrecognized tax benefits that, if recognized, would impact the effective tax rate of continuing operations $284 $329 $338 
Total amount of interest and penalties (benefit) recognized in "Provision for (benefit from) income taxes on continuing operations"$7 $8 $3 
Total accrual for interest and penalties associated with unrecognized tax benefits$43 $28 $16 
1.Total unrecognized tax benefits includes $140 million, $141 million and $128 million of benefits related to discontinued operations at December 31, 2024, 2023 and 2022.

Each year the Company files hundreds of tax returns in the various national, state and local income taxing jurisdictions in which it operates. These tax returns are subject to examination and possible challenge by the tax authorities. The Company has ongoing federal, state and international income tax audits in various jurisdictions and evaluates uncertain tax positions that may be challenged by local tax authorities. The impact, if any, of these audits to the Company’s unrecognized tax benefits is not estimable. Positions challenged by the tax authorities may be settled or appealed by the Company. As a result, there is an uncertainty in income taxes recognized in the Company’s financial statements in accordance with accounting for income taxes and accounting for uncertainty in income taxes. The ultimate resolution of such uncertainties is not expected to have a material impact on the Company's results of operations.

Tax years that remain subject to examination for the Company’s major tax jurisdictions are shown below:
Tax Years Subject to Examination by Major Tax Jurisdiction at December 31, 2024
Earliest Open Year
Jurisdiction
Brazil2019
Canada2017
China2014
Denmark2020
Germany2019
Japan2018
The Netherlands2019
Switzerland2019
United States:
Federal income tax 1
2012
State and local income tax2012
1. The U.S. Federal income tax jurisdiction is open back to 2012 with respect to EIDP pursuant to the DWDP Tax Matters Agreement.

Undistributed earnings of foreign subsidiaries and related companies that are deemed to be permanently invested amounted to $7,024 million as of December 31, 2024. In addition to the U.S. federal tax imposed by the Tax Cuts and Jobs Act ("The Act") on all accumulated unrepatriated earnings through December 31, 2017, The Act introduced additional U.S. federal tax on foreign earnings, effective as of January 1, 2018. The undistributed foreign earnings at December 31, 2024 may still be subject to certain taxes upon repatriation, primarily where foreign withholding taxes apply. It is not practicable to calculate the unrecognized deferred tax liability on undistributed foreign earnings due to the complexity of the hypothetical calculation.
Intended Electronics Separation
The Company is assessing the tax consequences of the Intended Electronics Separation, which if implemented may result in certain tax attributes being realized. The Company recorded income tax expense of $103 million for the year ended December 31, 2024, in connection with certain internal restructurings related to the Intended Electronics Separation. These restructurings in certain instances relied upon legal entity and asset valuations. The aforementioned tax expense is included in “Provision for (benefit from) income taxes on continuing operations” in the Consolidated Statements of Operations.

2023 Internal Restructurings
The Company recorded a deferred tax benefit of $324 million for the year ended December 31, 2023, in connection with certain internal restructurings. These restructurings in certain instances relied upon legal entity and asset valuations. The aforementioned tax benefit is included in “Provision for (benefit from) income taxes on continuing operations” in the Consolidated Statements of Operations.

M&M Divestitures
The Company recorded a net tax expense of $21 million and $127 million for the year ended December 31, 2023 and 2022, respectively, in connection with certain internal restructurings. These restructurings involve both legal entities within the M&M Businesses and legal entities retained by DuPont and in certain instances relied upon legal entity valuations. The aforementioned net tax expense is included in “Income from discontinued operations, net of tax” in the Consolidated Statements of Operations. See Note 4 for additional information on the M&M Divestitures.

Laird PM Acquisition
In connection with the integration of Laird PM, the Company completed certain internal restructurings that were determined to be tax free under the applicable sections of the Internal Revenue Code. If the aforementioned transactions were to fail to qualify for non-recognition treatment for U.S. federal income tax purposes, then the Company could be subject to significant tax liability.

N&B Transaction
Certain internal distributions and reorganizations that occurred during 2021 and 2020 in preparation for the N&B Transaction and the external distribution in 2021 qualified as tax-free transactions under the applicable sections of the Internal Revenue Code. If the aforementioned transactions were to fail to qualify for non-recognition treatment for U.S. federal income tax purposes, then the Company could be subject to significant tax liability. Under the N&B Tax Matters Agreement, the Company would generally be allocated such liability and not be indemnified, unless certain non qualifying actions are undertaken by N&B or IFF. To the extent that the Company is responsible for any such liability, there could be a material adverse impact on the Company's business, financial condition, results of operations and cash flows in future reporting periods.

DWDP
For periods between the DWDP Merger and the DWDP Distributions, DuPont's consolidated federal income tax group and consolidated tax return included the Dow and Corteva entities. Generally, the consolidated tax liability of the DuPont U.S. tax group for each year was apportioned among the members of the consolidated group in accordance with the terms of the Amended and Restated DWDP Tax Matters Agreement. DuPont, Corteva and Dow intend that to the extent Federal and/or State corporate income tax liabilities are reduced through the utilization of tax attributes of the other, settlement of any receivable and payable generated from the use of the other party’s sub-group attributes will be in accordance with the Amended and Restated DWDP Tax Matters Agreement.
v3.25.0.1
EARNINGS PER SHARE CALCULATIONS
 12 Months Ended
Dec. 31, 2024
Earnings Per Share [Abstract]  
EARNINGS PER SHARE CALCULATIONS EARNINGS PER SHARE CALCULATIONS
The following tables provide earnings per share calculations for the years ended December 31, 2024, 2023 and 2022:
Net Income for Earnings Per Share Calculations - Basic & Diluted
In millions
202420232022
Income from continuing operations, net of tax$778 $533 $1,061 
Net income from continuing operations attributable to noncontrolling interests35 39 53 
Income from continuing operations attributable to common stockholders$743 $494 $1,008 
(Loss) income from discontinued operations, net of tax(40)(71)4,856 
Net loss from discontinued operations attributable to noncontrolling interests— — (4)
(Loss) income from discontinued operations attributable to common stockholders(40)(71)4,860 
Net income available to common stockholders$703 $423 $5,868 
Earnings Per Share Calculations - Basic
Dollars per share
202420232022
Earnings from continuing operations attributable to common stockholders$1.77 $1.10 $2.02 
(Loss) earnings from discontinued operations, net of tax(0.10)(0.16)9.75 
Earnings available to common stockholders 1
$1.68 $0.94 $11.77 
Earnings Per Share Calculations - Diluted
Dollars per share
202420232022
Earnings from continuing operations attributable to common stockholders$1.77 $1.09 $2.02 
(Loss) earnings from discontinued operations, net of tax(0.10)(0.16)9.73 
Earnings available to common stockholders 1
$1.67 $0.94 $11.75 
Share Count Information
Shares in Millions
202420232022
Weighted-average common shares - basic419.2 449.9 498.5 
Plus dilutive effect of equity compensation plans1.4 1.3 0.9 
Weighted-average common shares - diluted420.6 451.2 499.4 
Stock options, restricted stock units, and performance-based restricted stock units excluded from EPS calculations 2
1.1 2.6 4.1 
1. Earnings per share amounts are computed independently for income from continuing operations, income from discontinued operations and net income attributable to common stockholders. As a result, the per share amounts from continuing operations and discontinued operations may not equal the total per share amounts for net income attributable to common stockholders.
2. These outstanding options to purchase shares of common stock, restricted stock units and performance based restricted stock units were excluded from the calculation of diluted earnings per share because the effect of including them would have been antidilutive.
v3.25.0.1
ACCOUNTS AND NOTES RECEIVABLE - NET
 12 Months Ended
Dec. 31, 2024
Receivables [Abstract]  
ACCOUNTS AND NOTES RECEIVABLE - NET ACCOUNTS AND NOTES RECEIVABLE - NET
In millionsDecember 31, 2024December 31, 2023
Accounts receivable – trade 1
$1,534 $1,513 
Income tax receivable81 301 
Other 2
584 556 
Total accounts and notes receivable - net$2,199 $2,370 
1.Accounts receivable – trade is net of allowances of $26 million at December 31, 2024 and $40 million at December 31, 2023. Allowances are equal to the estimated uncollectible amounts and current expected credit loss. That estimate is based on historical collection experience, current economic and market conditions, and review of the current status of customers' accounts.
2.Other includes receivables in relation to value added tax, indemnification assets, general sales tax and other taxes, and other receivables. No individual group represents more than ten percent of total receivables.
Accounts receivable are carried at amounts that approximate fair value.
v3.25.0.1
INVENTORIES
 12 Months Ended
Dec. 31, 2024
Inventory Disclosure [Abstract]  
INVENTORIES INVENTORIES
In millionsDecember 31, 2024December 31, 2023
Finished goods $1,162 $1,184 
Work in process 509 487 
Raw materials 332 350 
Supplies127 126 
Total inventories$2,130 $2,147 
v3.25.0.1
PROPERTY, PLANT AND EQUIPMENT
 12 Months Ended
Dec. 31, 2024
Property, Plant and Equipment [Abstract]  
PROPERTY, PLANT AND EQUIPMENT PROPERTY, PLANT AND EQUIPMENT
Estimated Useful Lives (Years)December 31, 2024December 31, 2023
In millions
Land and land improvements1-25$455 $449 
Buildings1-502,238 2,121 
Machinery, equipment, and other1-257,657 7,306 
Construction in progress606 849 
Total property, plant and equipment$10,956 $10,725 
Total accumulated depreciation$5,188 $4,841 
Total property, plant and equipment - net$5,768 $5,884 

In millions202420232022
Depreciation expense$599 $547 $545 
v3.25.0.1
NONCONSOLIDATED AFFILIATES
 12 Months Ended
Dec. 31, 2024
Equity Method Investments and Joint Ventures [Abstract]  
NONCONSOLIDATED AFFILIATES NONCONSOLIDATED AFFILIATES
The Company's investments in companies accounted for using the equity method ("nonconsolidated affiliates") are recorded in "Investments and other noncurrent receivables" in the Consolidated Balance Sheets. The Company's net investment in nonconsolidated affiliates at December 31, 2024 and December 31, 2023 is $778 million and $788 million, respectively. In the fourth quarter of 2023, the Company acquired an equity interest in Derby Group Holdings LLC ("Derby"). See Note 4 and below for further information. In the first quarter of 2022, the Company recorded an other-than-temporary impairment on an equity method investment. See Note 6 for more information.

The Company's dividends received from nonconsolidated affiliates is shown in the following table:
Dividends Received from Nonconsolidated Affiliates202420232022
(In millions) For the years ended December 31,
Dividends from nonconsolidated affiliates$73 $71 $103 

The Company had an ownership interest in seven nonconsolidated affiliates, with ownership interest (direct and indirect) ranging from 19.9 percent to 50 percent at December 31, 2024.

Sales to nonconsolidated affiliates represented less than 2 percent of total net sales for the years ended December 31, 2024, 2023 and 2022. Purchases from nonconsolidated affiliates represented less than 3 percent of “Cost of sales” for the years ended December 31, 2024 and 2023 and less than 4 percent for the year ended December 31, 2022.

Derby Equity Interest
As a result of the Delrin® Divestiture, on November 1, 2023, the Company received a 19.9 percent non-controlling equity interest in Derby. The financial results of Derby, subsequent to the transaction date, are included in DuPont's Consolidated Financial Statements with a three-month lag, using the equity method of accounting and with intercompany profits eliminated in accordance with DuPont’s accounting policy. DuPont's equity interest in Derby Holdings Group is reflected in Corporate & Other. For the year ended December 31, 2024, the Company recorded a loss of $7 million in "Equity in earnings of nonconsolidated affiliates" on the Consolidated Statement of Operations which includes the impact of approximately $17 million for transaction costs incurred by Derby and amortization expense from purchase accounting. The carry values of the equity interest as of December 31, 2024 and 2023, were $117 million and $121 million, respectively. The carry values of the note receivable as of December 31, 2024 and 2023, were $254 million and $228 million, respectively.

For the years ended December 31, 2024 and 2023, Company recognized non-cash interest income on the Derby Note Receivable of $26 million and $4 million, respectively, reported in "Sundry income (expense) - net" on the Consolidated Statements of Operations, and accreted to the carrying value of the note receivable.
v3.25.0.1
GOODWILL AND OTHER INTANGIBLE ASSETS
 12 Months Ended
Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
GOODWILL AND OTHER INTANGIBLE ASSETS GOODWILL AND OTHER INTANGIBLE ASSETS
The following table summarizes changes in the carrying amount of goodwill for the years ended December 31, 2024 and 2023:
Electronics & IndustrialWater & ProtectionCorporate & OtherTotal
In millions
Balance at December 31, 2022$9,397 $6,656 $610 $16,663 
Goodwill recognized for Spectrum Acquisition 1
818 — — 818 
Currency Translation Adjustment(10)48 5 43 
Impairment— (804)— (804)
Balance at December 31, 2023$10,205 $5,900 $615 $16,720 
Goodwill recognized for Donatelle Plastics Acquisition 2
114 — — 114 
Goodwill recognized for Spectrum Acquisition 1, 3
(4)— — (4)
Currency Translation Adjustment(113)(145)(9)(267)
Other4 — — 4 
Balance at December 31, 2024$10,206 $5,755 $606 $16,567 
1.On August 1, 2023, DuPont completed the acquisition of Spectrum, which is included in the Electronics & Industrial segment. See Note 3 for additional information.
2.On July 28, 2024, DuPont completed the acquisition of Donatelle Plastics, which is included in the Electronics & Industrial segment. See Note 3 for additional information.
3.In the third quarter 2024, the Company finalized the working capital settlements which impacted the residual goodwill recorded. See Note 3 for additional information.
The Company tests goodwill for impairment annually during the fourth quarter, or more frequently when events or changes in circumstances indicate that the fair value is below carrying value. As a result of the related acquisition method of accounting in connection with the DWDP Merger, EIDP’s assets and liabilities were measured at fair value resulting in increases to the Company’s goodwill and other intangible assets. The fair value valuation increased the risk that any declines in financial projections, including changes to key assumptions, could have a material, negative impact on the fair value of the Company’s reporting units and assets, and therefore could result in an impairment. The Company’s significant assumptions in these analyses include projected revenue growth, EBITDA margin, weighted average cost of capital and terminal growth rates and the tax rate for the income approach and projected EBITDA and derived multiples from comparable market transactions for the market approach.

The Company's estimates of future cash flows are based on current regulatory and economic climates, recent operating results, and planned business strategies. Should future cash flows differ materially from the Company's estimate, or should there be a future market downturn, the Company may be required to perform additional impairment analyses that could result in a non-cash goodwill impairment charge.

As part of its annual impairment test at October 1, 2024, the Company performed qualitative testing on seven of its reporting units and performed quantitative testing on one of its reporting units. The qualitative evaluation is an assessment of factors, including reporting unit or asset specific operating results and cost factors, as well as industry, market and macroeconomic conditions, to determine whether it is more likely than not (more than 50 percent) that the fair value of a reporting unit or asset is less than the respective carrying amount, including goodwill. The results of the qualitative assessments indicated that it is not more likely than not that the fair values of the seven reporting units were less than their carrying values. The Protection reporting unit (aggregation of the Safety and Shelter businesses), within the Water & Protection segment, was tested by applying the quantitative assessment. The Company used a combination of discounted cash flow models (a form of the income approach) and the Guideline Public Company Method (a form of the market approach). No impairments were identified. The estimated fair value of the Protection reporting unit, exceeded its carrying value by approximately five percent. Given this level of fair value, the reporting unit remains at risk for future impairment. Should adverse impacts from macroeconomic conditions, or other events occur indicating that the estimated future cash flows of the reporting unit have declined and the reporting unit is unable to meet or exceed its projections, the Company may be required to record future non-cash impairment charges related to goodwill. As of the date of the quantitative assessment, the carrying amount of goodwill within this reporting unit was $4.8 billion.

Effective as of January 1, 2024, Electronics & Industrial realigned certain of its product lines making up its lines of business (Industrial Solutions, Interconnect Solutions and Semiconductor Technologies). During the first quarter of 2024, the realignment of the businesses within Electronics & Industrial served as a triggering event requiring the Company to perform an impairment analysis related to goodwill carried by certain reporting units as of January 1, 2024, prior to the realignment. As part of the realignment, the Company assessed and re-defined certain reporting units effective January 1, 2024, including reallocation of goodwill on a relative fair value basis, as applicable, to reporting units impacted. Goodwill impairment analyses were then performed for reporting units impacted in the Electronics and Industrial segment and no impairments were identified. The fair value of each reporting unit tested was estimated using a combination of a discounted cash flow model and market approach. The Company’s assumptions in estimating fair value include projected revenue growth, gross margins, selling, administrative, research and development expenses (SARD), capital expenditures, weighted average cost of capital, terminal growth rates, and the tax rate for the income approach and projected EBITDA and derived multiples from comparable market transactions for the market approach.

In connection with the preparation of the full year 2023 financial statements, the continuation of previously disclosed challenging macroeconomic environment in the residential, non-residential, and the repair and remodel construction markets, as well as incremental channel inventory destocking in healthcare and industrial end-markets served as a triggering event requiring the Company to perform an impairment analysis of the goodwill associated with its Protection reporting unit as of December 31, 2023 As a result of the analysis performed, the Company concluded that the carrying amount of the Protection reporting unit exceeded its fair value resulting in a non-cash goodwill impairment charge of $804 million, which is recorded within “Goodwill impairment charge” on the Consolidated Statements of Operations for the year ended December 31, 2023.
Other Intangible Assets
The gross carrying amounts and accumulated amortization of other intangible assets by major class are as follows:
December 31, 2024December 31, 2023
In millionsGross
Carrying
Amount		Accum AmortNetGross Carrying AmountAccum AmortNet
Intangible assets with finite lives:
  Developed technology $1,975 $(1,124)$851 $2,079 $(1,092)$987 
  Trademarks/tradenames
901 (451)450 924 (414)510 
  Customer-related5,868 (2,623)3,245 5,815 (2,329)3,486 
  Other 27 (7)20 28 (1)27 
Total other intangible assets with finite lives$8,771 $(4,205)$4,566 $8,846 $(3,836)$5,010 
Intangible assets with indefinite lives:
  Trademarks/tradenames
804 — 804 804 — 804 
Total other intangible assets with indefinite lives$804 $— $804 $804 $— $804 
Total$9,575 $(4,205)$5,370 $9,650 $(3,836)$5,814 

During the fiscal year 2024, the Company retired fully amortized assets of $145 million of developed technology intangible assets and $27 million of trademarks/tradename intangible assets.

During the fiscal year 2023, the Company retired fully amortized assets of $399 million of customer-related intangible assets and $25 million of other intangible assets.

The following table provides the net carrying value of other intangible assets:
Net IntangiblesDecember 31, 2024December 31, 2023
In millions
Electronics & Industrial 1
$3,337 $3,521 
Water & Protection1,957 2,206 
Corporate & Other76 87 
Total$5,370 $5,814 
1.Includes intangible assets acquired as part of the Donatelle and Spectrum Acquisitions. See Note 3 for additional information.

Total estimated amortization expense for the next five fiscal years is as follows:
Estimated Amortization Expense
In millions
2025$555 
2026$527 
2027$480 
2028$427 
2029$337 
v3.25.0.1
SHORT-TERM BORROWINGS, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES AND OTHER OBLIGATIONS
 12 Months Ended
Dec. 31, 2024
Debt Disclosure [Abstract]  
SHORT-TERM BORROWINGS, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES AND OTHER OBLIGATIONS SHORT-TERM BORROWINGS, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES AND OTHER OBLIGATIONS
The following tables summarize the Company's short-term borrowings, long-term debt and finance lease obligations:
Short-Term BorrowingsDecember 31, 2024December 31, 2023
(In millions)
Long-term debt due within one year 1
$1,848 $— 
1.Presented net of current portion of unamortized debt issuance costs.

Long-Term DebtDecember 31, 2024
December 31, 2023
In millionsAmountWeighted Average RateAmountWeighted Average Rate
Promissory notes and debentures 1:
  Final maturity 2025$1,850 4.49 %$1,850 4.49 %
  Final maturity 20282,250 4.73 %2,250 4.73 %
  Final maturity 2030 and thereafter 2
3,102 5.47 %3,741 5.46 %
Other facilities:
Finance lease obligations9 10 
Less: Unamortized debt discount and issuance costs40 51 
Less: Long-term debt due within one year
1,848 — 
Total $5,323 $7,800 
1.Represents senior unsecured notes (the "2018 Senior Notes"), which are senior unsecured obligations of the Company.
2.Includes an unamortized basis adjustment of $48 million related to the dedesignation of the Company's interest rate swap agreements and a fair value hedging adjustment of $59 million, related to the Company's interest rate swap agreements at December 31, 2024 and 2023, respectively. See Note 21 for additional information.

In June 2024, the company partially redeemed $650 million aggregate principal amount of 2038 Notes at the redemption price set forth in the indenture of the 2038 Notes. The Company funded the repayment with cash on hand. Further details are discussed below. In November 2023, the $300 million Floating Rate Senior Unsecured Notes matured and was repaid at par plus the accrued and unpaid interest. The Company funded the repayment with cash on hand.

Principal payments of long-term debt for the five succeeding fiscal years are as follows:
Maturities of Long-Term Debt for Next Five Years at December 31, 2024
Total
In millions
2025$1,850 
2026$— 
2027$— 
2028$2,250 
2029$— 
The estimated fair value of the Company's long-term borrowings was determined using Level 2 inputs within the fair value hierarchy, as described in Note 22. Based on quoted market prices for the same or similar issues, or on current rates offered to the Company for debt of the same remaining maturities, the fair value of the Company's long-term borrowings, not including long-term debt due within one year, was $5,368 million and $7,995 million at December 31, 2024 and 2023, respectively.

Available Committed Credit Facilities
The following table summarizes the Company's credit facilities:
Committed and Available Credit Facilities at December 31, 2024
In millionsEffective DateCommitted CreditCredit AvailableMaturity DateInterest
Five-Year Revolving Credit Facility
April 2022$2,500 $2,484 April 2027Floating Rate
2024 $1B Revolving Credit Facility
May 20241,000 1,000 May 2025Floating Rate
Total Committed and Available Credit Facilities$3,500 $3,484 

In July 2022, the Company drew down $600 million under the 2022 $1B Revolving Credit Facility in order to facilitate certain intercompany internal restructurings related to the M&M Divestiture. The Company repaid the borrowing in September 2022.
Capital Structure Actions
DuPont, with its advisors, is evaluating considerations related to the design of the capital structures for the Previously Intended Business Separations and the Intended Electronics Separation. On June 5, 2024, DuPont issued a notice of redemption to the bond trustee with respect to a partial redemption of $650 million aggregate principal amount of its 2038 notes, (the "2038 Notes") in accordance with their terms. The partial redemption occurred on June 15, 2024, at the redemption price set forth in the indenture of the 2038 Notes. The Company funded the repayment with cash on hand. As a result of the early redemption of the debt for the year ended December 31, 2024, the Company incurred a loss of approximately $74 million to "Sundry income (expense) - net" within the Consolidated Statements of Operations, which consisted of the redemption premium, write-off of the deferred debt issuance costs and the basis adjustment from fair value hedge accounting on the Company's interest rate swap agreements associated with this borrowing. See Note 21 for further detail on the dedesignation of the Company's interest rate swap agreements.

Revolving Credit Facilities
On May 8, 2024, the Company entered into a $1 billion 364-day revolving credit facility (the "2024 $1B Revolving Credit Facility"). Prior to entering the new facility, the Company held another $1 billion 364-day revolving credit facility, entered into on May 10, 2023, (the "2023 364-Day Revolving Credit Facility"). There were no drawdowns of either facility during the year ended December 31, 2024. On April 12, 2022, the Company entered into a new $2.5 billion five-year revolving credit facility (the "Five-Year Revolving Credit Facility"). The Five-Year Revolving Credit Facility is generally expected to remain undrawn and serve as a backstop to the Company's commercial paper and letter of credit issuance.

Uncommitted Credit Facilities and Outstanding Letters of Credit
Unused bank credit lines on uncommitted credit facilities were approximately $650 million at December 31, 2024. These lines are available to support short-term liquidity needs and general corporate purposes including letters of credit. Outstanding letters of credit were approximately $124 million at December 31, 2024. These letters of credit support commitments made in the ordinary course of business.

Debt Covenants and Default Provisions
The Company's indenture covenants include customary limitations on liens, sale and leaseback transactions, and mergers and consolidations, subject to certain limitations. The 2018 Senior Notes also contain customary default provisions. The Five-Year Revolving Credit Facility and the 2024 $1B Revolving Credit Facility contain a financial covenant requiring that the ratio of Total Indebtedness to Total Capitalization for the Company and its consolidated subsidiaries not exceed 0.60. At December 31, 2024, the Company was in compliance with this financial covenant. There were no material changes to the debt covenants and default provisions at December 31, 2024.

Supplier Financing
The Company and certain of its designated suppliers, at their sole discretion, participate in a supplier financing program with a financial institution serving as an intermediary. Under this program, the Company agrees to pay the financial institution the stated amount of confirmed invoices from its designated suppliers on the same terms and on the original maturity dates of the confirmed invoices, which have a weighted average payment term of approximately 110 days. The Company does not pay any annual subscription or service fee to the financial institution, nor does the Company reimburse its suppliers for any costs they incur to participate in the program. The Company’s obligations are not impacted by the suppliers’ decision to participate in this program. The Company or the financial institution may terminate the agreement upon at least 30 days’ notice. The amount of invoices outstanding confirmed as valid under the supplier financing programs are shown in the table below and recorded in “Accounts Payable” in the Consolidated Balance Sheets.

The following table summarizes the outstanding obligations confirmed as valid under the supplier financing programs for the year ended December 31, 2024:
Supplier Financing Program ActivityAmount
In millions
Confirmed obligations outstanding as of January 1, 2024$97 
Invoices confirmed to financial institutions421 
Confirmed invoices paid to financial institution(413)
Foreign currency exchange impact(1)
Confirmed obligations outstanding as of December 31, 2024
$104 
v3.25.0.1
COMMITMENTS AND CONTINGENT LIABILITIES
 12 Months Ended
Dec. 31, 2024
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENT LIABILITIES COMMITMENTS AND CONTINGENT LIABILITIES
Litigation, Environmental Matters, and Indemnifications
The Company and certain subsidiaries are involved in various lawsuits, claims and environmental actions that have arisen in the normal course of business with respect to product liability, patent infringement, governmental regulation, contract and commercial litigation, as well as possible obligations to investigate and mitigate the effects on the environment of the disposal or release of certain substances at various sites. In addition, in connection with divestitures and the related transactions, the Company from time to time has indemnified and has been indemnified by third parties against certain liabilities that may arise in connection with, among other things, business activities prior to the completion of the respective transactions. The term of these indemnifications, which typically pertain to environmental, tax and product liabilities, is generally indefinite. The Company records liabilities for ongoing and indemnification matters when the information available indicates that it is probable that a liability will be incurred and the amount of the loss can be reasonably estimated.

As of December 31, 2024, the Company has recorded indemnification assets of $28 million within "Accounts and notes receivable - net" and $298 million within "Deferred charges and other assets" and indemnification liabilities of $178 million within "Accrued and other current liabilities" and $237 million within "Other noncurrent obligations" within the Consolidated Balance Sheets. As of December 31, 2023, the Company has recorded indemnified assets of $21 million within "Accounts and notes receivable - net" and $242 million within "Deferred charges and other assets" and indemnified liabilities of $200 million within "Accrued and other current liabilities" and $263 million within "Other noncurrent obligations" within the Consolidated Balance Sheets.

The Company’s accruals for indemnification liabilities related to the binding Memorandum of Understanding (“MOU”) between Chemours, Corteva, EIDP and the Company and to the DowDuPont ("DWDP") Separation and Distribution Agreement and the Letter Agreement between the Company and Corteva (together the “Agreements”) discussed below, are included in the balances above.

PFAS Stray Liabilities: Future Eligible PFAS Costs
On July 1, 2015, EIDP, a Corteva subsidiary since June 1, 2019, completed the separation of EIDP’s Performance Chemicals segment through the spin-off of Chemours to holders of EIDP common stock (the “Chemours Separation”). On June 1, 2019, the Company completed the separation of its agriculture business through the spin-off of Corteva, Inc. (“Corteva”), including Corteva’s subsidiary EIDP.

On January 22, 2021, the Company, Corteva, EIDP and Chemours entered into the MOU pursuant to which the parties have agreed to release certain claims that had been raised by Chemours including any claims arising out of or resulting from the process and manner in which EIDP structured or conducted the Chemours Separation, and any other claims that challenge the Chemours Separation or the assumption of Chemours Liabilities (as defined in the Chemours Separation Agreement) by Chemours and the allocation thereof, subject in each case to certain exceptions set forth in the MOU.

Pursuant to the MOU, the parties have agreed to share certain costs associated with potential future liabilities related to alleged historical releases of certain PFAS out of pre-July 1, 2015 conduct (“eligible PFAS costs”) until the earlier to occur of (i) December 31, 2040, (ii) the day on which the aggregate amount of Qualified Spend, as defined in the MOU, is equal to $4 billion or (iii) a termination in accordance with the terms of the MOU. PFAS refers to per- or polyfluoroalkyl substances, which include perfluorooctanoic acids and its ammonium salts (“PFOA”).

The parties have agreed that, during the term of this sharing arrangement, Qualified Spend up to $4 billion will be borne 50 percent by Chemours and 50 percent, up to a cap of $2 billion, by the Company and Corteva. The Company and Corteva will split their 50 percent of Qualified Spend in accordance with the Agreements; accordingly, the Company's portion of the $2 billion is approximately $1.4 billion. At December 31, 2024, the Company had paid Qualified Spend of approximately $605 million against its portion of the $2 billion cap. After the term of this arrangement, Chemours’ indemnification obligations under the Chemours Separation Agreement would continue unchanged.

In order to support and manage any potential future eligible PFAS costs, the parties also agreed to establish an escrow account (the "MOU Escrow Account"). The MOU provides that (1) no later than each of September 30, 2021 and September 30, 2022, Chemours shall deposit $100 million and DuPont and Corteva shall together deposit $100 million in the aggregate into the MOU Escrow Account and (2) no later than September 30 of each subsequent year through and including 2028, Chemours shall deposit $50 million and DuPont and Corteva shall together deposit $50 million in the aggregate into the MOU Escrow Account. Subject to the terms and conditions set forth in the MOU, each party may be permitted to defer funding in any calendar year beginning with 2022 through and including 2028. Additionally, if on December 31, 2028, the balance in the MOU Escrow Account (including interest) is less than $700 million, Chemours will make 50 percent of the deposits and DuPont and Corteva
together will make 50 percent of the deposits necessary to restore the balance to $700 million. Such payments will be made in a series of consecutive annual equal installments commencing on September 30, 2029 pursuant to the replenishment terms set forth in the MOU.

At December 31, 2024, each of Chemours, Corteva and DuPont have made additional deposits into the MOU Escrow Account totaling $100 million in the aggregate. DuPont's aggregate MOU escrow deposits of $35 million, not including interest, at December 31, 2024 are reflected in "Restricted cash and cash equivalents - noncurrent" on the Consolidated Balance Sheets.

Under the Agreements, Divested Operations and Businesses ("DDOB") liabilities of EIDP not allocated to or retained by Corteva or the Company are categorized as relating to either (i) PFAS Stray Liabilities, if they arise out of actions related to or resulting from the development, testing, manufacture or sale of PFAS; or (ii) Non-PFAS Stray Liabilities, (and together with PFAS Stray Liabilities, the “EIDP Stray Liabilities”).

The Agreements provide that the Company and Corteva will each bear a certain percentage of the Indemnifiable Losses, described below, rising from EIDP Stray Liabilities and that the percentage changes upon each company meeting its respective threshold of $150 million for PFAS Stray Liabilities and $200 million for EIDP Stray Liabilities. In addition, for certain Non-PFAS Liabilities, (“Specified Spend Non-PFAS Liabilities”), Corteva must spend specified amounts before costs associated with such matter will be considered Indemnifiable Losses.

The Agreements provide that the Company and Corteva each bear 50 percent of the first $300 million ($150 million) of total Indemnifiable Losses related to PFAS Stray Liabilities. In 2023, the companies met their respective $150 million threshold, and as a result the Company bears 71 percent of Indemnifiable Losses related to PFAS Stray Liabilities and Corteva bears 29 percent. At December 31, 2024, DuPont has accrued for future Qualified Spend and Indemnifiable Losses related to PFAS Stray Liabilities accordingly.

The $150 million of Indemnifiable Losses incurred for PFAS Stray Liabilities has been credited against each company’s $200 million threshold. Corteva has met its $200 million threshold. As a result, until the Company meets its $200 million threshold, it is responsible for managing the Non-PFAS Stray Liabilities, excluding Specified Spend Non-PFAS Liabilities for which Corteva has not reached its specified spend amount, and is bearing all Indemnifiable Losses associated with such Non-PFAS Stray Liabilities. DuPont met its $200 million threshold by December 31, 2024 and as a result, the Company will bear 71 percent and Corteva will bear 29 percent of Indemnifiable Losses related to Non-PFAS Stray Liabilities. At December 31, 2024, the Company has accrued for future Indemnifiable Losses related to Non-PFAS Stray Liabilities, including Specified Spend Non-PFAS Liabilities, accordingly.

Indemnifiable Losses, as defined in the DWDP Separation and Distribution Agreement, include, among other things, attorneys’, accountants’, consultants’ and other professionals’ fees and expenses incurred in the investigation or defense of EIDP Stray Liabilities.

In connection with the MOU and the Agreements, the Company has recognized the following indemnification liabilities related to eligible PFAS costs:
Indemnification Related Liabilities Associated with the MOU
In millionsDecember 31, 2024December 31, 2023Balance Sheet Classification
Current indemnification liabilities$99 $87 
Accrued and other current liabilities
Long-term indemnification liabilities123 119 Other noncurrent obligations
Total indemnification liabilities accrued under the MOU 1
$222 $206 
1.As of December 31, 2024 and 2023, total indemnified liabilities accrued include $128 million and $139 million, respectively, related to Chemours environmental remediation activities at their site in Fayetteville, North Carolina under the Consent Order between Chemours and the North Carolina Department of Environmental Quality (the "NC DEQ").

In addition to the above, beginning the second quarter of 2023, the Company recognized a liability related to the Water District Settlement Agreement, defined below, between Chemours, Corteva, EIDP and DuPont related to the aqueous film-forming foams multi-district litigation. The judgment became final in April 2024, therefore $408 million, including interest, is reflected as a cash outflow within cash flows from discontinued operations for the year ended December 31, 2024.

Future charges associated with the MOU will be recognized over the term of the agreement as a component of income from discontinued operations to the extent liabilities become probable and estimable.
In 2004 EIDP's reached a settlement in Leach v. E.I. DuPont de Nemours & Co., which gave certain residents in Ohio and West Virginia standing to pursue personal injury claims for just six health conditions that an expert panel appointed under the Leach settlement reported in 2012 had a “probable link” (as defined in the settlement) with PFOA: pregnancy-induced hypertension, including preeclampsia; kidney cancer; testicular cancer; thyroid disease; ulcerative colitis; and diagnosed high cholesterol. After the panel reported its findings, approximately 3,550 personal injury lawsuits filed in Ohio and West Virginia state and federal courts, were consolidated in multi-district litigation in the U.S. District Court for the Southern District of Ohio (“Ohio MDL”). In 2017, Chemours and EIDP settled the Ohio MDL for $670 million.

Post the 2017 settlement, approximately 100 additional cases were filed. EIDP and Chemours settled all but one of these cases in 2021 for $83 million with each of the Company and EIDP contributing $27 million and Chemours contributing $29 million. The remaining case resulted in a jury verdict for the plaintiff which has been paid. The Company was not a defendant but made its share of the payment in accordance with the Agreements and MOU. Since that time, Plaintiffs’ counsel had approximately 70 cases that were, or were to be, filed in the Ohio MDL. Prior to the start of the first trial in September 2024, EIDP and Chemours entered into an agreement in principle providing for settlement for all pending cases in the MDL as well as additional pre-suit claims. On September 6, 2024, the parties accepted a mediator’s proposal, and the trials were postponed. The parties ultimately entered into a settlement agreement on November 13, 2024 (“2024 Settlement”). The agreement included two payments to be made, the first for approximately $30 million, due upon receiving the dismissals for all the approximately 73 known filed and unfiled cases. A second payment of $29 million is contingent upon the court's order dissolving the Ohio MDL. In December 2024, the plaintiffs delivered dismissals for all cases, and filed a motion with the court to terminate the Ohio MDL and DuPont satisfied its portion ($11 million) of the first payment. DuPont has also recorded a charge of $10 million, representing its portion of the contingent second payment, which is accrued for as of December 31, 2024. On February 11, 2025, the court recommended a termination of the Ohio MDL. The second payment will become due if the panel overseeing the Ohio MDL accepts the court's recommendation.

In November 2023, DuPont, Chemours and Corteva (for itself and EIDP) reached a settlement agreement with the State of Ohio designed to benefit Ohio's natural resources and the people of the State of Ohio. Among other things, and subject to certain limitations and preservations, the settlement resolves the State's claims relating to releases of PFAS in or into the State from the companies' facilities and claims relating to the manufacture and sale of PFAS-containing products and the State's claims related to AFFF. As part of the settlement, the companies agreed to pay the State of Ohio a combined total of $110 million, 80 percent of which the State has allocated to restoration of natural resources related to operation of the Washington Works facility. The settlement will become effective and payable, upon resolution of the appeals process and entry of final judgment by the court. Consistent with the MOU, DuPont's share of the settlement will be approximately $39 million, which is accrued for as of December 31, 2024.

In July 2021, Chemours, Corteva (for itself and EIDP) and DuPont reached a resolution with the State of Delaware for $50 million among other consideration, that avoids litigation and addresses potential natural resources damages from known historical and current releases by the companies in or affecting Delaware. In 2022, the companies paid the settlement consistent with the MOU. DuPont's share was $13 million. The settlement provides for a potential Supplemental Payment to Delaware up to a total of $25 million, if certain conditions are met. As a result, upon the above described settlement with the State of Ohio reached in November 2023 becoming effective, a Supplemental Payment will be owed to the State of Delaware and paid in accordance to the terms of the MOU. The Company has accrued $9 million as of December 31, 2024 related to the Supplemental Payment.

As of December 31, 2024, there are various cases alleging damages due to PFAS which are discussed below. Such actions often include claims alleging that EIDP's transfer of certain PFAS liabilities to Chemours resulted in a fraudulent conveyance or voidable transaction. With the exception of the fraudulent conveyance claims, which are excluded from the MOU, legal fees, expenses, costs, and any potential liabilities for eligible PFAS costs presented by the following matters will be shared in accordance with the MOU between Chemours, EIDP, Corteva and DuPont.

Beginning in April 2019, lawsuits alleging damages from the use of PFAS-containing aqueous film-forming foams (“AFFF”) were filed against EIDP and Chemours, and companies such as 3M that made AFFF. The majority of these lawsuits were consolidated in a multi-district litigation (the “AFFF MDL”) captioned In Re: Aqueous Film Forming Foams (AFFF) Products Liability Litigation that is pending in the United States District Court for the District of South Carolina (the “Court”). The matters pending in the AFFF MDL allege damages as a result of contamination, in most cases allegedly from migration from airports or military installations, or personal injury from exposure to AFFF. The plaintiffs in the MDL include, among others, water districts, individuals and states attorneys general. DuPont has never made or sold AFFF, perfluorooctanesulfonic acid ("PFOS") or PFOS-containing products, and most of the actions in the AFFF MDL name DuPont as a defendant solely related to fraudulent transfer claims related to the Chemours Separation and the DowDuPont separations.
On June 30, 2023, Chemours, Corteva, EIDP and DuPont entered a definitive agreement to resolve for $1.185 billion in cash all PFAS-related claims of a defined class of U.S. public water systems, including claims that are part of the AFFF MDL, (the “Water District Settlement Agreement”).

DuPont paid its $400 million contribution into the Water District Settlement Fund in the third quarter 2023. That payment included $100 million that DuPont had deposited into the MOU Escrow Account as of June 30, 2023. The Company’s total contribution, including interest, of $408 million has been removed from "Restricted cash and cash equivalents - current" along with the associated "Accrued and other current liabilities" within the Consolidated Balance Sheets as of December 31, 2024, as the settlement became final in the second quarter 2024. DuPont's aggregate MOU escrow deposits of $405 million, including interest, at December 31, 2023 is reflected in "Restricted cash and cash equivalents - noncurrent" on the Consolidated Balance Sheets.

The Water District Settlement's defined class is composed of all Public Water Systems, as defined in 42 U.S.C § 300f, with a current detection of PFAS and all Public Water Systems, that are currently required to monitor for PFAS under the EPA’s Fifth Unregulated Contaminant Monitoring Rule (“UCMR 5”) or other applicable federal or state law. The class does not include water systems owned and operated by a State or the United States government or small systems that have not detected PFAS and are not currently required to monitor for it under federal or state requirements. While it is reasonably possible that the excluded systems or claims could result in additional future lawsuits, claims, assessments or proceedings, it is not possible to predict the outcome of any such matters, and as such, the Company is unable to develop an estimate of a possible loss or range of losses, if any, at this time.

As part of the approval process, the Court established, among other things, a mechanism for class members to submit requests to be excluded from the settlement. Approximately 900 of 14,167 entities on the list of potential class members submitted timely requests for exclusion. The time has passed for any further entities to opt out.

The Court ordered the dismissal of personal injury claims by September 10, 2024, that do not meet certain evidentiary requirements unless they allege one of the following eight health conditions: high cholesterol, pregnancy induced hypertension, ulcerative colitis, thyroid disease, testicular cancer, kidney cancer, liver cancer or thyroid cancer. Cases that are dismissed pursuant to the Court’s order may be re-filed within four years if plaintiffs later meet the evidentiary requirements specified in the Court’s order. There are about 5,200 personal injury cases currently pending in the AFFF MDL reflecting confirmed dismissals under the Court’s order and any newly filed cases. The Company expects additional personal injury cases – which include claims that identify one of the eight health conditions – will continue to be filed into the AFFF MDL.

The 25 bellwether personal injury cases have been further narrowed to a group of Tier 2 bellwether plaintiffs. The Tier 2 bellwether plaintiffs include nine cases that allege harm from kidney cancer, testicular cancer, ulcerative colitis, or thyroid disease. The court has set the first Tier 2 trial to occur on October 6, 2025. The trial will include a case or cases from Pennsylvania that allege harm from either kidney cancer or testicular cancer.

Some state attorneys general have filed lawsuits, on behalf of their respective states, against DuPont, outside of the AFFF MDL that allege environmental contamination by certain PFAS compounds distinct from AFFF. Generally, the states raise common law tort claims and seek economic impact damages for alleged harm to natural resources, punitive damages, present and future costs to clean up contamination from certain PFAS compounds, and to abate the alleged nuisance. Most of these actions include fraudulent transfer claims related to the Chemours Separation and the DowDuPont separations.

In April 2021, a historic DuPont Dutch subsidiary and the Dutch entities of Chemours and Corteva, received a civil summons issued by the Court of Rotterdam, the Netherlands, on behalf of four municipalities neighboring the Chemours Dordrecht facility. The municipalities are seeking liability declarations relating to the Dordrecht site’s current and historical PFAS operations and emissions. On September 27, 2023, the Court determined that the defendants were liable to the municipalities for (i) PFOA emissions between July 1, 1984 to March 1, 1998 and (ii) removal costs if deposited emissions on the municipalities' land infringes the applicable municipalities' property rights by an objective standard. Chemours entered into a Letter of Intent (“LOI”) with the municipalities on June 28, 2024, that includes the implementation of a specific remediation plan for the restoration of restricted vegetable gardens in certain areas of those municipalities to be funded by Chemours, sampling and developing a program to address the Merwelanden recreational lake, and further settlement discussions, including a fund to cover certain other expenditures aimed at environmental-related activities. The LOI contemplates the possibility of settling the court dispute, although still subject to further discussions which are ongoing with the municipalities and there is no guarantee that these discussions will result in a settlement. Although the Company believes a loss is probable, it is not estimable.
Additionally, there are cases in Canada that allege harm from PFAS contamination including property and natural resource damage claims, both related and unrelated to AFFF.

In addition to the above matters, there are other legal matters pending that make claims related to PFAS. The Company is specifically named in some of these legal matters and some are pending against Chemours and/or Corteva/EIDP in which the Company is not named. Certain of these actions may purport to be class actions and seek damages in very large amounts. Regardless of whether the Company is named, the costs of litigation and future liabilities, if any, in these matters, are or may be eligible PFAS costs under the MOU and Indemnification Losses under the Agreements.

While Management believes it has appropriately estimated the liability associated with eligible PFAS matters and Indemnifiable Losses as of the date of this report, it is reasonably possible that the Company could incur additional eligible PFAS costs and Indemnifiable Losses in excess of the amounts accrued. It is not possible to predict the outcome of any such matters due to various reasons including, among others, future actions and decisions, as well as factual and legal issues to be resolved in connection with PFAS matters. As such, at this time DuPont is unable to develop an estimate of a possible loss or range of losses, if any, above the liability accrued at December 31, 2024. It is possible that additional costs or losses could have a significant effect on the Company’s financial condition and/or cash flows in the period in which they occur; however, costs qualifying as Qualified Spend are limited by the terms of the MOU.

Other Litigation Matters
In addition to the matters described above, the Company is party to claims and lawsuits arising out of the normal course of business with respect to product liability, patent infringement, governmental regulation, contract and commercial litigation, and other actions. Certain of these actions may purport to be class actions and seek damages in very large amounts. As of December 31, 2024, the Company has liabilities of $26 million associated with these other litigation matters. It is the opinion of the Company’s management that the possibility is remote that the aggregate of all such other claims and lawsuits will have a material adverse impact on the results of operations, financial condition and cash flows of the Company. In accordance with its accounting policy for litigation matters, the Company will expense litigation defense costs as incurred, which could be significant to the Company’s financial condition and/or cash flows in the period.

Environmental Matters
Accruals for environmental matters are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated based on current law and existing technologies. At December 31, 2024, the Company had accrued obligations of $275 million for probable environmental remediation and restoration costs. These obligations are included in "Accrued and other current liabilities" and "Other noncurrent obligations" in the Consolidated Balance Sheets. It is reasonably possible that environmental remediation and restoration costs in excess of amounts accrued could have a material impact on the Company’s results of operations, financial condition and cash flows. Inherent uncertainties exist in these estimates primarily due to unknown conditions, changing governmental regulations and legal standards regarding liability, and emerging remediation technologies for handling site remediation and restoration.

The accrued environmental obligations include the following:
Environmental Accrued Obligations
In millionsDecember 31, 2024December 31, 2023
Potential exposure above the amount accrued 1
Environmental remediation liabilities not subject to indemnity$45 $46 $106 
Environmental remediation indemnified related liabilities:
    Indemnifications related to Dow and Corteva 2
83 101 177 
    MOU related obligations (discussed above) 3
146 152 31 
    Other environmental indemnifications1 1 2 
Total environmental related liabilities$275 $300 $316 
1.The environmental accrual represents management’s best estimate of the costs for remediation and restoration with respect to environmental matters, although it is reasonably possible that the ultimate cost with respect to these particular matters could range above the amount accrued as of December 31, 2024.
2.Pursuant to the DWDP Separation and Distribution Agreement and Letter Agreement, the Company is required to indemnify Dow and Corteva for certain Non-PFAS clean-up responsibilities and associated remediation costs.
3.The MOU related obligations include the Company's estimate of its liability under the MOU for remediation activities based on the current regulatory environment.
v3.25.0.1
LEASES
 12 Months Ended
Dec. 31, 2024
Leases [Abstract]  
LEASES LEASES
The Company has operating leases for real estate, an airplane, railcars, fleet, certain machinery and equipment, and information technology assets. The Company’s leases have remaining lease terms of approximately 1 year to 30 years. For purposes of calculating operating lease liabilities, lease terms may be deemed to include options to extend the lease when it is reasonably certain that the Company will exercise that option. Some leasing arrangements require variable payments that are dependent on usage, output, or may vary for other reasons, such as insurance and tax payments. The variable lease payments are not presented as part of the initial ROU asset or lease liability.

Certain of the Company's leases include residual value guarantees. These residual value guarantees are based on a percentage of the lessor's asset acquisition price and the amount of such guarantee declines over the course of the lease term. The portion of residual value guarantees that are probable of payment is included in the related lease liability in the Consolidated Balance Sheets. At December 31, 2024, the Company has future maximum payments for residual value guarantees in operating leases of $25 million with final expirations through 2034. The Company's lease agreements do not contain any material restrictive covenants.
The components of lease cost for operating leases for the years ended December 31, 2024, 2023 and 2022 were as follows:
In millions202420232022
Operating lease cost$125 $121 $113 
Short-term lease cost5 4 4 
Variable lease cost37 39 39 
Less: Sublease income 1
4 4 12 
Total lease cost$163 $160 $144 
1.Reflects income associated with subleases, not inclusive of all lessor arrangements disclosed below.

Operating cash flows from operating leases related to continuing operations were $120 million, $115 million, and $109 million for the year ended December 31, 2024, 2023 and 2022, respectively.

New operating lease assets and liabilities entered into during the year ended December 31, 2024, 2023 and 2022 were $53 million, $160 million and $131 million, respectively. Supplemental balance sheet information related to leases was as follows:
In millionsDecember 31, 2024December 31, 2023
Operating Leases
 
Operating lease right-of-use assets 1
$403 $484 
Current operating lease liabilities 2
84 97 
Noncurrent operating lease liabilities 3
322 390 
Total operating lease liabilities
$406 $487 
1.Included in "Deferred charges and other assets" in the Consolidated Balance Sheets.
2.Included in "Accrued and other current liabilities" in the Consolidated Balance Sheets.
3.Included in "Other noncurrent obligations" in the Consolidated Balance Sheets.

Operating lease ROU assets and lease liabilities are recognized at the commencement date based on the present value of the fixed minimum lease payments over the lease term. As most of the Company’s leases do not provide the lessor’s implicit rate, the Company uses its incremental borrowing rate at the commencement date in determining the present value of lease payments.
Lease Term and Discount Rate for Operating LeasesDecember 31, 2024December 31, 2023
Weighted-average remaining lease term (years)7.88.5
Weighted-average discount rate3.78 %3.55 %
Maturities of lease liabilities were as follows:
Maturity of Lease Liabilities at December 31, 2024Operating Leases
In millions
2025$97 
202676 
202761 
202844 
202934 
2030 and thereafter157 
Total lease payments$469 
Less: Interest63 
Present value of lease liabilities$406 

The Company has leases in which it is the lessor, with the largest being a result of the N&B Transaction. In connection with the N&B Transaction and the M&M Divestitures, DuPont entered into leasing arrangements with IFF and Celanese, whereby DuPont is leasing certain properties, including office spaces and R&D laboratories. These leases are classified as operating leases and lessor revenue and related expenses are not significant to the Company’s Consolidated Balance Sheets or Consolidated Statement of Operations. Lease agreements where the Company is the lessor have final expirations through 2036.
For the years ended December 31, 2024, 2023 and 2022 total lease income was $75 million, $73 million and $58 million, respectively, for which the net profits recognized from these leases were approximately $20 million, $18 million and $14 million, respectively. Total lease income for each period presented is recorded in "Selling, general, and administrative expenses" and "Research and development expenses". Contractual lease income for 2025 through 2029 ranges from $49 million to $75 million annually.
LEASES LEASES
The Company has operating leases for real estate, an airplane, railcars, fleet, certain machinery and equipment, and information technology assets. The Company’s leases have remaining lease terms of approximately 1 year to 30 years. For purposes of calculating operating lease liabilities, lease terms may be deemed to include options to extend the lease when it is reasonably certain that the Company will exercise that option. Some leasing arrangements require variable payments that are dependent on usage, output, or may vary for other reasons, such as insurance and tax payments. The variable lease payments are not presented as part of the initial ROU asset or lease liability.

Certain of the Company's leases include residual value guarantees. These residual value guarantees are based on a percentage of the lessor's asset acquisition price and the amount of such guarantee declines over the course of the lease term. The portion of residual value guarantees that are probable of payment is included in the related lease liability in the Consolidated Balance Sheets. At December 31, 2024, the Company has future maximum payments for residual value guarantees in operating leases of $25 million with final expirations through 2034. The Company's lease agreements do not contain any material restrictive covenants.
The components of lease cost for operating leases for the years ended December 31, 2024, 2023 and 2022 were as follows:
In millions202420232022
Operating lease cost$125 $121 $113 
Short-term lease cost5 4 4 
Variable lease cost37 39 39 
Less: Sublease income 1
4 4 12 
Total lease cost$163 $160 $144 
1.Reflects income associated with subleases, not inclusive of all lessor arrangements disclosed below.

Operating cash flows from operating leases related to continuing operations were $120 million, $115 million, and $109 million for the year ended December 31, 2024, 2023 and 2022, respectively.

New operating lease assets and liabilities entered into during the year ended December 31, 2024, 2023 and 2022 were $53 million, $160 million and $131 million, respectively. Supplemental balance sheet information related to leases was as follows:
In millionsDecember 31, 2024December 31, 2023
Operating Leases
 
Operating lease right-of-use assets 1
$403 $484 
Current operating lease liabilities 2
84 97 
Noncurrent operating lease liabilities 3
322 390 
Total operating lease liabilities
$406 $487 
1.Included in "Deferred charges and other assets" in the Consolidated Balance Sheets.
2.Included in "Accrued and other current liabilities" in the Consolidated Balance Sheets.
3.Included in "Other noncurrent obligations" in the Consolidated Balance Sheets.

Operating lease ROU assets and lease liabilities are recognized at the commencement date based on the present value of the fixed minimum lease payments over the lease term. As most of the Company’s leases do not provide the lessor’s implicit rate, the Company uses its incremental borrowing rate at the commencement date in determining the present value of lease payments.
Lease Term and Discount Rate for Operating LeasesDecember 31, 2024December 31, 2023
Weighted-average remaining lease term (years)7.88.5
Weighted-average discount rate3.78 %3.55 %
Maturities of lease liabilities were as follows:
Maturity of Lease Liabilities at December 31, 2024Operating Leases
In millions
2025$97 
202676 
202761 
202844 
202934 
2030 and thereafter157 
Total lease payments$469 
Less: Interest63 
Present value of lease liabilities$406 

The Company has leases in which it is the lessor, with the largest being a result of the N&B Transaction. In connection with the N&B Transaction and the M&M Divestitures, DuPont entered into leasing arrangements with IFF and Celanese, whereby DuPont is leasing certain properties, including office spaces and R&D laboratories. These leases are classified as operating leases and lessor revenue and related expenses are not significant to the Company’s Consolidated Balance Sheets or Consolidated Statement of Operations. Lease agreements where the Company is the lessor have final expirations through 2036.
For the years ended December 31, 2024, 2023 and 2022 total lease income was $75 million, $73 million and $58 million, respectively, for which the net profits recognized from these leases were approximately $20 million, $18 million and $14 million, respectively. Total lease income for each period presented is recorded in "Selling, general, and administrative expenses" and "Research and development expenses". Contractual lease income for 2025 through 2029 ranges from $49 million to $75 million annually.
v3.25.0.1
STOCKHOLDERS' EQUITY
 12 Months Ended
Dec. 31, 2024
Equity [Abstract]  
STOCKHOLDERS' EQUITY STOCKHOLDERS' EQUITY
Share Repurchase Programs
In February 2022, the Company's Board of Directors authorized a $1.0 billion share buyback program which expires on March 31, 2023, (the “2022 Share Buyback Program”). As of September 30, 2022, the Company repurchased and retired a total of 11.9 million shares for $750 million under the 2022 Share Buyback Program. In November 2022, DuPont’s Board of Directors approved a new share repurchase program authorizing the repurchase and retirement of up to $5 billion of common stock (the “$5B Share Buyback Program", together with the 2022 Share Buyback Program, the "2022 Stock Repurchase Programs") in addition to the $250 million remaining under the Company’s existing share repurchase program.

In November 2022, DuPont entered into accelerated share repurchase ("ASR") agreements with each of three financial institutions (the "$3.25B ASR Transaction"). DuPont paid an aggregate of approximately $3.25 billion of common stock with $250 million of such repurchases under the 2022 Share Buyback Program and the remaining $3 billion under the $5B Share Buyback Program. Pursuant to the terms of the $3.25B ASR Transaction, DuPont paid an aggregate of $3.25 billion to the ASR Counterparties and received initial deliveries of 38.8 million shares in aggregate of DuPont common stock, which were retired immediately and recorded as a reduction to retained earnings of $2.6 billion. The $3.25B ASR Transaction was completed during the third quarter of 2023 with DuPont receiving and retiring an additional 8.0 million shares of DuPont common stock. In connection with the completion of the transaction the remaining $613 million based on the price of the shares at the time of delivery was settled as a forward contract indexed to DuPont common stock at the time of settlement, classified within stockholders’ equity. At the completion of the $3.25B ASR Transaction, the Company had repurchased and retired a total of 46.8 million shares at an average price of $69.44 per share.

In the third quarter of 2023, DuPont entered into new accelerated share repurchase agreements with three financial counterparties to repurchase an aggregate of $2 billion of common stock ("$2B ASR Transaction"). DuPont paid an aggregate of $2 billion to the counterparties and received initial deliveries of 21.2 million shares in aggregate of DuPont common stock, which were retired immediately and recorded as a reduction to retained earnings of $1.6 billion. In the first quarter of 2024, the $2B ASR Transaction was completed. The settlement resulted in the delivery of 6.7 million additional shares of DuPont common stock, which were retired immediately and will be recorded as a reduction of retained earnings in the first quarter of 2024. In total, the Company repurchased 27.9 million shares at an average price of $71.67 per share under the $2B ASR Transaction. The completion of the $2B ASR Transaction effectively completes the $5B Share Buyback Program and the Company's stock repurchase authorization.

In the first quarter 2024, the Company’s Board of Directors approved a new share repurchase program authorizing the repurchase and retirement of up to $1 billion of common stock (“the $1B Share Buyback Program”). Under the $1B Share Buyback Program, repurchases may be made from time to time on the open market at prevailing market prices or in privately negotiated transactions off market, including additional ASR agreements in accordance with applicable federal securities laws. The $1B Program terminates on June 30, 2025, unless extended or shortened by the Board of Directors.

Also in the first quarter 2024, DuPont entered an ASR agreement with one counterparty for the repurchase of about $500 million of common stock ("Q1 2024 ASR Transaction"). DuPont paid an aggregate of $500 million to the counterparty and received initial deliveries of 6.0 million shares of DuPont common stock, which were retired immediately and recorded as a reduction of retained earnings of $400 million. The remaining $100 million was evaluated as an unsettled forward contract indexed to DuPont common stock, classified within stockholders' equity as of March 31, 2024.

In the second quarter of 2024, the Q1 2024 ASR Transaction was completed. The settlement resulted in the delivery of approximately 1.0 million additional shares of DuPont common stock, which were retired immediately and recorded as a reduction of retained earnings of $72 million. In total, the Company repurchased 6.9 million shares at an average price of $71.96 per share under the Q1 2024 ASR Transaction.

The Inflation Reduction Act of 2022 introduced a 1 percent nondeductible excise tax imposed on the net value of certain stock repurchases made after December 31, 2022. The net value is determined by the fair market value of the stock repurchased during the tax year, reduced by the fair market value of stock issued during the tax year. The Company recorded total excise tax of $8 million and $21 million, respectively, as a reduction to retained earnings for the years ended December 31, 2024 and 2023, reflected within stockholders' equity and a corresponding liability within "Accounts Payable" in our Consolidated Balance Sheets as of December 31, 2024 and 2023.
Common Stock
The following table provides a reconciliation of DuPont Common Stock activity for the years ended December 31, 2024, 2023 and 2022:
Shares of DuPont Common StockIssuedHeld in Treasury
In thousands
Balance at January 1, 2022511,793 — 
Issued 2,074 — 
Repurchased— 55,743 
Retired(55,743)(55,743)
Balance at December 31, 2022458,124 — 
Issued 1,225 — 
Repurchased
— 29,239 
Retired
(29,239)(29,239)
Balance at December 31, 2023430,110 — 
Issued1,513 — 
Repurchased
— 13,629 
Retired
(13,629)(13,629)
Balance at December 31, 2024417,994 — 

Retained Earnings
There are no significant restrictions limiting the Company's ability to pay dividends. Dividends declared and paid to common stockholders during the years ended December 31, 2024, 2023 and 2022 are summarized in the following table:
Dividends Declared and Paid202420232022
In millions
Dividends declared to common stockholders$635 $651 $652 
Dividends paid to common stockholders$635 $651 $652 

Undistributed earnings of nonconsolidated affiliates included in retained earnings were $626 million at December 31, 2024 and $637 million at December 31, 2023.
Accumulated Other Comprehensive Loss
The following table summarizes the activity related to each component of accumulated other comprehensive loss ("AOCL") for the years ended December 31, 2024, 2023 and 2022:
Accumulated Other Comprehensive LossCumulative Translation AdjPension and OPEB
Derivative Instruments 1
Total
In millions
2022
Balance at January 1, 2022$(88)$73 $56 $41 
Other comprehensive (loss) income before reclassifications(1,101)44 61 (996)
Amounts reclassified from accumulated other comprehensive income— (3)— (3)
M&M Divestiture reclassification adjustment221 (54)— 167 
Net other comprehensive (loss) income$(880)$(13)$61 $(832)
Balance at December 31, 2022$(968)$60 $117 $(791)
2023
Other comprehensive income (loss) before reclassifications46 (83)(41)(78)
Amounts reclassified from accumulated other comprehensive income— (9)— (9)
Delrin® Divestiture reclassification adjustment
(9)(23)— (32)
Net other comprehensive income (loss)$37 $(115)$(41)$(119)
Balance at December 31, 2023$(931)$(55)$76 $(910)
2024
Other comprehensive (loss) income before reclassifications(562)(59)32 (589)
Amounts reclassified from accumulated other comprehensive income — (1)— (1)
Net other comprehensive (loss) income$(562)$(60)$32 $(590)
Balance at December 31, 2024$(1,493)$(115)$108 $(1,500)
1. Includes cumulative translation adjustment impact associated with derivative instruments.

The tax effects on the net activity related to each component of other comprehensive income (loss) for the years ended December 31, 2024, 2023 and 2022 were as follows:
Tax Benefit (Expense)202420232022
In millions
Pension and other post-employment benefit plans$11 $26 $16 
Derivative instruments(9)12 (15)
Tax benefit from income taxes related to other comprehensive income (loss) items$2 $38 $1 

A summary of the reclassifications out of AOCL for the years ended December 31, 2024, 2023 and 2022 is provided as follows:
Reclassifications Out of Accumulated Other Comprehensive Loss 202420232022Income Classification
In millions
Cumulative translation adjustments$— $(9)$221 See (1) below
Pension and other post-employment benefit plans(2)(35)(71)See (1) below
Tax expense (benefit) 1 3 14 See (1) below
    Pension and other post-employment benefit plans,
    after tax
(1)(32)(57)
Total reclassifications for the period, after tax$(1)$(41)$164 
1. The activity for the year ended December 31, 2024 is classified within "Sundry income (expense) - net" as part of continuing operations. The activity for the year ended December 31, 2023 is classified almost entirely within "(Loss) income from discontinued operations, net of tax" as part of the Delrin® Divestiture, with a portion classified within "Sundry income (expense) - net" as part of continuing operations. The activity for the year ended December 31, 2022 is classified almost entirely within "(Loss) income discontinued operations, net of tax" as part of the M&M Divestiture, with a portion classified within "Sundry income (expense) - net" as part of continuing operations.
v3.25.0.1
PENSION PLANS AND OTHER POST-EMPLOYMENT BENEFITS
 12 Months Ended
Dec. 31, 2024
Retirement Benefits [Abstract]  
PENSION PLANS AND OTHER POST-EMPLOYMENT BENEFITS PENSION PLANS AND OTHER POST-EMPLOYMENT BENEFITS
The significant defined benefit pension and OPEB plans of the Company are summarized below. Unless otherwise noted, all values within this footnote are inclusive of balances and activity associated with discontinued operations.

Defined Benefit Pension Plans
DuPont has both funded and unfunded defined benefit pension plans covering employees in a number of non-US countries. The United Kingdom qualified plan is the largest pension plan held by DuPont.

DuPont's funding policy is consistent with the funding requirements of each country's laws and regulations. Pension coverage for employees of DuPont's non-U.S. consolidated subsidiaries is provided, to the extent deemed appropriate, through separate plans. Obligations under such plans are funded by depositing funds with trustees, covered by insurance contracts, or remain unfunded. During 2024, the Company contributed $51 million to its benefit plans. DuPont expects to contribute approximately $56 million to its benefit plans in 2025.

The weighted-average assumptions used to determine pension plan obligations and net periodic benefit costs for all plans are summarized in the table below:
Weighted-Average Assumptions for Pension Plans Benefit Obligations
 at December 31,		Net Periodic Costs
for the Years Ended
 20242023202420232022
Discount rate3.67 %3.26 %3.46 %3.05 %1.48 %
Interest crediting rate for applicable benefits1.75 %2.00 %2.00 %2.25 %1.25 %
Rate of compensation increase3.41 %3.11 %3.11 %3.25 %3.15 %
Expected return on plan assetsN/AN/A4.43 %3.61 %2.69 %

Other Post-employment Benefit Plans
The Company retained U.S. and foreign other post-employment benefit obligations with the Canadian plan and the U.S. long-term disabilities plan being the two largest and accounting for the majority of the Company's total other post-employment benefit obligations. In comparison to the Company's defined benefit pension plans, the Company's other post-employment benefit plans are not significant. The total other post-employment benefits projected benefit obligation was $27 million as of December 31, 2024 and $29 million as of December 31, 2023.

Assumptions
The Company determines the expected long-term rate of return on plan assets by performing a detailed analysis of key economic and market factors driving historical returns for each asset class and formulating a projected return based on factors in the current environment. Factors considered include, but are not limited to, inflation, real economic growth, interest rate yield, interest rate spreads, and other valuation measures and market metrics.

Service cost and interest cost for all other plans are determined on the basis of the discount rates derived in determining those plan obligations. The discount rates utilized to measure the majority of pension and other postretirement obligations are based on the Aon AA corporate bond yield curves applicable to each country at the measurement date. DuPont utilizes the mortality tables and generational mortality improvement scales, where available, developed in each of the respective countries in which the Company holds plans.
Summarized information on the Company's pension and other postretirement benefit plans is as follows:
Change in Projected Benefit Obligations of All Plans20242023
In millions
Change in projected benefit obligations:
Benefit obligations at beginning of year$2,704 $2,726 
Service cost17 25 
Interest cost84 99 
Plan participants' contributions9 7 
Actuarial changes in assumptions and experience
(49)132 
Benefits paid(208)(208)
Acquisitions/divestitures/other 1
— (209)
Effect of foreign exchange rates(122)133 
Termination benefits/curtailment cost/settlements— (1)
Benefit obligations at end of year$2,435 $2,704 
1.The year ended 2023 is primarily related to the Delrin® Divestiture.

Change in Plan Assets and Funded Status of All Plans20242023
In millions
Change in plan assets:
Fair value of plan assets at beginning of year$2,424 $2,596 
Actual return on plan assets (14)109 
Employer contributions51 66 
Plan participants' contributions9 7 
Benefits paid(208)(208)
Acquisitions/divestitures/other 1
— (285)
Effect of foreign exchange rates(101)139 
Fair value of plan assets at end of year$2,161 $2,424 
Funded status:
Plans with plan assets$186 $233 
All other plans(460)(513)
Funded status at end of year$(274)$(280)
1.The year ended 2023 is primarily related to the Delrin® Divestiture.

The following tables summarize the amounts recognized in the Consolidated Balance Sheets for all significant plans:
Amounts Recognized in the Consolidated Balance Sheets for All Significant PlansDecember 31, 2024December 31, 2023
In millions
Amounts recognized in the consolidated balance sheets:
Deferred charges and other assets$291 $338 
Accrued and other current liabilities(42)(53)
Pension and other postretirement benefits - noncurrent(523)(565)
Net amount recognized$(274)$(280)
Pretax amounts recognized in accumulated other comprehensive loss (income):
Net loss (gain)$167 $95 
Prior service credit(4)(8)
Pretax balance in accumulated other comprehensive loss at end of year
$163 $87 

The increase in the Company's actuarial losses for the year ended December 31, 2024 was primarily due to losses on assets in excess of what was expected, partially offset by the changes in weighted-average discount rates, which increased from 3.26 percent at December 31, 2023 to 3.67 percent at December 31, 2024.
The actuarial loss for the year ended December 31, 2023 was primarily due to the changes in weighted-average discount rates, which decreased from 3.71 percent at December 31, 2022 to 3.26 percent at December 31, 2023 and due to divestitures, partially offset by gains on assets in excess of what was expected.

The accumulated benefit obligation for all pension plans was $2.4 billion and $2.6 billion at December 31, 2024 and December 31, 2023, respectively.
Pension Plans with Accumulated Benefit Obligations in Excess of Plan AssetsDecember 31, 2024December 31, 2023
In millions
Accumulated benefit obligations$646 $700 
Fair value of plan assets$134 $138 
Pension Plans with Projected Benefit Obligations in Excess of Plan AssetsDecember 31, 2024December 31, 2023
In millions
Projected benefit obligations$683 $743 
Fair value of plan assets$144 $154 
Net Periodic Benefit Costs for All Significant Plans for the Years Ended December 31,202420232022
In millions
Net Periodic Benefit Costs:
Service cost$17 $25 $43 
Interest cost84 99 55 
Expected return on plan assets(100)(92)(97)
Amortization of prior service credit(3)(3)(5)
Amortization of unrecognized net (gain) loss— (1)1 
Curtailment/settlement1 (3)(4)
Net periodic benefit (credits) costs - Total$(1)$25 $(7)
Less: Net periodic benefit credits - Discontinued operations— (6)(9)
Net periodic benefit (credit) costs - Continuing operations 1
$(1)$31 $2 
Changes in plan assets and benefit obligations recognized in other comprehensive loss (income):
Net loss (gain)$70 $108 $(35)
Amortization of prior service credit3 3 5 
Amortization of unrecognized gain (loss)— 1 (1)
Settlement (loss) gain(1)3 4 
Effect of foreign exchange rates(1)1 5 
Total recognized in other comprehensive loss (income)$71 $116 $(22)
Total recognized in net periodic benefit costs (credits) and other comprehensive loss (income)$70 $147 $(20)
1. Refer to the separate table below for details of Net Periodic Benefit Costs for Plans in Continuing Operations.
Net Periodic Benefit Costs for Plans in Continuing Operations for the Years Ended December 31,202420232022
In millions
Net Periodic Benefit Costs:
Service cost$17 $22 $30 
Interest cost84 93 49 
Expected return on plan assets(100)(78)(73)
Amortization of prior service credit(3)(2)(4)
Amortization of unrecognized net (gain) loss— (1)4 
Curtailment/settlement1 (3)(4)
Net periodic benefit costs - Continuing operations$(1)$31 $2 
Estimated Future Benefit Payments
The estimated future benefit payments of continuing operations, reflecting expected future service, as appropriate, are presented in the following table:
Estimated Future Benefit Payments at December 31, 2024
In millions
2025$173 
2026171 
2027167 
2028169 
2029174 
Years 2030-2034845 
Total$1,699 

Plan Assets
Plan assets consist primarily of equity and fixed income securities of U.S. and foreign issuers, and alternative investments such as insurance contracts, pooled investment vehicles and private market securities. At December 31, 2024, plan assets totaled $2.2 billion.

The Company establishes strategic asset allocation percentage targets and appropriate benchmarks for significant asset classes with the aim of achieving a prudent balance between return and risk. Strategic asset allocations in other countries are selected in accordance with the laws and practices of those countries. Where appropriate, asset liability studies are utilized in this process. The assets are managed by professional investment firms unrelated to the Company. Pension trust funds are permitted to enter into certain contractual arrangements generally described as derivative instruments. Derivatives are primarily used to reduce specific market risks, hedge currency and adjust portfolio duration and asset allocation in a cost-effective manner.

Equity securities primarily included investments in large- and small-cap companies located in both developed and emerging markets around the world. Global equity securities include varying market capitalization levels. U.S. equity investments are primarily large-cap companies. Fixed income securities included investment and non-investment grade corporate bonds of companies diversified across industries, U.S. treasuries, non-U.S. developed market securities, U.S. agency mortgage-backed securities, emerging market securities and fixed income related funds. Global fixed income investments include corporate-issued, government-issued and asset-backed securities. Corporate debt investments include a range of credit risk and industry diversification. U.S. fixed income investments are weighted heavier than non-U.S fixed income securities. Alternative investments primarily included investments in real estate, various insurance contracts and interest rate, equity, commodity and foreign exchange derivative investments and hedges. Other investments include cash and cash equivalents, pooled investment vehicles, hedge funds and private market securities such as interests in private equity and venture capital partnerships.

The weighted-average target allocation for plan assets of DuPont's pension plans is summarized as follows:
Target Allocation for Plan Assets at December 31, 2024DuPont
Asset Category
Equity securities2 %
Fixed income securities9 
Alternative investments24 
Hedge funds26 
Pooled investment vehicles32 
Other investments7 
Total 100 %

Fair value calculations may not be indicative of net realizable value or reflective of future fair values. Furthermore, although the Company believes its valuation methods are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different fair value measurement at the reporting date.

For pension plan assets classified as Level 1 measurements (measured using quoted prices in active markets), total fair value is either the price of the most recent trade at the time of the market close or the official close price, as defined by the exchange on which the asset is most actively traded on the last trading day of the period, multiplied by the number of units held without consideration of transaction costs.
For pension plan assets classified as Level 2 measurements, where the security is frequently traded in less active markets, fair value is based on the closing price at the end of the period; where the security is less frequently traded, fair value is based on the price a dealer would pay for the security or similar securities, adjusted for any terms specific to that asset or liability. Market inputs are obtained from well-established and recognized vendors of market data and subjected to tolerance and quality checks. For derivative assets and liabilities, standard industry models are used to calculate the fair value of the various financial instruments based on significant observable market inputs, such as foreign exchange rates, commodity prices, swap rates, interest rates and implied volatilities obtained from various market sources. For other pension plan assets for which observable inputs are used, fair value is derived through the use of fair value models, such as a discounted cash flow model or other standard pricing models.

For pension plan assets classified as Level 3 measurements, total fair value is based on significant unobservable inputs including assumptions where there is little, if any, market activity for the investment. Valuations of the investments are provided by investment managers or fund managers. These valuations are reviewed for reasonableness based on applicable sector, benchmark and company performance. Valuations of insurance contracts are contractually determined and are based on exit price valuations or contract value. Adjustments to valuations are made where appropriate.

Certain pension plan assets are held in funds where fair value is based on an estimated net asset value per share (or its equivalent) as of the most recently available fund financial statements which are received on a monthly or quarterly basis. These valuations are reviewed for reasonableness based on applicable sector, benchmark and company performance. Adjustments to valuations are made where appropriate to arrive at an estimated net asset value per share at the measurement date. Where available, audited annual financial statements are obtained and reviewed for the investments as support for the manager’s investment valuation. These funds are not classified within the fair value hierarchy.
The following table summarizes the bases used to measure the Company’s pension plan assets at fair value for the years ended December 31, 2024 and 2023:
Basis of Fair Value MeasurementsDecember 31, 2024December 31, 2023
In millionsTotalLevel 1Level 2Level 3TotalLevel 1Level 2Level 3
Cash and cash equivalents$52 $52 $— $— $55 $55 $— $— 
Equity securities:
U.S. equity securities$20 $20 $— $— $20 $20 $— $— 
Non - U.S. equity securities26 26 — — 29 29 — — 
Total equity securities$46 $46 $— $— $49 $49 $— $— 
Fixed income securities:
Debt - government-issued$34 $— $34 $— $34 $— $34 $— 
Debt - corporate-issued4 — 4 — 5 — 5 — 
Total fixed income securities$38 $— $38 $— $39 $— $39 $— 
Alternative investments:
Real estate$75 $— $— $75 $79 $— $— $79 
   Insurance contracts468 — — 468 524 — — 524 
Derivatives - asset position— — — — 3 — 3 — 
Derivatives - liability position(3)— (3)— — — — — 
Total alternative investments$540 $— $(3)$543 $606 $— $3 $603 
Other Investments:
Pooled Investment Vehicles$685 $685 $— $— $681 $681 $— $— 
Total other investments$685 $685 $— $— $681 $681 $— $— 
Subtotal$1,361 $783 $35 $543 $1,430 $785 $42 $603 
Investments measured at net asset value:
Debt - government-issued$147 $187 
Hedge funds552 667 
Private market securities101 126 
Total investments measured at net asset value
$800 $980 
Items to reconcile to fair value of plan assets:
Pension trust receivables 1
$—    $14    
Pension trust payables 2
—    — 
Total$2,161    $2,424    
1. Primarily receivables for investment securities sold.
2. Primarily payables for investment securities purchased.
The following table summarizes the changes in the fair value of Level 3 pension plan assets for the years ended December 31, 2024 and 2023:
Fair Value Measurement of Level 3 Pension Plan AssetsReal EstateInsurance ContractsTotal
In millions
Balance at Jan 1, 2023$75 $524 $599 
Actual return on assets:
Relating to assets held at Dec 31, 20232 26 28 
Purchases, sales and settlements, net2 (16)(14)
Transfers out of Level 3 1
— (10)(10)
Balance at Dec 31, 2023$79 $524 $603 
Actual return on assets:
Relating to assets held at Dec 31, 2024(6)(56)(62)
Purchases, sales and settlements, net2 (3)(1)
Transfers into Level 3— 3 3 
Balance at Dec 31, 2024$75 $468 $543 
1. Related to the Delrin® Divestiture

Defined Contribution Plans
The Company provides defined contribution benefits to its employees. The most significant is the U.S. Retirement Savings Plan ("the Plan"), which covers all U.S. full-service employees. This Plan includes a non-leveraged Employee Stock Ownership Plan ("ESOP"). Employees are not required to participate in the ESOP and those who do are free to diversify out of the ESOP. The purpose of the Plan is to provide retirement savings benefits for employees and to provide employees an opportunity to become stockholders of the Company. The Plan is a tax qualified contributory profit sharing plan, with cash or deferred arrangement and any eligible employee of the Company may participate. Currently, the Company contributes 100 percent of the first 6 percent of the employee's contribution election and also contributes 3 percent of each eligible employee's eligible compensation regardless of the employee's contribution. The Company's matching contributions vest immediately upon contribution. The 3 percent nonmatching employer contribution vests after employees complete three years of service. The Company's matching contributions to the Plan were $60 million in 2024 and $65 million in 2023. The Company's nonmatching contributions to the Plan were $32 million in 2024 and $34 million in 2023. In total, the Company's contributions to the Plan were $92 million in 2024 and $99 million in 2023. All amounts for 2023 are inclusive of Delrin® activity related to discontinued operations.
In addition, the Company made contributions to other defined contribution plans in 2024 in the amount of $32 million and $35 million in 2023. 2023 is inclusive of Delrin® activity related to discontinued operations.
v3.25.0.1
STOCK-BASED COMPENSATION
 12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
STOCK-BASED COMPENSATION STOCK-BASED COMPENSATION
Effective with the DWDP Merger, on August 31, 2017, DowDuPont assumed all TDCC and EIDP equity incentive compensation awards outstanding immediately prior to the DWDP Merger. The TDCC and EIDP stock-based compensation plans were assumed by DowDuPont and remained in place with the ability to grant and issue DowDuPont common stock until the DWDP Distributions.

Immediately following the Corteva Distribution, DuPont adopted the DuPont Omnibus Incentive Plan ("DuPont OIP") which provides for equity-based and cash incentive awards to certain employees, directors, independent contractors and consultants. Upon adoption of the DuPont OIP, the TDCC and EIDP plans were rolled into the DuPont OIP as separate subplans and no longer granted new awards. All previously granted equity awards under these subplans have the same terms and conditions that were applicable to the awards under the TDCC and EIDP plans immediately prior to the DWDP Distributions. Due to reaching the plan term of the DuPont OIP, no further awards will be granted from the plan. Awards that are outstanding under the DuPont OIP remain outstanding in accordance with their terms.

During the second quarter of 2020, the stockholders of DuPont approved the DuPont 2020 Equity and Incentive Plan (the "2020 EIP"), which allows the Company to grant options, share appreciation rights, restricted shares, restricted stock units ("RSUs"), share bonuses, other share-based awards, cash awards, each as defined in the 2020 EIP, or any combination of the foregoing. Under the EIP, a maximum of 15 million shares of common stock are available for award as of December 31, 2024. The approval of the 2020 Plan had no effect on the Company’s ability to make future grants under the DuPont OIP in accordance with its terms, and awards that are outstanding under the DuPont OIP remain outstanding in accordance with their terms.
A description of the Company's stock-based compensation is discussed below followed by a description of TDCC and EIDP stock-based compensation.

Accounting for Stock-Based Compensation
The Company grants stock-based compensation awards that vest over a specified period or upon employees meeting certain performance and/or retirement eligibility criteria. The fair value of equity instruments issued to employees is measured on the grant date. The fair value of liability instruments issued to employees is measured at the end of each quarter. The fair value of equity and liability instruments is expensed over the vesting period or, in the case of retirement, from the grant date to the date on which retirement eligibility provisions have been met and additional service is no longer required. The Company estimates expected forfeitures.

DuPont recognized share-based compensation expense in continuing operations of $77 million, $74 million, and $75 million during the years ended December 31, 2024, 2023 and 2022, respectively. The income tax benefits related to stock-based compensation arrangements were $16 million for the years ended December 31, 2024, 2023 and 2022,.

Total unrecognized pretax compensation cost in continuing operations related to nonvested stock option awards of $0.2 million at December 31, 2024, is expected to be recognized over a weighted-average period of 0.1 years. Total unrecognized pretax compensation cost in continuing operations related to RSUs and performance based stock units ("PSUs") of $77 million at December 31, 2024, is expected to be recognized over a weighted average period of 1.8 years. The total fair value of RSUs and PSUs vested in the year ended December 31, 2024 was $78 million. The weighted average grant-date fair value of RSUs and PSUs granted during 2024 was $70.70.

At the time of the M&M Divestiture, outstanding, unvested share-based compensation awards granted in 2022 and held by Employees transferred to Celanese were terminated and reissued as equity awards under the Celanese stock plan. Pre-2022 awards held by M&M Employees were settled by DuPont based on vesting conditions noted in respective grant agreements.

DuPont 2020 Equity Incentive Plan
EIP Stock Options
The exercise price of shares subject to option is equal to the market price of the Company's stock on the date of grant. Stock option awards expire 10 years after the grant date. The plan allows retirement-eligible employees of the Company to retain any granted awards upon retirement provided the employee has rendered at least 12 months of service following the grant date.

The Company uses the Black-Scholes option pricing model to determine the fair value of stock option awards and the assumptions set forth in the table below. The weighted-average assumptions used to calculate total stock-based compensation are included in the following table:
EIP Weighted-Average Assumptions 1
2022
Dividend yield1.8 %
Expected volatility26.4 %
Risk-free interest rate1.9 %
Expected life of stock options granted during period (years)6.0
1. No stock options were granted by the Company out of the EIP plan in 2024 or 2023.

The Company determines the dividend yield by dividing the annualized dividend on DuPont's common stock by the option exercise price. A historical daily measurement of volatility is determined based on the expected life of the option granted. The risk-free interest rate is determined by reference to the yield on an outstanding U.S. Treasury note with a term equal to the expected life of the option granted. Expected life is determined by reference to DuPont's historical experience, adjusted for expected exercise patterns of in-the-money options.
The following table summarizes stock option activity for 2024 under the EIP:
EIP Stock OptionsNumber of Shares
 (in thousands)		Weighted Average Exercise Price (per share)Weighted Average Remaining Contractual Term (in years)Aggregate Intrinsic Value (in thousands)
Outstanding at January 1, 2024627 $74.48 
Granted 1
— $— 
Exercised(106)$73.91 
Forfeited/Expired(12)$74.40 
Outstanding at December 31, 2024509 $74.61 6.58$837 
Exercisable at December 31, 2024375 $74.45 6.41$674 
1. No awards were granted by the Company out of the EIP plan in 2024 and 2023.

Additional Information about EIP Stock Options 1
In millions, except per share amounts202420232022
Weighted-average fair value per share of options granted 1
$— $— $17.41 
Total compensation expense for stock options plans 2
$12 $10 $8 
  Related tax benefit 2
$2 $2 $2 
1. No stock options were granted by the Company out of the EIP plan in 2024 and 2023.
2. These amounts represent life to date.

The aggregate intrinsic values in the table above represent the total pretax intrinsic value (the difference between the closing stock price on the last trading day of 2024 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their in-the-money options at year end.

EIP Restricted Stock Units and Performance Based Stock Units
The Company grants RSUs to certain employees that generally vest over a three-year period and, upon vesting, convert one-for-one to DuPont common stock. For grants issued prior to 2024, retirement eligible employee retains any granted awards upon retirement provided the employee has rendered at least 12 months of service following the grant date. For grants issued in 2024, a retirement eligible employee retains a prorated portion of any granted awards upon retirement provided the employee has rendered at least 12 months of service following the grant date. The fair value of all stock-settled RSUs is based upon the market price of the underlying common stock as of the grant date.

The Company grants PSUs to senior leadership under the DuPont EIP. Vesting for PSUs granted is based upon achieving certain return on invested capital ("ROIC") targets and certain adjusted corporate net income annual growth targets, weighted evenly between the metrics and modified by a relative total shareholder return ("TSR") percentile ranking goal as compared to the S&P 500. The actual award, delivered as DuPont common stock, can range from zero percent to 200 percent of the original grant. The weighted-average grant-date fair value of the PSUs, subject to the TSR metric, is based upon the market price of the underlying common stock as of the grant date and estimated using a Monte Carlo simulation.

Nonvested awards of RSUs and PSUs are shown below:
EIP RSUs and PSUsNumber of Shares
(in thousands)		Weighted Average Grant Date Fair Value
(per share)
Nonvested at January 1, 20241,991 $69.85 
Granted1,212 $70.70 
Vested(880)$72.86 
Forfeited(119)$69.88 
Nonvested at December 31, 20242,204 $69.11 

DuPont Omnibus Incentive Plan
The DuPont OIP has two subplans that have the same terms and conditions of the TDCC and EIDP plans immediately prior to the DWDP Distributions. Awards previously granted under those plans that were nonvested will now vest in each subplan. No awards were granted by the Company out of the OIP plan in 2024, 2023 or 2022. All new awards will be granted by the EIP.
OIP Stock Options
The exercise price of shares subject to option is equal to the market price of the Company's stock on the date of grant. Stock option awards expire 10 years after the grant date. The plan allows retirement-eligible employees of the Company to retain any granted awards upon retirement provided the employee has rendered at least six months of service following the grant date.

The Company uses the Black-Scholes option pricing model to determine the fair value of stock option awards. No awards were granted by the Company out of the OIP plan in 2024, 2023 and 2022.

The Company determines the dividend yield by dividing the annualized dividend on DuPont's common stock by the option exercise price. A historical daily measurement of volatility (using DowDuPont stock information after the DWDP Merger date and a weighted average of TDCC and EIDP prior to DWDP Merger date) is determined based on the expected life of the option granted. The risk-free interest rate is determined by reference to the yield on an outstanding U.S. Treasury note with a term equal to the expected life of the option granted. Expected life is determined by reference to DuPont's historical experience, adjusted for expected exercise patterns of in-the-money options.

The following table summarizes stock option activity for 2024 under the OIP:
OIP Stock OptionsNumber of Shares
 (in thousands)		Weighted Average Exercise Price (per share)Weighted Average Remaining Contractual Term (in years)Aggregate Intrinsic Value (in thousands)
Outstanding at January 1, 20241,637 $62.58 
Granted— $— 
Exercised(217)$62.55 
Forfeited/Expired(30)$64.16 
Outstanding at December 31, 20241,390 $62.55 5.12$19,041 
Exercisable at December 31, 20241,390 $62.55 5.12$19,041 

Additional Information about OIP Stock Options 1
In millions, except per share amounts202420232022
Total compensation expense for stock options plans 2
$27 $26 $25 
  Related tax benefit 2
$6 $6 $5 
1. No awards were granted by the Company out of the OIP plan in 2024, 2023 or 2022.
2.These amounts represent life to date.

The aggregate intrinsic values in the table above represent the total pretax intrinsic value (the difference between the closing stock price on the last trading day of 2024 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their in-the-money options at year end.

OIP Restricted Stock Units and Performance Based Stock Units
The Company grants RSUs to certain employees that serially vested over a three-year period and, upon vesting, convert one-for-one to DuPont common stock. A retirement eligible employee retains any granted awards upon retirement provided the employee has rendered at least six months of service following the grant date. The fair value of all stock-settled RSUs is based upon the market price of the underlying common stock as of the grant date.

The Company grants PSUs to senior leadership under a subplan of the DuPont OIP. Vesting for PSUs granted is based upon achieving certain return on invested capital ("ROIC") targets and certain adjusted corporate net income annual growth targets, weighted evenly between the metrics and modified by a relative total shareholder return ("TSR") percentile ranking goal as compared to the S&P 500. The actual award, delivered as DuPont common stock, can range from zero percent to 200 percent of the original grant. The weighted-average grant-date fair value of the PSUs, subject to the TSR metric, is based upon the market price of the underlying common stock as of the grant date and estimated using a Monte Carlo simulation.
Nonvested awards of RSUs and PSUs are shown below.
OIP RSUs and PSUsNumber of Shares
(in thousands)		Weighted Average Grant Date Fair Value
(per share)
Nonvested at January 1, 2024163 $68.01 
Granted— $— 
Vested(109)$71.93 
Forfeited(3)$71.42 
Nonvested at December 31, 202451 $59.40 

TDCC Stock Incentive Plan
In connection with the DWDP Merger, on August 31, 2017 all outstanding TDCC stock options under the TDCC 2012 Stock Incentive Plan (the "2012 Plan") were converted into stock options with respect to DowDuPont Common Stock.

TDCC Stock Options
TDCC granted stock options to certain employees, subject to certain annual and individual limits, with terms of the grants fixed at the grant date. The exercise price of each stock option equals the market price of TDCC’s stock on the grant date. Options vest from one year to three years, and had a maximum term of 10 years. To measure the fair value of the awards on the date of grant, TDCC used the Black-Scholes option pricing model. No awards were granted by the Company out of the TDCC plan during 2024, 2023 and 2022.

EIDP Equity Incentive Plan
EIDP Stock Options
The exercise price of shares subject to option is equal to the market price of EIDP's stock on the date of grant. All options vest serially over a three-year period. Stock option awards expire ten years after the grant date. The plan allowed retirement-eligible employees of EIDP to retain any granted awards upon retirement provided the employee has rendered at least six months of service following the grant date. There were no options granted out of the EIDP EIP in 2024, 2023 and 2022.

EIDP determined the dividend yield by dividing the annualized dividend on DowDuPont's Common Stock by the option exercise price. A historical daily measurement of volatility (using DowDuPont stock information after the DWDP Merger date and a weighted average of TDCC and EIDP prior to DWDP Merger date) is determined based on the expected life of the option granted. The risk-free interest rate is determined by reference to the yield on an outstanding U.S. Treasury note with a term equal to the expected life of the option granted. Expected life is determined by reference to EIDP's historical experience, adjusted for expected exercise patterns of in-the-money options.

The following table summarizes stock option activity for 2024:
EIDP Stock OptionsNumber of Shares
(in thousands)		Weighted Average Grant Date Fair Value
(per share)		Weighted Average Remaining Contractual Term (in years)Aggregate Intrinsic Value (in thousands)
Outstanding at January 1, 20242,228 $73.49 
Exercised(205)$70.48 
Forfeited/Expired(21)$76.58 
Outstanding at December 31, 20242,002 $73.77 2.7$8,804 
Exercisable at December 31, 20241,997 $73.78 2.7$8,760 

EIDP Restricted Stock Units
EIDP issued RSUs that serially vested over a three-year period. A retirement eligible employee retains any granted awards upon retirement provided the employee has rendered at least six months of service following the grant date. Additional RSUs were also granted periodically to key senior management employees. These RSUs generally vested over periods ranging from three years to five years. The fair value of all stock-settled RSUs is based upon the market price of the underlying common stock as of the grant date. The awards have the same terms and conditions as were applicable to such equity awards immediately prior to the DWDP Merger closing date. As of December 31, 2024, there are no material nonvested awards of RSUs and no RSUs granted out of the EIDP EIP in 2024, 2023 and 2022.
v3.25.0.1
FINANCIAL INSTRUMENTS
 12 Months Ended
Dec. 31, 2024
Investments, All Other Investments [Abstract]  
FINANCIAL INSTRUMENTS FINANCIAL INSTRUMENTS
The following table summarizes the fair value of financial instruments at December 31, 2024 and December 31, 2023:
Fair Value of Financial InstrumentsDecember 31, 2024December 31, 2023
In millionsCostGainLossFair ValueCostGainLossFair Value
Cash equivalents$314 $— $— $314 $408 $— $— $408 
Restricted cash equivalents 1
$42 $— $— $42 $411 $— $— $411 
Total cash and restricted cash equivalents$356 $— $— $356 $819 $— $— $819 
Long-term debt including debt due within one year 2
$(7,171)$14 $(57)$(7,214)$(7,859)$70 $(206)$(7,995)
Derivatives relating to:
Net investment hedge 3
— 137 — 137 — 96 — 96 
Foreign currency 4, 5
— 8 (8)— — 26 (23)3 
Interest rate swap agreements 6
— — (206)(206)— — (59)(59)
Total derivatives$— $145 $(214)$(69)$— $122 $(82)$40 
1.Refer to Note 7 and Note 16 for more information on Restricted cash equivalents.
2.At December 31, 2024 the balance included unamortized basis adjustment of $48 million related to the 2022 Swaps, discussed below. At December 31, 2023, the balance included a fair value hedging revaluation related to the 2022 Swaps of $59 million, discussed below. Fair value of long-term debt including debt due within one year is based on quoted market prices for the same or similar issues, or on current rates offered to the company for debt of the same remaining maturities and terms and represents a Level 2 fair value measurement.
3.Classified as "Deferred charges and other assets" in the Consolidated Balance Sheets.
4.Classified as "Prepaid and other current assets" and "Accrued and other current liabilities" in the Consolidated Balance Sheets.
5.Presented net of cash collateral where master netting arrangements allow.
6.The loss on the 2022 and 2024 Swaps are classified as "Other noncurrent obligations" and "Accrued and other current liabilities", respectively, in the Consolidated Balance Sheets.

Derivative Instruments
Objectives and Strategies for Holding Derivative Instruments
In the ordinary course of business, the Company enters into contractual arrangements (derivatives) to reduce its exposure to foreign currency, interest rate and commodity price risks. The Company has established a variety of derivative programs to be utilized for financial risk management. These programs reflect varying levels of exposure coverage and time horizons based on an assessment of risk.

Derivative programs have procedures and controls and are approved by the Corporate Financial Risk Management Committee, consistent with the Company's financial risk management policies and guidelines. Derivative instruments used are forwards, options, futures and swaps.

The Company's financial risk management procedures also address counterparty credit approval, limits and routine exposure monitoring and reporting. The counterparties to these contractual arrangements are major financial institutions and major commodity exchanges. The Company is exposed to credit loss in the event of nonperformance by these counterparties. The Company utilizes collateral support annex agreements with certain counterparties to limit its exposure to credit losses. The Company anticipates performance by counterparties to these contracts and therefore no material loss is expected. Market and counterparty credit risks associated with these instruments are regularly reported to management.

The notional amounts of the Company's derivative instruments were as follows:
Notional AmountsDecember 31, 2024December 31, 2023
In millions
Derivatives designated as hedging instruments:
   Net investment hedge$1,000 $1,000 
   Interest rate swap agreements$— $1,000 
Derivatives not designated as hedging instruments:
Foreign currency contracts 1
$(1,176)$(907)
Interest rate swap agreements 2
$4,150 $— 
1.Presented net of contracts bought and sold.
2.Includes notional amounts related to the 2022 Swaps and 2024 Swaps, described further below.
Derivatives Designated in Hedging Relationships
Net Foreign Investment Hedge
In the second quarter of 2021, the Company entered into a fixed-for-fixed cross currency swaps with an aggregate notional amount totaling $1 billion to hedge the variability of exchange rate impacts between the U.S. Dollar and Euro. Under the terms of the cross-currency swap agreement, the Company notionally exchanged $1 billion at an interest rate of 4.73 percent for €819 million at a weighted average interest rate of 3.26 percent. The cross-currency swap is designated as a net investment hedge and expires on November 15, 2028.

The Company has made an accounting policy election to account for the net investment hedge using the spot method. The Company has also elected to amortize the excluded components in interest expense in the related quarterly accounting period that such interest is accrued. The cross-currency swap is marked to market at each reporting date and any unrealized gains or losses are included in unrealized currency translation adjustments within AOCL, net of amounts associated with excluded components which are recognized in interest expense in the Consolidated Statements of Operations.

Derivatives not Designated in Hedging Relationships
Foreign Currency Contracts
The Company routinely uses forward exchange contracts to reduce its net exposure, by currency, related to foreign currency-denominated monetary assets and liabilities of its operations so that exchange gains and losses resulting from exchange rate changes are minimized. The netting of such exposures precludes the use of hedge accounting; however, the required revaluation of the forward contracts and the associated foreign currency-denominated monetary assets and liabilities intends to achieve a minimal earnings impact, after taxes. The Company also uses foreign currency exchange contracts to offset a portion of the Company's exposure to certain foreign currency-denominated revenues so that gains and losses on the contracts offset changes in the USD value of the related foreign currency-denominated revenues.

Foreign currency derivatives not designated as hedges are used to offset foreign exchange gains or losses resulting from the underlying exposures of foreign currency-denominated assets and liabilities. The amount charged on a pretax basis related to foreign currency derivatives not designated as a hedge, which was included in “Sundry income (expense) - net” in the Consolidated Statements of Operations, was a loss of $32 million for the year ended December 31, 2024 ($64 million loss for the year ended December 31, 2023 and $32 million loss for the year ended December 31, 2022).

Interest Rate Swap Agreements
In the second quarter of 2022, the Company entered into fixed-to-floating interest rate swap agreements ("2022 Swaps") with an aggregate notional principal amount totaling $1 billion to hedge changes in the fair value of the Company’s long-term debt due to interest rate change movements. These swaps converted $1 billion of the Company’s $1.65 billion principal amount of fixed rate notes due 2038 into floating rate debt for the portion of their terms through 2032 with an interest rate based on the Secured Overnight Financing Rate ("SOFR"). Under the terms of the agreements, the Company agrees to exchange, at specified intervals, fixed for floating interest amounts based on the agreed upon notional principal amount. The 2022 Swaps expire on November 15, 2032 and are carried at fair value.

Since inception of the 2022 Swaps, fair value hedge accounting has been applied and thus, changes in the fair value of the 2022 Swaps and changes in the fair value of the related hedged portion of long-term debt were presented and net to zero in "Sundry income (expense) – net" in the Consolidated Statements of Operations. On June 5, 2024, DuPont issued a notice of redemption to the bond trustee with respect to a partial redemption of $650 million aggregate principal amount of its 2038 Notes in accordance with their terms. The redemption was effective on June 15, 2024. As a result of the announced redemption, the Company dedesignated the current hedging relationship. At the time of dedesignation, the total amount recorded as a cumulative fair value basis adjustment on the 2038 Notes was a loss of $81 million of which $32 million was recognized as a component of the loss from partial extinguishment of debt. The remaining basis adjustment is amortized to interest expense over the remaining term of the 2038 Notes. The basis adjustment amortization for the year December 31, 2024 was $1 million. Refer to Note 15 for additional details on the partial redemption of the 2038 Notes.

In June 2024, the Company entered into two forward-starting fixed-to-floating interest rate swap agreements (“2024 Swaps”) to hedge the changes in the fair value of the Company’s long-term debt due to interest rate change movements. One swap converted $2.15 billion principal amount of the fixed rate notes due 2048 into floating rate debt for the portion of their terms from 2025 through 2048 with an interest rate based on SOFR. The other swap converted $1 billion principal amount of the fixed rate notes due 2038 into floating rate debt for the portion of their terms from 2032 through 2038 with an interest rate also based on SOFR. The 2024 Swaps have a mandatory early termination date of December 15, 2025 and are carried at fair value. At December 31, 2024, the mark-to-market value of the 2024 Swaps is $116 million, and final settlement will depend on movements in interest rates. Fair value hedge accounting has not been applied.
The 2022 Swaps and 2024 Swaps are considered economic hedges of the Company’s fixed rate debt. As such, changes in the fair value and gain or loss from net interest settlement of the 2022 Swaps after the date of dedesignation and changes in the fair value of the 2024 Swaps since inception have been recorded in “Sundry income (expense) – net” in the Consolidated Statements of Operations. The amount charged related to interest rate swaps not designated as hedges was a loss of $138 million and zero for the years December 31, 2024 and 2023, respectively.
v3.25.0.1
FAIR VALUE MEASUREMENTS
 12 Months Ended
Dec. 31, 2024
Fair Value Disclosures [Abstract]  
FAIR VALUE MEASUREMENTS FAIR VALUE MEASUREMENTS
Fair Value Measurements on a Recurring Basis
The following tables summarize the basis used to measure certain assets and liabilities at fair value on a recurring basis:
Basis of Fair Value Measurements on a Recurring Basis of Significant Other Observable Inputs (Level 2)
December 31, 2024December 31, 2023
In millions
Assets at fair value:
Cash equivalents 1
$314 $364 
Derivatives relating to: 2
Net investment hedge137 96 
Foreign currency contracts 3
23 37 
Total assets at fair value$474 $497 
Liabilities at fair value:
Derivatives relating to: 2
Interest rate swap agreements206 59 
Foreign currency contracts 3
23 34 
Total liabilities at fair value$229 $93 
1.Time deposits included in "Cash and cash equivalents" in the Consolidated Balance Sheets are held at amortized cost, which approximates fair value. "Restricted cash and cash equivalents" and "Restricted cash and cash equivalents - noncurrent" in the Consolidated Balance Sheets at December 31, 2024 included $42 million of money market funds representing Level 1 fair value measurement investments which are held at amortized cost. "Cash and cash equivalents" and "Restricted cash and cash equivalents" in the Consolidated Balance Sheets at December 31, 2023, included $50 million of money market funds and $405 million deposited within a qualified settlement fund consisting of treasury bills, respectively, representing Level 1 fair value measurement investment, also held at amortized cost.
2.See Note 21 for the classification of derivatives in the Consolidated Balance Sheets.
3.Assets and liability derivatives subject to an enforceable master netting arrangement with the same counterparty are presented on a net basis in the Consolidated Balance Sheets. The offsetting counterparty and cash collateral amounts were $15 million and zero, respectively, for both assets and liabilities as of December 31, 2024. The offsetting counterparty and cash collateral amounts were $11 million and zero, respectively, for both assets and liabilities as of December 31, 2023.

As part of the Donatelle Plastics Acquisition, the purchase agreement includes annual contingent earn-out payments based upon customer specific revenue generated through December 31, 2029, with total accumulated earn-out payments of up to $85 million. The contingent earn-out liability was established using a Monte Carlo simulation and the significant assumption used is the estimated likelihood the customer specific revenue is earned. The contingent earn-out liability estimate represents a recurring fair value measurement with significant unobservable inputs. The fair value of the contingent earn-out liability is sensitive to changes in the interest rates, discount rates and the timing of the future payments, which are based upon estimates of future achievement of the customer specific revenue. Changes in the fair values of the contingent earn-out liability will be recognized in Sundry income/expense, net in the Consolidated Statements of Operations. The fair value of the contingent earn-out liability is reflected in “Accrued expenses and other liabilities” on the Consolidated Balance Sheets. See Note 3 for additional information.
Basis of Fair Value Measurements on a Recurring Basis of Significant Unobservable Inputs (Level 3)
December 31, 2024December 31, 2023
In millions
Liabilities at fair value:
Contingent earn-out liabilities
$40 $— 
Total liabilities at fair value$40 $— 

For assets and liabilities classified as Level 2 measurements, where the security is frequently traded in less active markets, fair value is based on the closing price at the end of the period; where the security is less frequently traded, fair value is based on the price a dealer would pay for the security or similar securities, adjusted for any terms specific to that asset or liability, or by using observable market data points of similar, more liquid securities to imply the price. For time deposits classified as held-to-maturity investments and reported at amortized cost, fair value is based on an observable interest rate for similar securities.
Market inputs are obtained from well-established and recognized vendors of market data and subjected to tolerance and quality checks.

For derivative assets and liabilities, standard industry models are used to calculate the fair value of the various financial instruments based on significant observable market inputs, such as foreign exchange rates, commodity prices, swap rates, interest rates and implied volatility obtained from various market sources. Market inputs are obtained from well-established and recognized vendors of market data and subjected to tolerance/quality checks.

For all other assets and liabilities for which observable inputs are used, fair value is derived through the use of fair value models, such as a discounted cash flow model or other standard pricing models.

There were no transfers between Levels 1 and 2 during the years ended December 31, 2024 and December 31, 2023.

Fair Value Measurements on a Nonrecurring Basis
The following table summarizes the basis used to measure certain assets at fair value on a nonrecurring basis:
Basis of Fair Value Measurements on a Nonrecurring Basis 1
Significant Other Unobservable Inputs (Level 3)Total Losses
In millions
At December 31, 2023
Assets at fair value:
   Goodwill$4,814 $(804)
At December 31, 2022
Assets at fair value:
    Long-lived assets, intangible assets, and other assets$55 $(94)
1.The Company did not incur any losses associated with fair value measurements on a nonrecurring basis for the year ended December 31, 2024.

2023 Fair Value Measurements on a Nonrecurring Basis
During the fourth quarter of 2023, the Company recorded an impairment charge related to goodwill within Water & Protection. The impairment analysis was performed using Level 3 inputs within the fair value hierarchy. See Note 14 for further discussion.

2022 Fair Value Measurements on a Nonrecurring Basis
During the first quarter of 2022, the Company recorded an impairment charge related to equity method investments within Electronics & Industrial. The impairment analysis was performed using Level 3 inputs within the fair value hierarchy. See Note 6 for further discussion.
v3.25.0.1
SEGMENTS AND GEOGRAPHIC REGIONS
 12 Months Ended
Dec. 31, 2024
Segment Reporting [Abstract]  
SEGMENTS AND GEOGRAPHIC REGIONS SEGMENTS AND GEOGRAPHIC REGIONS
The Company's segments are aligned with the market verticals they serve, while maintaining integration and innovation strengths within strategic value chains. DuPont is comprised of two operating segments: Electronics & Industrial and Water & Protection. Major products by segment include: Electronics & Industrial (printing and packaging materials, photopolymers, electronic materials, specialty silicones and lubricants); and Water & Protection (nonwovens, aramids, construction materials, water filtration and purification resins, elements and membranes). The Company operates globally in substantially all of its product lines. Transfers of products between operating segments are generally valued at cost, to the extent such transfers are applicable.

The revenues and certain expenses of the M&M Divestitures are classified as discontinued operations in the current and historical periods. The Auto Adhesives & Fluids, MultibaseTM and Tedlar® product lines within the historical Mobility & Materials segment (the "Retained Businesses") are not included in the scope of the M&M Divestitures and are reflected within Corporate & Other. Corporate & Other includes DuPont's equity interest in Derby Holdings Group related to the Delrin® Divestiture.

The historic Mobility & Material segment costs that are classified as discontinued operations include only direct operating expenses incurred prior to the November 1, 2022 M&M Divestiture and November 1, 2023 Delrin® Divestiture. Indirect costs, such as those related to corporate and shared service functions previously allocated to the M&M Businesses, do not meet the criteria for discontinued operations and remain reported within continuing operations. A portion of these indirect costs include costs related to activities the Company will continue to undertake post-closing of the M&M Divestitures, and for which it is reimbursed (“Future Reimbursable Indirect Costs”). Future Reimbursable Indirect Costs are reported within continuing operations but are excluded from operating EBITDA as defined below. The remaining portion of these indirect costs are not subject to future reimbursement (“Stranded Costs”). Stranded Costs are reported within continuing operations in Corporate & Other and are included within Operating EBITDA.

The Company's measure of profit/loss for segment reporting purposes is Operating EBITDA as this is the manner in which the Company's chief operating decision maker ("CODM"), the Chief Executive Officer, assesses performance and allocates resources. The CODM utilizes Operating EBITDA to assess financial performance and allocate resources by comparing actual results to historical and previously forecasted results. The Company defines Operating EBITDA as earnings (i.e., “Income from continuing operations before income taxes") before interest, depreciation, amortization, non-operating pension / OPEB benefits / charges, and foreign exchange gains / losses, excluding Future Reimbursable Indirect Costs, and adjusted for significant items. Reconciliations of these measures are provided on the following pages.

Sales are attributed to geographic regions based on customer location; long-lived assets are attributed to geographic regions based on asset location.
Net Trade Revenue by Geographic Region202420232022
(In millions) For the years ended December 31,
United States$4,102 $3,914 $4,066 
Canada273 271 293 
EMEA 1
2,146 2,203 2,193 
Asia Pacific 2
5,368 5,191 6,022 
Latin America497 489 443 
Total$12,386 $12,068 $13,017 
1.Europe, Middle East and Africa.
2. Net sales attributed to China/Hong Kong, for the years ended December 31, 2024, 2023 and 2022 were $2,345 million, $2,206 million, and $2,744 million, respectively.

Long-lived Assets by Geographic RegionDecember 31,
In millions202420232022
United States$3,590 $3,559 $3,501 
Canada60 54 49 
EMEA 1
1,259 1,336 1,271 
Asia Pacific823 896 883 
Latin America36 39 27 
Total$5,768 $5,884 $5,731 
1.Europe, Middle East and Africa.
Segment Revenue, Significant Segment Expenses and Segment Operating EBITDAFor the years ended December 31,
202420232022
(In millions)Electronics & IndustrialWater & ProtectionElectronics & IndustrialWater & ProtectionElectronics & IndustrialWater & Protection
Segment net sales$5,930 $5,423 $5,337 $5,633 $5,917 $5,957 
Less 1:
Cost of sales$3,420 $3,674 $3,139 $3,879 $3,341 $4,149 
Selling, general and administrative expenses761 574 647 545 632 554 
Research and development expenses366 141 348 138 377 131 
Amortization of intangibles & other segment items 2
341 226 354 225 342 225 
Add:
Equity in earnings of nonconsolidated affiliates$37 $30 $16 $35 $31 $39 
Depreciation and amortization 3
638 522 607 507 580 494 
Segment Operating EBITDA$1,717 $1,360 $1,472 $1,388 $1,836 $1,431 
1.The significant expense categories and amounts align with the segment-level information that is regularly provided to the chief operating decision maker.
2.Other segment items include immaterial other gains or losses and miscellaneous income and expenses.
3.Depreciation is a reconciling item to segment Operating EBITDA as it is included within Cost of sales, Selling, general and administrative expenses and Research and development expenses.

Total reportable segment net sales are $11,353 million, $10,970 million and $11,874 million for the years ended December 31, 2024, 2023 and 2022, respectively.

Reconciliation of Segment Operating EBITDA to Income from continuing operations before income taxesFor the years ended December 31,
(In millions)202420232022
Electronics & Industrial Segment Operating EBITDA$1,717 $1,472 $1,836 
Water & Protection Segment Operating EBITDA1,360 1,388 1,431 
Reportable Segment Operating EBITDA$3,077 $2,860 $3,267 
+Corporate & Other Operating EBITDA$67 $82 $(6)
-Depreciation and amortization1,194 1,147 1,135 
+
Interest income 1
73 155 50 
-
Interest expense 2
364 396 486 
+
Non-operating pension/OPEB benefit costs (credits) 1
18 (9)28 
+
Foreign exchange gains (losses), net 1
3 (73)15 
-Future reimbursable indirect costs— 7 52 
+Significant items charge(488)(961)(233)
Income from continuing operations before income taxes$1,192 $504 $1,448 
1.Included in "Sundry income (expense) - net."
2.The years ended December 31, 2024 and 2022 excludes significant items, refer to details below.
The following tables summarize the pre-tax impact of significant items that are excluded from Operating EBITDA above:
Significant Items for the Year Ended December 31, 2024Electronics & IndustrialWater & ProtectionCorporate & OtherTotal
In millions
Acquisition, integration and separation costs 1
$(12)$— $(156)$(168)
Restructuring and asset related charges - net 2
(5)(50)(32)(87)
Inventory write-offs 3
— (25)— (25)
Inventory step-up amortization 4
(2)— — (2)
Loss on debt extinguishment 5
— — (74)(74)
Interest rate swap items 6
— — (140)(140)
Income tax items 7
— — 8 8 
Total$(19)$(75)$(394)$(488)
1. Acquisition, integration and separation costs related to the Previously Intended Business Separations and the Intended Electronics Separation, and the acquisitions of Spectrum and Donatelle Plastics.
2. Includes restructuring actions and asset related charges. See Note 6 for additional information.
3. Reflects inventory write-offs recorded in “Cost of Sales” in connection with restructuring actions. See Note 6 for additional information.
4. Reflects the amortization of an inventory step-up adjustment related the Donatelle Plastics Acquisition.
5. Reflects the loss on extinguishment of debt related to the partial redemption of an aggregate principal amount of the 2038 Notes. Refer to Note 15 for further details.
6. Includes the non-cash mark-to-market loss related to the 2022 Swaps and 2024 Swaps, net interest settlement loss related to the 2022 Swaps and $2 million of basis amortization on the 2022 Swaps. Refer to Note 21 for further details.
7. Reflects the impact of an indemnified international tax audit.

Significant Items for the Year Ended December 31, 2023Electronics & IndustrialWater & ProtectionCorporate & OtherTotal
In millions
Acquisition, integration and separation costs 1
$(20)$— $— $(20)
Restructuring and asset related charges - net 2
(49)(55)(42)(146)
Goodwill impairment charge 3
— (804)— (804)
Gain on divestiture 4
7 1 1 9 
Total$(62)$(858)$(41)$(961)
1. Acquisition, integration and separation costs related to the Spectrum Acquisition.
2. Includes restructuring actions and asset related charges. See Note 6 for additional information.
3. Reflects a non-cash goodwill impairment charge in the Protection Reporting unit (aggregation of Safety and Shelter businesses). See Note 14 for additional information.
4. Reflected in "Sundry income (expense) - net."

Significant Items for the Year Ended December 31, 2022Electronics & IndustrialWater & ProtectionCorporate & OtherTotal
In millions
Acquisition, integration and separation costs 1
$— $— $(193)$(193)
Restructuring and asset related charges - net 2
(24)(17)(20)(61)
Asset impairment charges 3
(94)— — (94)
Gain on divestiture 4
— 37 32 69 
Terminated Intended Rogers Acquisition financing fees 5
— — (6)(6)
Employee Retention Credit 6
20 20 12 52 
Total$(98)$40 $(175)$(233)
1. Acquisition, integration and separation costs related to strategic initiatives including the sale of the Biomaterials business unit, the acquisition of Laird PM, and the termination fee of $162.5 million associated with the Terminated Intended Rogers Corporation Acquisition.
2. Includes restructuring actions and asset related charges. See Note 6 for additional information.
3. Relates to an impairment of an equity method investment. See Note 6 for additional information.
4. Reflected in "Sundry income (expense) - net." See Note 4 for additional information.
5. Includes acquisition costs associated with the Terminated Intended Rogers Corporation Acquisition related to the financing agreements, specifically the structuring fees and the amortization of the commitment fees reflected in "Interest Expense."
6. Employee Retention Credit pursuant to the Coronavirus Aid, Relief, and Economic Security (“CARES”) Act as enhanced by the Consolidated Appropriations Act (“CAA”) and American Rescue Plan Act (“ARPA”) reflected in "Cost of sales," "Research and development expenses" and "Selling, general and administrative expenses."
Segment and Corporate & Other InformationElectronics & IndustrialWater & ProtectionCorporate & OtherTotal
In millions
For the Year Ended December 31, 2024
Assets of continuing operations$18,537 $13,098 $5,001 $36,636 
Investment in nonconsolidated affiliates382 278 118 778 
Capital expenditures340 230 49 619 
For the Year Ended December 31, 2023
Assets of continuing operations$18,622 $13,750 $6,180 $38,552 
Investment in nonconsolidated affiliates386 280 122 788 
Capital expenditures306 240 44 590 
For the Year Ended December 31, 2022
Assets of continuing operations$17,110 $14,831 $8,123 $40,064 
Investment in nonconsolidated affiliates396 290 — 686 
Capital expenditures290 289 80 659 

Total Asset Reconciliation at December 31,202420232022
In millions
Assets of continuing operations$36,636 $38,552 $40,064 
Assets of discontinued operations— — 1,291 
Total assets$36,636 $38,552 $41,355 

Capital Expenditure Reconciliation to Consolidated Financial Statements202420232022
In millions
Segment and Corporate & Other Totals$619 $590 $659 
Other 1
(40)29 3 
Total$579 $619 $662 
1.Reflects the incremental cash spent or unpaid on capital expenditures; total capital expenditures are presented on a cash basis.
v3.25.0.1
Pay vs Performance Disclosure - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Pay vs Performance Disclosure      
Net Income (Loss) $ 703 $ 423 $ 5,868
v3.25.0.1
Insider Trading Arrangements
 3 Months Ended
Dec. 31, 2024
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.25.0.1
Insider Trading Policies and Procedures
 12 Months Ended
Dec. 31, 2024
Insider Trading Policies and Procedures [Line Items]  
Insider Trading Policies and Procedures Adopted true
v3.25.0.1
Cybersecurity Risk Management and Strategy Disclosure
 12 Months Ended
Dec. 31, 2024
Cybersecurity Risk Management, Strategy, and Governance [Line Items]  
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]
DuPont has implemented processes for assessing, identifying and managing material risks from cybersecurity threats, which are integrated into the Company’s overall risk management systems and processes. DuPont’s cybersecurity risk management program leverages the National Institute of Standards and Technology (NIST) framework. The Company regularly assesses the threat landscape and takes a holistic view of cybersecurity risks, with a layered cybersecurity strategy based on prevention, detection and containment. The Company has other policies and procedures which directly or indirectly relate to cybersecurity, including those related to remote access monitoring, encryption standards, antivirus protection, multifactor authentication, confidential information and the use of the internet, social media, email and wireless devices. The Company also engages third parties in connection with the assessment of its cybersecurity risk management processes against the NIST framework.

DuPont has dedicated Information Technology security professionals that form the DuPont Cyber Incident Response Team (“DCIRT”). The DCIRT is led by our Chief Information Security Officer (“CISO”) and is responsible for the detection and initial assessment of cybersecurity threats and incidents (collectively, “cyber incidents”), whether internal or experienced by significant third-party service providers, using, among other means, third-party software. The DCIRT classifies detected cyber incidents into one of four categories based on potential impact to the functionality of the affected systems, possible or known information involved and recoverability effort. The classification of a cyber incident is designed to allow rapid prioritization, response and escalation. The CISO and the Chief Information Officer (“CIO”) are alerted as to any detected cyber incident that is potentially significant. Incidents are documented for regular internal reporting processes including notations and considerations of related attacks.

The CIO and CISO are required to engage the Cybersecurity Incident Review Committee (“CIRC”), a subcommittee of the DuPont Disclosure Committee, if a cyber incident has materially affected, or is reasonably likely to materially affect, the Company, including its business strategy, results of operations or financial condition. The CIRC is engaged if, in the opinion of the DCIRT, based on information then-available, a cyber incident is, or it is reasonably possible it may be, classified in one of the highest two severity categories discussed above. The CIRC includes membership representation from information technology, legal, finance, investor relations and internal audit and, if appropriate, the impacted business. The CIRC is responsible for performing a materiality assessment, activating the Crisis Management Committee (“CMC”) when applicable, and overseeing the public disclosure of material cybersecurity matters, as appropriate. The CIRC coordinates with the Company’s legal counsel and third parties, such as consultants and legal advisors, as needed. The CMC is a standing committee comprised of senior management and reports to the CEO. In the event the CMC is activated in relation to a cyber incident, the CEO is required by Board adopted policy to notify the Lead Director and any member of the Board of Directors identified as having cybersecurity expertise.

As part of preparatory and post-closing integration activities in connection with merger and acquisition activity, the Company: (i) conducts a cybersecurity risk threat assessment and when evidence of a breach is uncovered, conducts additional due diligence; (ii) based on the assessment, the Company develops and implements risk mitigation plans if needed and brings the acquisition under the Company’s cyber-attack/breach detection and response programs; and (iii) conducts an internal controls risk and compliance assessment and creates, as needed, responsive action plans intended to mitigate and remediate identified weaknesses in the control environment.

DuPont deploys annual cybersecurity training for employees and considers this a critical step in safeguarding the Company’s data and assets. The training provides employees and contractors with a baseline understanding of cybersecurity fundamentals to prevent security breaches and safely identify potential threats. The course includes enhancements to strengthen our defensive stance against the increasing number and sophistication of cyberattacks worldwide and includes interactive modules covering various areas, including insider attacks, phishing and email attacks, preventing malware attacks, data protection, data handling, passwords, cloud and internet security and cybersecurity fundamentals for mobile devices.
Cybersecurity Risk Management Processes Integrated [Flag] true
Cybersecurity Risk Management Processes Integrated [Text Block] DuPont has implemented processes for assessing, identifying and managing material risks from cybersecurity threats, which are integrated into the Company’s overall risk management systems and processes. DuPont’s cybersecurity risk management program leverages the National Institute of Standards and Technology (NIST) framework. The Company regularly assesses the threat landscape and takes a holistic view of cybersecurity risks, with a layered cybersecurity strategy based on prevention, detection and containment. The Company has other policies and procedures which directly or indirectly relate to cybersecurity, including those related to remote access monitoring, encryption standards, antivirus protection, multifactor authentication, confidential information and the use of the internet, social media, email and wireless devices. The Company also engages third parties in connection with the assessment of its cybersecurity risk management processes against the NIST framework.
Cybersecurity Risk Management Third Party Engaged [Flag] true
Cybersecurity Risk Third Party Oversight and Identification Processes [Flag] true
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag] false
Cybersecurity Risk Board of Directors Oversight [Text Block]
The Board, acting through its committee structure, is responsible for overseeing management’s implementation and execution of the risk management process and for coordinating the outcome of reviews by Committees in their respective risk areas. Although each Committee is responsible for overseeing the management of certain risks, the full Board is regularly informed by the Committees about these risks. This helps enable the Board and the Committees to coordinate risk oversight and the relationships among the various risks faced by the Company, including cybersecurity risk.

The full Board is responsible for oversight of cybersecurity risk and receives regular reports from the CIO and the CISO. The CIO and the CISO also present their assessment of material risks from cybersecurity threats to the Board at least annually. The Audit Committee receives periodic reports regarding information technology general controls (“ITGC”) in connection with its oversight of internal control over financial reporting. The impact, if any, of cyber incidents on internal control over financial reporting is also discussed with the full Board. The Nomination and Governance Committee considers cyber expertise in vetting nominees for the Board and recommending Committee appointments, and DuPont’s Board of Directors has determined that one of its independent board members has cybersecurity expertise.
Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]
The full Board is responsible for oversight of cybersecurity risk and receives regular reports from the CIO and the CISO. The CIO and the CISO also present their assessment of material risks from cybersecurity threats to the Board at least annually. The Audit Committee receives periodic reports regarding information technology general controls (“ITGC”) in connection with its oversight of internal control over financial reporting. The impact, if any, of cyber incidents on internal control over financial reporting is also discussed with the full Board. The Nomination and Governance Committee considers cyber expertise in vetting nominees for the Board and recommending Committee appointments, and DuPont’s Board of Directors has determined that one of its independent board members has cybersecurity expertise.
Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]
Cybersecurity is an important part of our risk management processes and an area of focus for DuPont’s Board of Directors and management. The CIO and the CISO are primarily responsible for assessing and managing material risks from cybersecurity threats. The CIO has sixteen years of cybersecurity experience, including seven years with DuPont, and the CISO has seventeen years of cybersecurity experience, including over three years with DuPont. Each of the CIO and CISO maintain industry recognized credentials relevant to their roles.

The Board, acting through its committee structure, is responsible for overseeing management’s implementation and execution of the risk management process and for coordinating the outcome of reviews by Committees in their respective risk areas. Although each Committee is responsible for overseeing the management of certain risks, the full Board is regularly informed by the Committees about these risks. This helps enable the Board and the Committees to coordinate risk oversight and the relationships among the various risks faced by the Company, including cybersecurity risk.

The full Board is responsible for oversight of cybersecurity risk and receives regular reports from the CIO and the CISO. The CIO and the CISO also present their assessment of material risks from cybersecurity threats to the Board at least annually. The Audit Committee receives periodic reports regarding information technology general controls (“ITGC”) in connection with its oversight of internal control over financial reporting. The impact, if any, of cyber incidents on internal control over financial reporting is also discussed with the full Board. The Nomination and Governance Committee considers cyber expertise in vetting nominees for the Board and recommending Committee appointments, and DuPont’s Board of Directors has determined that one of its independent board members has cybersecurity expertise.
Cybersecurity Risk Role of Management [Text Block]
Cybersecurity is an important part of our risk management processes and an area of focus for DuPont’s Board of Directors and management. The CIO and the CISO are primarily responsible for assessing and managing material risks from cybersecurity threats. The CIO has sixteen years of cybersecurity experience, including seven years with DuPont, and the CISO has seventeen years of cybersecurity experience, including over three years with DuPont. Each of the CIO and CISO maintain industry recognized credentials relevant to their roles.
Cybersecurity Risk Management Positions or Committees Responsible [Flag] true
Cybersecurity Risk Management Positions or Committees Responsible [Text Block] The CIO and the CISO are primarily responsible for assessing and managing material risks from cybersecurity threats.
Cybersecurity Risk Management Expertise of Management Responsible [Text Block] The CIO has sixteen years of cybersecurity experience, including seven years with DuPont, and the CISO has seventeen years of cybersecurity experience, including over three years with DuPont. Each of the CIO and CISO maintain industry recognized credentials relevant to their roles.
Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]
The full Board is responsible for oversight of cybersecurity risk and receives regular reports from the CIO and the CISO. The CIO and the CISO also present their assessment of material risks from cybersecurity threats to the Board at least annually. The Audit Committee receives periodic reports regarding information technology general controls (“ITGC”) in connection with its oversight of internal control over financial reporting. The impact, if any, of cyber incidents on internal control over financial reporting is also discussed with the full Board. The Nomination and Governance Committee considers cyber expertise in vetting nominees for the Board and recommending Committee appointments, and DuPont’s Board of Directors has determined that one of its independent board members has cybersecurity expertise.
Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag] true
v3.25.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
 12 Months Ended
Dec. 31, 2024
Accounting Policies [Abstract]  
Principles of Consolidation
Principles of Consolidation and Basis of Presentation
The accompanying Consolidated Financial Statements of DuPont de Nemours, Inc. ("DuPont” or the "Company”) were prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The significant accounting policies described below, together with the other notes that follow, are an integral part of the Consolidated Financial Statements.

The Consolidated Financial Statements include the accounts of the Company and subsidiaries in which a controlling interest is maintained. The Consolidated Financial Statements also include the accounts of joint ventures that are variable interest entities ("VIEs") in which the Company is the primary beneficiary due to the Company's power to direct the VIEs significant activities. For those consolidated subsidiaries in which the Company's ownership is less than 100 percent, the outside stockholders' interests are shown as noncontrolling interests. Investments in affiliates over which the Company has the ability to exercise significant influence but does not have a controlling interest are accounted for under the equity method.

The Company is also involved with certain joint ventures accounted for under the equity method of accounting that are VIEs. The Company is not the primary beneficiary, as the nature of the Company's involvement with the VIEs does not provide it the power to direct the VIEs significant activities. Future events may require these VIEs to be consolidated if the Company becomes the primary beneficiary. At December 31, 2024 and 2023, the maximum exposure to loss related to the nonconsolidated VIEs is not considered material to the Consolidated Financial Statements.

DWDP Distributions
Effective August 31, 2017, E. I. du Pont de Nemours and Company ("EID") and The Dow Chemical Company ("TDCC") each merged with subsidiaries of DowDuPont Inc. (n/k/a "DuPont”) and, as a result, EID and TDCC became subsidiaries of the Company. On April 1, 2019, the Company completed the separation of the materials science business through the spin-off of Dow Inc., (“Dow”) including Dow’s subsidiary TDCC (the “Dow Distribution”). On June 1, 2019, the Company completed the separation of the agriculture business through the spin-off of Corteva, Inc. (“Corteva”) including Corteva’s subsidiary EID (subsequently renamed EIDP, Inc. (n/k/a "EIDP")), (the “Corteva Distribution" and together with the Dow Distribution, the “DWDP Distributions”). Following the Corteva Distribution, DuPont holds the specialty products business as continuing operations. DowDuPont Inc. changed its registered name to DuPont de Nemours, Inc. (“DuPont”) (for certain events prior to June 1, 2019, the Company may be referred to as DowDuPont). Beginning on June 3, 2019, the Company's common stock is traded on the New York Stock Exchange under the ticker symbol "DD."

Intended Electronics Separation
On May 22, 2024, DuPont announced a plan to separate each of its Electronics and Water businesses in a tax-free manner to its shareholders, (the “Previously Intended Business Separations”). On January 15, 2025, DuPont announced it is targeting November 1, 2025, for the completion of the intended separation of the Electronics business (the “Intended Electronics Separation”). DuPont also announced that it would retain the Water business. The Intended Electronics Separation will not require a shareholder vote and is subject to satisfaction of customary conditions, including final approval by DuPont's Board of Directors, receipt of tax opinion from counsel, the filing and effectiveness of a Form 10 registration statement with the U.S. Securities and Exchange Commission, applicable regulatory approvals and satisfactory completion of financing.

M&M Transactions
On November 1, 2022, DuPont completed the previously announced divestiture of the majority of its historic Mobility & Materials segment, including the Engineering Polymers business line and select product lines within the Advanced Solutions and Performance Resins business lines (the “M&M Divestiture”), to Celanese Corporation (“Celanese”) for cash proceeds of $11.0 billion. On November 1, 2023, the Company closed the sale of the Delrin® business to TJC LP ("TJC"), (the “Delrin® Divestiture”). The Delrin® Divestiture and together with the M&M Divestiture, collectively the "M&M Divestitures” and the businesses in scope of the M&M Divestitures collectively the "M&M Businesses". See Note 4 for more information.

The results of operations for the year ended December 31, 2023, present the financial results of Delrin® as discontinued operations through November 1, 2023. The results of operations for the year ended December 31, 2022, present the financial results of the M&M Businesses as discontinued operations. For the year ended December 31, 2023, the Consolidated Statements of Cash Flows present the cash flows of the Delrin® Divestiture as discontinued operations for activity. The Consolidated Statements of Cash Flows for the year ended December 31, 2022, present the cash flows from the M&M Businesses as discontinued operations. The comprehensive income of the M&M Businesses has not been segregated and is included in the Consolidated Statements of Comprehensive Income for all periods presented. Unless otherwise indicated, the information in the notes to the Consolidated Financial Statements refer only to DuPont's continuing operations and do not include discussion of balances or activity of the M&M Businesses.
Basis of Presentation
Principles of Consolidation and Basis of Presentation
The accompanying Consolidated Financial Statements of DuPont de Nemours, Inc. ("DuPont” or the "Company”) were prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The significant accounting policies described below, together with the other notes that follow, are an integral part of the Consolidated Financial Statements.

The Consolidated Financial Statements include the accounts of the Company and subsidiaries in which a controlling interest is maintained. The Consolidated Financial Statements also include the accounts of joint ventures that are variable interest entities ("VIEs") in which the Company is the primary beneficiary due to the Company's power to direct the VIEs significant activities. For those consolidated subsidiaries in which the Company's ownership is less than 100 percent, the outside stockholders' interests are shown as noncontrolling interests. Investments in affiliates over which the Company has the ability to exercise significant influence but does not have a controlling interest are accounted for under the equity method.

The Company is also involved with certain joint ventures accounted for under the equity method of accounting that are VIEs. The Company is not the primary beneficiary, as the nature of the Company's involvement with the VIEs does not provide it the power to direct the VIEs significant activities. Future events may require these VIEs to be consolidated if the Company becomes the primary beneficiary. At December 31, 2024 and 2023, the maximum exposure to loss related to the nonconsolidated VIEs is not considered material to the Consolidated Financial Statements.

DWDP Distributions
Effective August 31, 2017, E. I. du Pont de Nemours and Company ("EID") and The Dow Chemical Company ("TDCC") each merged with subsidiaries of DowDuPont Inc. (n/k/a "DuPont”) and, as a result, EID and TDCC became subsidiaries of the Company. On April 1, 2019, the Company completed the separation of the materials science business through the spin-off of Dow Inc., (“Dow”) including Dow’s subsidiary TDCC (the “Dow Distribution”). On June 1, 2019, the Company completed the separation of the agriculture business through the spin-off of Corteva, Inc. (“Corteva”) including Corteva’s subsidiary EID (subsequently renamed EIDP, Inc. (n/k/a "EIDP")), (the “Corteva Distribution" and together with the Dow Distribution, the “DWDP Distributions”). Following the Corteva Distribution, DuPont holds the specialty products business as continuing operations. DowDuPont Inc. changed its registered name to DuPont de Nemours, Inc. (“DuPont”) (for certain events prior to June 1, 2019, the Company may be referred to as DowDuPont). Beginning on June 3, 2019, the Company's common stock is traded on the New York Stock Exchange under the ticker symbol "DD."

Intended Electronics Separation
On May 22, 2024, DuPont announced a plan to separate each of its Electronics and Water businesses in a tax-free manner to its shareholders, (the “Previously Intended Business Separations”). On January 15, 2025, DuPont announced it is targeting November 1, 2025, for the completion of the intended separation of the Electronics business (the “Intended Electronics Separation”). DuPont also announced that it would retain the Water business. The Intended Electronics Separation will not require a shareholder vote and is subject to satisfaction of customary conditions, including final approval by DuPont's Board of Directors, receipt of tax opinion from counsel, the filing and effectiveness of a Form 10 registration statement with the U.S. Securities and Exchange Commission, applicable regulatory approvals and satisfactory completion of financing.

M&M Transactions
On November 1, 2022, DuPont completed the previously announced divestiture of the majority of its historic Mobility & Materials segment, including the Engineering Polymers business line and select product lines within the Advanced Solutions and Performance Resins business lines (the “M&M Divestiture”), to Celanese Corporation (“Celanese”) for cash proceeds of $11.0 billion. On November 1, 2023, the Company closed the sale of the Delrin® business to TJC LP ("TJC"), (the “Delrin® Divestiture”). The Delrin® Divestiture and together with the M&M Divestiture, collectively the "M&M Divestitures” and the businesses in scope of the M&M Divestitures collectively the "M&M Businesses". See Note 4 for more information.

The results of operations for the year ended December 31, 2023, present the financial results of Delrin® as discontinued operations through November 1, 2023. The results of operations for the year ended December 31, 2022, present the financial results of the M&M Businesses as discontinued operations. For the year ended December 31, 2023, the Consolidated Statements of Cash Flows present the cash flows of the Delrin® Divestiture as discontinued operations for activity. The Consolidated Statements of Cash Flows for the year ended December 31, 2022, present the cash flows from the M&M Businesses as discontinued operations. The comprehensive income of the M&M Businesses has not been segregated and is included in the Consolidated Statements of Comprehensive Income for all periods presented. Unless otherwise indicated, the information in the notes to the Consolidated Financial Statements refer only to DuPont's continuing operations and do not include discussion of balances or activity of the M&M Businesses.
Use of Estimates in Financial Statement Preparation
Use of Estimates in Financial Statement Preparation
The preparation of financial statements in accordance with U.S. GAAP requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. The Company’s Consolidated Financial Statements include amounts that are based on management’s best estimates and judgments. Actual results could differ from those estimates.
Cash and Cash Equivalents
Cash and Cash Equivalents
Cash equivalents represent investments with maturities of three months or less from time of purchase. They are carried at cost plus accrued interest, which approximates fair value.
Restricted Cash and Cash Equivalents
Restricted Cash and Cash Equivalents
Restricted cash and cash equivalents represents trust assets, cash held in escrow and cash within qualified settlement funds. These funds are restricted as to withdrawal or use under the terms of certain contractual agreements. Restricted cash is classified as a current or non-current asset based on the timing and nature of when or how the cash is expected to be used.
Marketable Securities
Marketable Securities
Marketable securities represent investments in fixed and floating rate financial instruments with maturities greater than three months and up to twelve months at time of purchase. Investments classified as held-to-maturity are recorded at amortized cost. The carrying value approximates fair value due to the short-term nature of the investments.
Fair Value Measurements
Fair Value Measurements
Under the accounting guidance for fair value measurements and disclosures, a fair value hierarchy was established that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). A financial instrument's level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.

The Company uses the following valuation techniques to measure fair value for its assets and liabilities:
Level 1–Quoted market prices in active markets for identical assets or liabilities;
Level 2–Significant other observable inputs (e.g. quoted prices for similar items in active markets, quoted prices for identical or similar items in markets that are not active, inputs other than quoted prices that are observable such as interest rate and yield curves, and market-corroborated inputs);
Level 3–Unobservable inputs for the asset or liability, which are valued based on management's estimates of assumptions that market participants would use in pricing the asset or liability.
Foreign Currency Translation
Foreign Currency Translation
The Company's worldwide operations utilize the U.S. dollar ("USD") or local currency as the functional currency, where applicable. The Company identifies its separate and distinct foreign entities and groups the foreign entities into two categories: 1) extension of the parent or foreign subsidiaries operating in a hyper-inflationary environment (USD functional currency) and 2) self-contained (local functional currency). If a foreign entity does not align with either category, factors are evaluated and a judgment is made to determine the functional currency.

For foreign entities where the USD is the functional currency, all foreign currency-denominated asset and liability amounts are re-measured into USD at end-of-period exchange rates, except for inventories, prepaid expenses, property, plant and equipment, goodwill, other intangible assets and other non-monetary items, which are re-measured at historical rates. Foreign currency income and expenses are re-measured at average exchange rates in effect during the year, except for expenses related to balance sheet amounts re-measured at historical exchange rates. Exchange gains and losses arising from re-measurement of foreign currency-denominated monetary assets and liabilities are included in income in the period in which they occur.

For foreign entities where the local currency is the functional currency, assets and liabilities denominated in local currencies are translated into USD at end-of-period exchange rates and the resultant translation adjustments are reported, net of their related tax effects, as a component of accumulated other comprehensive loss in equity. Assets and liabilities denominated in other than the local currency are re-measured into the local currency prior to translation into USD and the resultant exchange gains or
losses are included in income in the period in which they occur. Income and expenses are translated into USD at average exchange rates in effect during the period.

The Company changes the functional currency of its separate and distinct foreign entities only when significant changes in economic facts and circumstances indicate clearly that the functional currency has changed.
Interest Rate Swap Agreements and Net Foreign Investment Hedge
Interest Rate Swap Agreements
The Company has entered into a fixed-to-floating interest rate swap agreement to hedge changes in the fair value of the Company’s long-term debt due to interest rate movements. Under the terms of the agreement, the Company agrees to exchange, at specified intervals, fixed for floating interest amounts based on the agreed upon notional principal amount. The interest rate swaps are designated and carried as fair value hedges. Fair value hedge accounting has been applied and thus, changes in the fair value of these swaps and changes in the fair value of the related hedged portion of long-term debt will be presented and will net to zero in Sundry income (expense) – net in the Consolidated Statements of Operations.

In 2024, the Company issued a notice of partial redemption concerning the associated long-term debt linked to this hedging relationship. As a result, the Company dedesignated the hedging relationship, and fair value hedge accounting is no longer applied to these swaps. After dedesignation, changes in fair value of these swaps are recognized directly in earnings in “Sundry income (expense) – net” in the Consolidated Statements of Operations, resulting in gains or losses that are separate from the hedged item.

In addition, the Company has entered into two forward-starting fixed-to-floating interest rate swap agreements to hedge changes in the fair value of the Company’s long-term debt resulting from interest rate movements. These new derivatives convert fixed interest rate payments to floating rate payments. The Company employs both the dedesignated fixed-to-floating interest rate swaps and the forward-starting fixed-to-floating interest rate swaps as economic hedges of its fixed-rate debt. Changes in the fair value of the economic hedges, and any gains or losses from net interest settlements associated with the dedesignated swaps, are recorded in “Sundry income (expense) – net” in the Consolidated Statements of Operations.

Cash payments or receipts associated with interest rate swaps are classified as operating activities in the Consolidated Statements of Cash Flows.

Net Foreign Investment Hedge
The Company has fixed-for-fixed cross currency swaps which are designated as a net investment hedge and has made an accounting policy election to account for the net investment hedge using the spot method. The Company has also elected to amortize the excluded components in interest expense in the related quarterly accounting period that such interest is accrued. The cross-currency swap is marked to market at each reporting date and any unrealized gains or losses are included in unrealized currency translation adjustments within "Accumulated other comprehensive loss" ("AOCL"), net of amounts associated with excluded components which are recognized in interest expense in the Consolidated Statements of Operations.
Inventories
Inventories
The Company's inventories are valued at the lower of cost or net realizable value. Elements of cost in inventories include raw materials, direct labor and manufacturing overhead. Stores and supplies are valued at cost or net realizable value, whichever is lower; cost is generally determined by the average cost method. The Company's inventories are generally accounted for under the average cost method. The Company establishes allowances for obsolescence of inventory based upon quality considerations and assumptions about future demand and market conditions.

In periods of abnormally low production, certain fixed costs normally absorbed into inventory are recorded directly to cost of sales in the period incurred.
Property, Plant and Equipment
Property, Plant and Equipment
Property, plant and equipment are carried at cost less accumulated depreciation. Depreciation is based on the estimated service lives of depreciable assets and is calculated using the straight-line method. Fully depreciated assets are retained in property and accumulated depreciation accounts until they are removed from service. When assets are surrendered, retired, sold, or otherwise disposed of, their gross carrying values and related accumulated depreciation are removed from the Consolidated Balance Sheets and included in determining gain or loss on such disposals.
Goodwill and Other Intangible Assets
Goodwill and Other Intangible Assets
The Company records goodwill when the purchase price of a business acquisition exceeds the estimated fair value of net identified tangible and intangible assets acquired. Goodwill is tested for impairment at the reporting unit level annually during the fourth quarter, or more frequently when events or changes in circumstances indicate that the fair value of a reporting unit has more likely than not declined below its carrying value.

When testing goodwill for impairment, the Company has the option to first perform qualitative testing to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value. If the Company chooses not to complete a qualitative assessment for a given reporting unit or if the initial assessment indicates that it is more likely than not that the carrying value of a reporting unit exceeds its estimated fair value, additional quantitative testing is required. If the carrying value of a reporting unit exceeds its fair value, an impairment loss is recognized in the amount by which the carrying value of the reporting unit exceeds its fair value, limited to the amount of goodwill at the reporting unit. The Company determines fair values for each of the reporting units using a combination of the income approach and/or market approach. Under the income approach, fair value is determined based on the net present value of estimated future cash flows, discounted at an appropriate risk-adjusted rate. Under the market approach, the Company selects peer sets based on close competitors and reviews the EBITDA multiples to determine the fair value. When applicable, third-party purchase offers may be utilized to measure fair value. The Company applies a weighting to the market approach and income approach to determine the fair value. See Note 14 for further information on goodwill.

Indefinite-lived intangible assets are tested for impairment at least annually during the fourth quarter; however, these tests are performed more frequently when events or changes in circumstances indicate that the asset may be impaired. When testing indefinite-lived intangible assets for impairment, the Company has the option to first perform qualitative testing to determine whether it is more likely than not that the fair value of indefinite-lived intangible assets is less than carrying value. If the Company chooses not to complete a qualitative assessment for indefinite-lived intangible assets or if the initial assessment indicates that it is more likely than not that the carrying value of indefinite-lived intangible assets exceeds the fair value, additional quantitative testing is required. Impairment exists when carrying value exceeds fair value. The Company's fair value methodology is primarily based on discounted cash flow techniques.
Definite-lived intangible assets are amortized over their estimated useful lives, generally on a straight-line basis for periods ranging primarily from 1 to 20 years. The Company continually evaluates the reasonableness of the useful lives of these assets.
Impairment and Disposals of Long-Lived Assets
Impairment and Disposals of Long-Lived Assets
The Company evaluates the carrying value of long-lived assets to be held and used when events or changes in circumstances indicate the carrying value may not be recoverable. The carrying value of a long-lived asset group is considered for impairment when the total projected undiscounted cash flows from the assets are separately identifiable and are less than its carrying value. In that event, a loss would be recognized based on the amount by which the carrying value exceeds the fair value of the long-lived asset group. The Company's fair value methodology is an estimate of fair market value which is made based on prices of similar assets or other valuation methodologies, including present value techniques. Long-lived assets to be disposed of by sale, if material, are classified as held for sale and reported at the lower of carrying amount or fair value less cost to sell, and depreciation is ceased. Long-lived assets to be disposed of other than by sale are classified as held and used until they are disposed. Depreciation is recognized over the remaining useful life of the assets.
Acquisitions
Acquisitions
In accordance with ASC 805, Business Combinations, acquisitions are recorded using the acquisition method of accounting. The Company includes the operating results of acquired entities from their respective dates of acquisition. The Company recognizes and measures the identifiable assets acquired and liabilities assumed as of the acquisition date fair value, where applicable. The excess, if any, of total consideration transferred in a business combination over the fair value of identifiable assets acquired and liabilities assumed is recognized as goodwill. Costs incurred as a result of a business combination other than costs related to the issuance of debt or equity securities are recorded in the period the costs are incurred.
Leases
Leases
The Company determines whether an arrangement is a lease at the inception of the arrangement based on the terms and conditions in the contract, in accordance with ASC 842, Leases. A contract contains a lease if there is an identified asset and the Company has the right to control the asset. Operating lease right-of-use ("ROU") assets are included in "Deferred charges and other assets" on the Consolidated Balance Sheets. Operating lease liabilities are included in "Accrued and other current liabilities" and "Other noncurrent obligations" on the Consolidated Balance Sheets. Finance lease ROU assets are included in "Property, plant and equipment - net" and the corresponding lease liabilities are included in "Long-term debt" or "Short-term borrowings" on the Consolidated Balance Sheets.
ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. As most of the Company’s leases do not provide the lessor's implicit rate, the Company uses its incremental borrowing rate at the commencement date in determining the present value of lease payments. Lease terms include options to extend the lease when it is reasonably certain those options will be exercised. Leases with an initial term of 12 months or less are not recorded on the balance sheet, and lease expense is recognized on a straight-line basis over the lease term.

The Company has lease agreements with lease and non-lease components, which are accounted for as a single lease component for all asset classes. Additionally, for certain equipment leases, the portfolio approach is applied to account for the operating lease ROU assets and lease liabilities. In the Consolidated Statements of Operations, lease expense for operating lease payments is recognized on a straight-line basis over the lease term. For finance leases, interest expense is recognized on the lease liability and the ROU asset is amortized over the lease term.
The Company has leases in which it is the lessor, these leases are classified as operating leases and lessor revenue and related expenses are not significant to the Company’s Consolidated Balance Sheets or Consolidated Statement of Operations. Lease income is recorded in "Selling, general, and administrative expenses" and "Research and development expenses".
Derivative Instruments
Derivative Instruments
Derivative instruments are reported in the Consolidated Balance Sheets at their fair values. The Company utilizes derivatives to manage exposures to foreign currency exchange rates and commodity prices. Changes in the fair values of derivative instruments that are not designated as hedges are recorded in current period earnings. For derivative instruments designated as cash flow hedges, the gain or loss is reported in AOCL until it is cleared to earnings during the same period in which the hedged item affects earnings.

In the event that a derivative designated as a hedge of a firm commitment or an anticipated transaction is terminated prior to the maturation of the hedged transaction, the net gain or loss in AOCL generally remains in AOCL until the item that was hedged affects earnings. If a hedged transaction matures, or is sold, extinguished, or terminated prior to the maturity of a derivative designated as a hedge of such transaction, gains or losses associated with the derivative through the date the transaction matured are included in the measurement of the hedged transaction and the derivative is reclassified as for trading purposes. Derivatives designated as hedges of anticipated transactions are reclassified as for trading purposes if the anticipated transaction is no longer probable.

For derivative instruments designated as net investment hedges, the gain or loss is reported as a component of Other comprehensive income (loss) and recorded in AOCL. The gain or loss will be subsequently reclassified into net earnings when the hedged net investment is either sold or substantially liquidated.
Environmental Matters
Environmental Matters
Accruals for environmental matters are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated. These accruals are adjusted periodically as assessment and remediation efforts progress or as additional technical or legal information becomes available. Accruals for environmental liabilities are included in the Consolidated Balance Sheets in "Accrued and other current liabilities" and "Other noncurrent obligations" at undiscounted amounts. Accruals for related insurance or other third-party recoveries for environmental liabilities are recorded when it is probable that a recovery will be realized and are included in the Consolidated Balance Sheets as "Accounts and notes receivable - net."

Environmental costs are capitalized if the costs extend the life of the property, increase its capacity, and/or mitigate or prevent contamination from future operations. Environmental costs are also capitalized in recognition of legal asset retirement obligations resulting from the acquisition, construction and/or normal operation of a long-lived asset. Costs related to environmental contamination treatment and cleanup are charged to expense. Estimated future incremental operations, maintenance and management costs directly related to remediation are accrued when such costs are probable and reasonably estimable.
Revenue Recognition
Revenue Recognition
The Company recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration which the Company expects to receive in exchange for those goods or services. To determine revenue recognition for the arrangements that the Company determines are within the scope of Revenue from Contracts with Customers (Topic 606), the Company performs the following five steps: (1) identify the contract(s) with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when (or as) the entity satisfies a performance obligation. See Note 5 for additional information on revenue recognition.
Cost of Sales
Cost of Sales
Cost of sales primarily includes the cost of manufacture and delivery, ingredients or raw materials, direct salaries, wages and benefits and overhead, non-capitalizable costs associated with capital projects and other operational expenses. No amortization of intangibles is included within costs of sales.
Research and Development
Research and Development
Research and development costs are expensed as incurred. Research and development expense includes costs (primarily consisting of employee costs, materials, contract services, research agreements, and other external spend) relating to the discovery and development of new products, and enhancement of existing products.
Selling, General and Administrative Expenses
Selling, General and Administrative Expenses
Selling, general and administrative expenses primarily include selling and marketing expenses, commissions, functional costs, and business management expenses.
Acquisition, Integration and Separation Costs
Acquisition, Integration and Separation Costs
Acquisition, integration and separation costs primarily consist of financial advisory, information technology, legal, accounting, consulting, other professional advisory fees and other contractual transaction payments associated with the preparation and execution of activities related to strategic initiatives.
Litigation
Litigation
Accruals for legal matters are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated. Legal costs, such as outside counsel fees and expenses, are charged to expense in the period incurred.
Restructuring and Asset Related Charges
Restructuring and Asset Related Charges
Charges for restructuring programs generally include targeted actions involving employee severance and related benefit costs, contract termination charges, and asset related charges, which include impairments or accelerated depreciation/amortization of long-lived assets associated with such actions. Employee severance and related benefit costs are provided to employees under the Company’s ongoing benefit arrangements. These charges are accrued during the period when management commits to a plan of termination and it becomes probable that employees will be entitled to benefits at amounts that can be reasonably estimated. Contract termination charges primarily reflect costs to terminate a contract before the end of its term or costs that will continue to be incurred under the contract for its remaining term without economic benefit to the Company. Asset related charges reflect impairments to long-lived assets and indefinite-lived intangible assets no longer deemed recoverable and depreciation/amortization of long-lived assets, which is accelerated over their remaining economic lives.
Income Taxes
Income Taxes
The Company accounts for income taxes using the asset and liability method. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences of temporary differences between the carrying amounts and tax bases of assets and liabilities using enacted tax rates. The effect of a change in tax rates on deferred tax assets or liabilities is recognized in income in the period that includes the enactment date.

The Company recognizes the financial statement effects of an uncertain income tax position when it is more likely than not, based on the technical merits, that the position will be sustained upon examination. The Company accrues for other tax contingencies, such as indemnifications, when it is probable that a liability to a taxing authority has been incurred and the amount of the contingency can be reasonably estimated. The current portion of uncertain income tax positions is included in "Income taxes payable" and the long-term portion is included in "Other noncurrent obligations" in the Consolidated Balance Sheets.
Recently Adopted Accounting Guidance and Accounting Guidance Issued But Not Adopted
Recently Adopted Accounting Guidance
In September 2022, the FASB issued Accounting Standards Update No. 2022-04, "Liabilities-Supplier Finance Programs (Subtopic 405-50)" ("ASU 2022-04") to enhance transparency about the use of supplier finance programs. The new guidance requires that a buyer in a supplier finance program provides additional qualitative and quantitative disclosures about its program including the nature of the program, activity during the period, changes from period to period, and the potential magnitude of the program. The amendments in ASU 2022-04 are effective for fiscal years beginning after December 15, 2022 on a retrospective basis, including interim periods within those fiscal years, except for the amendment on rollforward information which is effective prospectively for fiscal years beginning after December 15, 2023. The Company implemented the new disclosures, other than the rollforward information, as required in the first quarter of 2023. The rollforward information disclosures have been implemented as required for the year ended December 31, 2024. See Note 15 for more information.

In November 2023, the FASB issued Accounting Standards Update No. 2023-07, "Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures" ("ASU 2023-07") to improve disclosure requirements about reportable segments and address requests from investors for additional, more detailed information about a reportable segment’s expenses. The new guidance requires disclosures of significant segment expenses regularly provided to the Chief Operating Decision Maker ("CODM") and included in reported measures of segment profit and loss. Disclosure of the title and position of the CODM is required. The guidance requires interim and annual disclosures about a reportable segment's profit or loss and assets. Additionally, the guidance requires disclosure of other segment items by reportable segment including a description of its composition. The amendments in ASU 2023-07 are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, on a retrospective basis. The disclosures have been implemented as required for the year ended December 31, 2024. See Note 23 for more information.

Accounting Guidance Issued But Not Adopted at December 31, 2024
In December 2023, the FASB issued Accounting Standards Update No. 2023-09, "Income Taxes (Topic 740): Improvements to Income Tax Disclosures" ("ASU 2023-09") to improve transparency and disclosure requirements for the rate reconciliation, income taxes paid and other tax disclosures. The amendments in ASU 2023-09 are effective for fiscal years beginning after December 15, 2024, on a prospective basis. The disclosures will be implemented as required for the Company's 2025 annual report. The Company is currently evaluating the impact of adopting this guidance.

In March 2024, the U.S. Securities and Exchange Commission ("SEC") adopted rules under SEC Release No. 33-11275, "The Enhancement and Standardization of Climate-Related Disclosures for Investors", which require a registrant to disclose information in annual reports and registration statements about climate-related risks that are reasonably likely to have a material impact on its business, results of operations, or financial condition. The information would include disclosure of a registrant's greenhouse gas emissions. In addition, certain disclosures related to severe weather events and other natural conditions will be required in a registrant’s audited financial statements. Certain annual disclosure requirements would be effective as early as the fiscal year beginning January 1, 2025. However, in April 2024, the SEC voluntarily stayed the final rules pending certain legal challenges. The Company is currently evaluating the impact of these rules on its disclosures.

In November 2024, the FASB issued Accounting Standards Update No. 2024-03, "Income Statement: Reporting Comprehensive Income (Topic 220): Expense Disaggregation Disclosures" ("ASU 2024-03") to improve disclosures about the nature of expenses within line items on the statements of operations. The amendments in ASU 2024-03 are effective for the Company's 2028 annual report and subsequent interim periods; however, early adoption is permitted. The amendments can be applied prospectively or retrospectively to all periods presented. The Company is currently evaluating the impact of adopting this guidance.
v3.25.0.1
ACQUISITIONS (Tables)
 12 Months Ended
Dec. 31, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]  
Schedule Assets Acquired and Liabilities Assumed Final determination of the fair values are presented in the following table:
Spectrum Assets Acquired and Liabilities Assumed on August 1, 2023
In millions
Fair value of assets acquired
Cash and cash equivalents$31 
Accounts and notes receivable68 
Inventories52 
Property, plant and equipment125 
Other intangible assets916 
Deferred charges and other assets34 
Total Assets Acquired$1,226 
Fair value of liabilities assumed
Accounts payable$21 
Income taxes payable17 
Deferred income tax liabilities177 
Other noncurrent liabilities44 
Total Liabilities Assumed$259 
Goodwill814 
Total Consideration$1,781 
Schedule of Acquisition, Integration and Separation Costs
These costs are recorded within "Acquisition, integration and separation costs" within the Consolidated Statements of Operations.
(In millions) For the years ended December 31, 202420232022
Acquisition, integration and separation costs$168 $20 $193 
v3.25.0.1
DIVESTITURES (Tables)
 12 Months Ended
Dec. 31, 2024
Discontinued Operations and Disposal Groups [Abstract]  
Schedule of Divestitures Including Discontinued Operations The results of operations of the M&M Businesses are presented as discontinued operations as summarized below for all periods. The M&M Divestiture is reflected through the Transaction Date and the Delrin® Divestiture is reflected through November 1, 2023:
For the Years Ended December 31,
In millions20232022
Net sales$460 $3,532 
Cost of sales295 2,712 
Research and development expenses3 46 
Selling, general and administrative expenses2 127 
Amortization of intangibles— 28 
Acquisition, integration and separation costs 1
195 555 
Equity in earnings of nonconsolidated affiliates— (9)
Sundry income (expense) - net9 4 
(Loss) income from discontinued operations before income taxes$(26)$59 
Provision for income taxes on discontinued operations31 128 
(Loss) income from discontinued operations, net of tax$(57)$(69)
Net (loss) income from discontinued operations attributable to noncontrolling interests— (4)
Gain on sale, net of tax 2
480 5,024 
Income from discontinued operations attributable to DuPont stockholders, net of tax$423 $4,959 
1. Includes costs related to the M&M Divestitures for all periods presented.
2. Gain includes purchase price adjustments related to the M&M Divestitures in 2023.
Discontinued operations activity consists of the following:
For the Years Ended December 31,
In millions202420232022
M&M Divestitures 1
$(27)$423 $4,955 
MOU Activity 2
(36)(426)(74)
Indemnification activity - environmental and legal 3
(24)(50)— 
Tax related matters 4
57 — — 
Other(10)(18)(25)
(Loss) income from discontinued operations, net of tax$(40)$(71)$4,856 
1.The year ended December 31, 2024 primarily includes separation costs and purchase price adjustments.
2.Includes the activity subject to the binding Memorandum of Understanding (“MOU”) between Chemours, Corteva Inc ("Corteva"), E. I. du Pont de Nemours and Company ("EIDP") and the Company. The year ended December 31, 2023 includes a charge related to the Water District Settlement Agreement, as defined in Note 16.
3.Primarily related to the DWDP Separation and Distribution Agreement and Letter Agreement between Corteva and EIDP. For additional information on these matters, refer to Note 16.
4.The year ended December 31, 2024 includes tax indemnification activity associated with divested businesses.
v3.25.0.1
REVENUE (Tables)
 12 Months Ended
Dec. 31, 2024
Revenue from Contract with Customer [Abstract]  
Schedule of Net Trade Revenue
Net Trade Revenue202420232022
(In millions) For the years ended December 31,
Industrial Solutions$1,922 $1,756 $1,633 
Interconnect Solutions1,822 1,688 2,045 
Semiconductor Technologies2,186 1,893 2,239 
Electronics & Industrial$5,930 $5,337 $5,917 
Safety Solutions$2,375 $2,519 $2,649 
Shelter Solutions1,640 1,655 1,815 
Water Solutions1,408 1,459 1,493 
Water & Protection$5,423 $5,633 $5,957 
Retained Businesses 1
$1,033 $1,098 $1,067 
Other 2
— — 76 
Corporate & Other$1,033 $1,098 $1,143 
Total$12,386 $12,068 $13,017 
1.Net sales reflected in Retained Businesses includes the Auto Adhesives & Fluids, MultibaseTM and Tedlar® businesses.
2.Net sales reflected in Other includes activity of the previously divested Biomaterials business.
Schedule of Contract Balances
Contract BalancesDecember 31, 2024December 31, 2023
In millions
Accounts receivable - trade 1
$1,561 $1,543 
Deferred revenue - current 2
$2 $1 
Deferred revenue - non-current 3
$36 $22 
1.Included in "Accounts and notes receivable - net" in the Consolidated Balance Sheets.
2.Included in "Accrued and other current liabilities" in the Consolidated Balance Sheets.
3.Included in "Other noncurrent obligations" in the Consolidated Balance Sheets.
v3.25.0.1
RESTRUCTURING AND ASSET RELATED CHARGES - NET (Tables)
 12 Months Ended
Dec. 31, 2024
Restructuring and Related Activities [Abstract]  
Schedule of Restructuring Charges
The following table summarizes the charges incurred by segment related to the 2023-2024 Restructuring Program:
2023-2024 Restructuring Program Charges by Segment20242023
(In millions) For the Year Ended December 31,
Electronics & Industrial$2 $21 
Water & Protection50 57 
Corporate & Other37 32 
Total$89 $110 
The following table summarizes the charges incurred by segment related to the 2022 Restructuring Program:
2022 Restructuring Program Charges by Segment202420232022
(In millions) For the years ended December 31,
Electronics & Industrial$3 $29 $23 
Water & Protection— (2)16 
Corporate & Other(5)8 22 
Total$(2)$35 $61 
Schedule of Restructuring Reserve
The following table summarizes the activities related to the 2023-2024 Restructuring Program:
2023-2024 Restructuring ProgramSeverance and Related Benefit CostAsset Related ChargesTotal
In millions
Reserve balance at December 31, 2022$— $— $— 
Restructuring charges80 30 110 
Reductions against the reserve(1)(30)(31)
Reserve balance at December 31, 2023$79 $— $79 
Restructuring charges34 55 89 
Reductions against the reserve(3)(55)(58)
Cash payments(63)— (63)
Reserve balance at December 31, 2024$47 $— $47 
v3.25.0.1
SUPPLEMENTARY INFORMATION (Tables)
 12 Months Ended
Dec. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Sundry Income (Expense), Net
Sundry Income (Expense) - Net
(In millions) For the years ended December 31,202420232022
Non-operating pension and other post-employment benefit ("OPEB") credits (costs)$18 $(9)$28 
Interest income 1, 2
73 155 50 
Net gain on divestiture and sales of other assets and investments 3, 4, 5
20 19 78 
Foreign exchange gains (losses), net3 (73)15 
Loss on debt extinguishment 6
(74)— — 
Interest rate swap mark-to-market loss 7
(138)— — 
Miscellaneous income (expenses) - net22 10 20 
Sundry income (expense) - net$(76)$102 $191 
1.The years ended December 31, 2024 and 2023 include non-cash interest income of $26 million and $4 million, respectively, related to the $350 million Delrin® related party note receivable. Refer to Note 4 for additional information.
2.The year ended December 31, 2023 includes interest on cash and marketable securities. Fluctuations in interest income are due to changes in cash balances and/or changes in interest rates.
3.The year ended December 31, 2024 primarily reflects income related to gains on sale of intellectual property.
4.The year ended December 31, 2023 primarily reflects income related to a land sale within the Water & Protection segment and gain adjustments from previously divested businesses.
5.The year ended December 31, 2022 primarily reflects income of $26 million related to the gain on sale of the Biomaterials business unit and income of $37 million related to the sale of a land use right within the Water & Protection segment.
6.Reflects the loss on the partial redemption of an aggregate principal amount of the 2038 Notes. Refer to Note 15 for further details.
7.Includes the mark-to-market loss related to the 2022 Swaps and 2024 Swaps. Refer to Note 21 for further details.
v3.25.0.1
INCOME TAXES (Tables)
 12 Months Ended
Dec. 31, 2024
Income Tax Disclosure [Abstract]  
Schedule of Geographic Allocation of Income (Loss) and Provision for (Benefit from) Income Taxes
Geographic Allocation of Income (Loss) and Provision for (Benefit from) Income Taxes 202420232022
(In millions) For the years ended December 31,
(Loss) income from continuing operations before income taxes
Domestic$(505)$(695)$(308)
Foreign1,697 1,199 1,756 
Income from continuing operations before income taxes$1,192 $504 $1,448 
Current tax expense
Federal$148 $80 $211 
State and local16 9 7 
Foreign 389 246 373 
Total current tax expense$553 $335 $591 
Deferred tax (benefit) expense
Federal $(141)$(24)$(191)
State and local(31)(27)(16)
Foreign 33 (313)3 
Total deferred tax benefit$(139)$(364)$(204)
Provision for (benefit from) income taxes on continuing operations414 (29)387 
Net income from continuing operations$778 $533 $1,061 
Schedule of Effective Income Tax Rate Reconciliation
Reconciliation to U.S. Statutory Rate202420232022
(In millions) For the years ended December 31,
Statutory U.S. federal income tax rate21.0 %21.0 %21.0 %
Equity earning effect(0.4)(1.2)0.2 
Foreign income taxed at rates other than the statutory U.S. federal income tax rate2.8 4.9 (3.9)
U.S. tax effect of foreign earnings and dividends4.6 13.0 5.0 
Unrecognized tax benefits(0.1)(0.1)1.0 
Acquisitions, divestitures and ownership restructuring activities 1
9.0 (64.4)2.5 
Exchange gains/losses 2
1.5 (1.1)0.4 
State and local income taxes(0.6)(2.8)0.2 
Change in valuation allowance0.5 — — 
Goodwill impairments — 33.5 — 
Stock-based compensation0.2 (1.0)(0.2)
Foreign-derived intangible income (FDII)(1.9)(6.0)(2.0)
Other - net(1.9)(1.6)2.5 
Effective tax rate34.7 %(5.8)%26.7 %
1.Includes a tax expense of $103 million and a tax benefit of $324 million in connection with internal restructurings involving foreign subsidiaries for the years ended December 31, 2024 and 2023, respectively.
2. Principally reflects the impact of foreign exchange gains and losses on net monetary assets for which no corresponding tax impact is realized.
Schedule of Deferred Tax Assets and Liabilities
Deferred Tax Balances at December 31,20242023
(In millions)
Deferred tax assets:
Tax losses and credit carryforwards 1
$800 $870 
Lease liability 98 116 
Pension and postretirement benefit obligations98 46 
Other accruals and reserves124 131 
Research and development268 218 
Inventory7 16 
Other – net254 202 
Gross deferred tax assets$1,649 $1,599 
Valuation allowances 1
(772)(738)
Total deferred tax assets$877 $861 
Deferred tax liabilities:
Investments(176)(204)
Unrealized exchange losses, net(36)(17)
Operating lease asset(98)(116)
Property(360)(343)
Intangibles(876)(999)
Total deferred tax liabilities$(1,546)$(1,679)
Total net deferred tax liability$(669)$(818)
1.Primarily related to recorded tax benefits and the non-realizability of tax losses and credit carryforwards from operations in the United States, Europe and Asia Pacific.
Schedule of Operating Loss and Tax Credit Carryforwards
Operating Loss and Tax Credit CarryforwardsDeferred Tax Asset
(In millions) As of December 31,20242023
Operating loss carryforwards
Expire within 5 years$5 $40 
Expire after 5 years or indefinite expiration617 624 
Total operating loss carryforwards$622 $664 
Tax credit carryforwards
Expire within 5 years$40 $37 
Expire after 5 years or indefinite expiration138 169 
Total tax credit carryforwards$178 $206 
Total Operating Loss and Tax Credit Carryforwards$800 $870 
Schedule of Gross Unrecognized Tax Benefits
Total Gross Unrecognized Tax Benefits202420232022
(In millions)
Total unrecognized tax benefits at January 1,$473 $470 $351 
Decreases related to positions taken on items from prior years(32)(4)(4)
Increases related to positions taken on items from prior years17 3 4 
Increases related to positions taken in the current year5 18 164 
Settlement of uncertain tax positions with tax authorities(21)(10)(10)
Decreases due to expiration of statutes of limitations(5)(9)— 
Exchange (gain) loss(9)5 (9)
Divestiture of M&M— — (26)
Total unrecognized tax benefits at December 31, 1
$428 $473 $470 
Total unrecognized tax benefits that, if recognized, would impact the effective tax rate of continuing operations $284 $329 $338 
Total amount of interest and penalties (benefit) recognized in "Provision for (benefit from) income taxes on continuing operations"$7 $8 $3 
Total accrual for interest and penalties associated with unrecognized tax benefits$43 $28 $16 
1.Total unrecognized tax benefits includes $140 million, $141 million and $128 million of benefits related to discontinued operations at December 31, 2024, 2023 and 2022.
Schedule of Tax Years Subject to Examination
Tax years that remain subject to examination for the Company’s major tax jurisdictions are shown below:
Tax Years Subject to Examination by Major Tax Jurisdiction at December 31, 2024
Earliest Open Year
Jurisdiction
Brazil2019
Canada2017
China2014
Denmark2020
Germany2019
Japan2018
The Netherlands2019
Switzerland2019
United States:
Federal income tax 1
2012
State and local income tax2012
1. The U.S. Federal income tax jurisdiction is open back to 2012 with respect to EIDP pursuant to the DWDP Tax Matters Agreement.
v3.25.0.1
EARNINGS PER SHARE CALCULATIONS (Tables)
 12 Months Ended
Dec. 31, 2024
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share
The following tables provide earnings per share calculations for the years ended December 31, 2024, 2023 and 2022:
Net Income for Earnings Per Share Calculations - Basic & Diluted
In millions
202420232022
Income from continuing operations, net of tax$778 $533 $1,061 
Net income from continuing operations attributable to noncontrolling interests35 39 53 
Income from continuing operations attributable to common stockholders$743 $494 $1,008 
(Loss) income from discontinued operations, net of tax(40)(71)4,856 
Net loss from discontinued operations attributable to noncontrolling interests— — (4)
(Loss) income from discontinued operations attributable to common stockholders(40)(71)4,860 
Net income available to common stockholders$703 $423 $5,868 
Earnings Per Share Calculations - Basic
Dollars per share
202420232022
Earnings from continuing operations attributable to common stockholders$1.77 $1.10 $2.02 
(Loss) earnings from discontinued operations, net of tax(0.10)(0.16)9.75 
Earnings available to common stockholders 1
$1.68 $0.94 $11.77 
Earnings Per Share Calculations - Diluted
Dollars per share
202420232022
Earnings from continuing operations attributable to common stockholders$1.77 $1.09 $2.02 
(Loss) earnings from discontinued operations, net of tax(0.10)(0.16)9.73 
Earnings available to common stockholders 1
$1.67 $0.94 $11.75 
Share Count Information
Shares in Millions
202420232022
Weighted-average common shares - basic419.2 449.9 498.5 
Plus dilutive effect of equity compensation plans1.4 1.3 0.9 
Weighted-average common shares - diluted420.6 451.2 499.4 
Stock options, restricted stock units, and performance-based restricted stock units excluded from EPS calculations 2
1.1 2.6 4.1 
1. Earnings per share amounts are computed independently for income from continuing operations, income from discontinued operations and net income attributable to common stockholders. As a result, the per share amounts from continuing operations and discontinued operations may not equal the total per share amounts for net income attributable to common stockholders.
2. These outstanding options to purchase shares of common stock, restricted stock units and performance based restricted stock units were excluded from the calculation of diluted earnings per share because the effect of including them would have been antidilutive.
v3.25.0.1
ACCOUNTS AND NOTES RECEIVABLE - NET (Tables)
 12 Months Ended
Dec. 31, 2024
Receivables [Abstract]  
Schedule of Accounts, Notes, Loans and Financing Receivable
In millionsDecember 31, 2024December 31, 2023
Accounts receivable – trade 1
$1,534 $1,513 
Income tax receivable81 301 
Other 2
584 556 
Total accounts and notes receivable - net$2,199 $2,370 
1.Accounts receivable – trade is net of allowances of $26 million at December 31, 2024 and $40 million at December 31, 2023. Allowances are equal to the estimated uncollectible amounts and current expected credit loss. That estimate is based on historical collection experience, current economic and market conditions, and review of the current status of customers' accounts.
2.Other includes receivables in relation to value added tax, indemnification assets, general sales tax and other taxes, and other receivables. No individual group represents more than ten percent of total receivables.
v3.25.0.1
INVENTORIES (Tables)
 12 Months Ended
Dec. 31, 2024
Inventory Disclosure [Abstract]  
Schedule of Inventory
In millionsDecember 31, 2024December 31, 2023
Finished goods $1,162 $1,184 
Work in process 509 487 
Raw materials 332 350 
Supplies127 126 
Total inventories$2,130 $2,147 
v3.25.0.1
PROPERTY, PLANT AND EQUIPMENT (Tables)
 12 Months Ended
Dec. 31, 2024
Property, Plant and Equipment [Abstract]  
Schedule of Property, Plant and Equipment
Estimated Useful Lives (Years)December 31, 2024December 31, 2023
In millions
Land and land improvements1-25$455 $449 
Buildings1-502,238 2,121 
Machinery, equipment, and other1-257,657 7,306 
Construction in progress606 849 
Total property, plant and equipment$10,956 $10,725 
Total accumulated depreciation$5,188 $4,841 
Total property, plant and equipment - net$5,768 $5,884 

In millions202420232022
Depreciation expense$599 $547 $545 
v3.25.0.1
NONCONSOLIDATED AFFILIATES (Tables)
 12 Months Ended
Dec. 31, 2024
Equity Method Investments and Joint Ventures [Abstract]  
Schedule of Dividend Received and Equity Earnings
The Company's dividends received from nonconsolidated affiliates is shown in the following table:
Dividends Received from Nonconsolidated Affiliates202420232022
(In millions) For the years ended December 31,
Dividends from nonconsolidated affiliates$73 $71 $103 
v3.25.0.1
GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)
 12 Months Ended
Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Goodwill
The following table summarizes changes in the carrying amount of goodwill for the years ended December 31, 2024 and 2023:
Electronics & IndustrialWater & ProtectionCorporate & OtherTotal
In millions
Balance at December 31, 2022$9,397 $6,656 $610 $16,663 
Goodwill recognized for Spectrum Acquisition 1
818 — — 818 
Currency Translation Adjustment(10)48 5 43 
Impairment— (804)— (804)
Balance at December 31, 2023$10,205 $5,900 $615 $16,720 
Goodwill recognized for Donatelle Plastics Acquisition 2
114 — — 114 
Goodwill recognized for Spectrum Acquisition 1, 3
(4)— — (4)
Currency Translation Adjustment(113)(145)(9)(267)
Other4 — — 4 
Balance at December 31, 2024$10,206 $5,755 $606 $16,567 
1.On August 1, 2023, DuPont completed the acquisition of Spectrum, which is included in the Electronics & Industrial segment. See Note 3 for additional information.
2.On July 28, 2024, DuPont completed the acquisition of Donatelle Plastics, which is included in the Electronics & Industrial segment. See Note 3 for additional information.
3.In the third quarter 2024, the Company finalized the working capital settlements which impacted the residual goodwill recorded. See Note 3 for additional information.
Schedule of Other Finite Intangible Assets
The gross carrying amounts and accumulated amortization of other intangible assets by major class are as follows:
December 31, 2024December 31, 2023
In millionsGross
Carrying
Amount		Accum AmortNetGross Carrying AmountAccum AmortNet
Intangible assets with finite lives:
  Developed technology $1,975 $(1,124)$851 $2,079 $(1,092)$987 
  Trademarks/tradenames
901 (451)450 924 (414)510 
  Customer-related5,868 (2,623)3,245 5,815 (2,329)3,486 
  Other 27 (7)20 28 (1)27 
Total other intangible assets with finite lives$8,771 $(4,205)$4,566 $8,846 $(3,836)$5,010 
Intangible assets with indefinite lives:
  Trademarks/tradenames
804 — 804 804 — 804 
Total other intangible assets with indefinite lives$804 $— $804 $804 $— $804 
Total$9,575 $(4,205)$5,370 $9,650 $(3,836)$5,814 
Schedule of Other Indefinite Intangible Assets
The gross carrying amounts and accumulated amortization of other intangible assets by major class are as follows:
December 31, 2024December 31, 2023
In millionsGross
Carrying
Amount		Accum AmortNetGross Carrying AmountAccum AmortNet
Intangible assets with finite lives:
  Developed technology $1,975 $(1,124)$851 $2,079 $(1,092)$987 
  Trademarks/tradenames
901 (451)450 924 (414)510 
  Customer-related5,868 (2,623)3,245 5,815 (2,329)3,486 
  Other 27 (7)20 28 (1)27 
Total other intangible assets with finite lives$8,771 $(4,205)$4,566 $8,846 $(3,836)$5,010 
Intangible assets with indefinite lives:
  Trademarks/tradenames
804 — 804 804 — 804 
Total other intangible assets with indefinite lives$804 $— $804 $804 $— $804 
Total$9,575 $(4,205)$5,370 $9,650 $(3,836)$5,814 
Schedule of Net Intangibles by Segment
The following table provides the net carrying value of other intangible assets:
Net IntangiblesDecember 31, 2024December 31, 2023
In millions
Electronics & Industrial 1
$3,337 $3,521 
Water & Protection1,957 2,206 
Corporate & Other76 87 
Total$5,370 $5,814 
1.Includes intangible assets acquired as part of the Donatelle and Spectrum Acquisitions. See Note 3 for additional information.
Schedule of Estimated Future Amortization Expense
Total estimated amortization expense for the next five fiscal years is as follows:
Estimated Amortization Expense
In millions
2025$555 
2026$527 
2027$480 
2028$427 
2029$337 
v3.25.0.1
SHORT-TERM BORROWINGS, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES AND OTHER OBLIGATIONS (Tables)
 12 Months Ended
Dec. 31, 2024
Debt Disclosure [Abstract]  
Schedule of Short-Term Borrowings and Capital Lease Obligations
The following tables summarize the Company's short-term borrowings, long-term debt and finance lease obligations:
Short-Term BorrowingsDecember 31, 2024December 31, 2023
(In millions)
Long-term debt due within one year 1
$1,848 $— 
1.Presented net of current portion of unamortized debt issuance costs.
Schedule of Long-Term Debt Instruments
Long-Term DebtDecember 31, 2024
December 31, 2023
In millionsAmountWeighted Average RateAmountWeighted Average Rate
Promissory notes and debentures 1:
  Final maturity 2025$1,850 4.49 %$1,850 4.49 %
  Final maturity 20282,250 4.73 %2,250 4.73 %
  Final maturity 2030 and thereafter 2
3,102 5.47 %3,741 5.46 %
Other facilities:
Finance lease obligations9 10 
Less: Unamortized debt discount and issuance costs40 51 
Less: Long-term debt due within one year
1,848 — 
Total $5,323 $7,800 
1.Represents senior unsecured notes (the "2018 Senior Notes"), which are senior unsecured obligations of the Company.
2.Includes an unamortized basis adjustment of $48 million related to the dedesignation of the Company's interest rate swap agreements and a fair value hedging adjustment of $59 million, related to the Company's interest rate swap agreements at December 31, 2024 and 2023, respectively. See Note 21 for additional information.
Schedule of Maturities of Long-Term Debt
Principal payments of long-term debt for the five succeeding fiscal years are as follows:
Maturities of Long-Term Debt for Next Five Years at December 31, 2024
Total
In millions
2025$1,850 
2026$— 
2027$— 
2028$2,250 
2029$— 
Schedule of Line of Credit Facilities
The following table summarizes the Company's credit facilities:
Committed and Available Credit Facilities at December 31, 2024
In millionsEffective DateCommitted CreditCredit AvailableMaturity DateInterest
Five-Year Revolving Credit Facility
April 2022$2,500 $2,484 April 2027Floating Rate
2024 $1B Revolving Credit Facility
May 20241,000 1,000 May 2025Floating Rate
Total Committed and Available Credit Facilities$3,500 $3,484 
Schedule of Supplier Finance Program
The following table summarizes the outstanding obligations confirmed as valid under the supplier financing programs for the year ended December 31, 2024:
Supplier Financing Program ActivityAmount
In millions
Confirmed obligations outstanding as of January 1, 2024$97 
Invoices confirmed to financial institutions421 
Confirmed invoices paid to financial institution(413)
Foreign currency exchange impact(1)
Confirmed obligations outstanding as of December 31, 2024
$104 
v3.25.0.1
COMMITMENTS AND CONTINGENT LIABILITIES (Tables)
 12 Months Ended
Dec. 31, 2024
Commitments and Contingencies Disclosure [Abstract]  
Schedule of Indemnified Liabilities Related to the MOU
In connection with the MOU and the Agreements, the Company has recognized the following indemnification liabilities related to eligible PFAS costs:
Indemnification Related Liabilities Associated with the MOU
In millionsDecember 31, 2024December 31, 2023Balance Sheet Classification
Current indemnification liabilities$99 $87 
Accrued and other current liabilities
Long-term indemnification liabilities123 119 Other noncurrent obligations
Total indemnification liabilities accrued under the MOU 1
$222 $206 
1.As of December 31, 2024 and 2023, total indemnified liabilities accrued include $128 million and $139 million, respectively, related to Chemours environmental remediation activities at their site in Fayetteville, North Carolina under the Consent Order between Chemours and the North Carolina Department of Environmental Quality (the "NC DEQ").
Schedule of Environmental Accrued Obligations
The accrued environmental obligations include the following:
Environmental Accrued Obligations
In millionsDecember 31, 2024December 31, 2023
Potential exposure above the amount accrued 1
Environmental remediation liabilities not subject to indemnity$45 $46 $106 
Environmental remediation indemnified related liabilities:
    Indemnifications related to Dow and Corteva 2
83 101 177 
    MOU related obligations (discussed above) 3
146 152 31 
    Other environmental indemnifications1 1 2 
Total environmental related liabilities$275 $300 $316 
1.The environmental accrual represents management’s best estimate of the costs for remediation and restoration with respect to environmental matters, although it is reasonably possible that the ultimate cost with respect to these particular matters could range above the amount accrued as of December 31, 2024.
2.Pursuant to the DWDP Separation and Distribution Agreement and Letter Agreement, the Company is required to indemnify Dow and Corteva for certain Non-PFAS clean-up responsibilities and associated remediation costs.
3.The MOU related obligations include the Company's estimate of its liability under the MOU for remediation activities based on the current regulatory environment.
v3.25.0.1
LEASES (Tables)
 12 Months Ended
Dec. 31, 2024
Leases [Abstract]  
Schedule of Lease Cost / Lease Term and Discount Rates
The components of lease cost for operating leases for the years ended December 31, 2024, 2023 and 2022 were as follows:
In millions202420232022
Operating lease cost$125 $121 $113 
Short-term lease cost5 4 4 
Variable lease cost37 39 39 
Less: Sublease income 1
4 4 12 
Total lease cost$163 $160 $144 
1.Reflects income associated with subleases, not inclusive of all lessor arrangements disclosed below.
Lease Term and Discount Rate for Operating LeasesDecember 31, 2024December 31, 2023
Weighted-average remaining lease term (years)7.88.5
Weighted-average discount rate3.78 %3.55 %
Schedule of Supplemental Balance Sheet Information Supplemental balance sheet information related to leases was as follows:
In millionsDecember 31, 2024December 31, 2023
Operating Leases
 
Operating lease right-of-use assets 1
$403 $484 
Current operating lease liabilities 2
84 97 
Noncurrent operating lease liabilities 3
322 390 
Total operating lease liabilities
$406 $487 
1.Included in "Deferred charges and other assets" in the Consolidated Balance Sheets.
2.Included in "Accrued and other current liabilities" in the Consolidated Balance Sheets.
3.Included in "Other noncurrent obligations" in the Consolidated Balance Sheets.
Schedule of Maturity of Lease Liabilities
Maturities of lease liabilities were as follows:
Maturity of Lease Liabilities at December 31, 2024Operating Leases
In millions
2025$97 
202676 
202761 
202844 
202934 
2030 and thereafter157 
Total lease payments$469 
Less: Interest63 
Present value of lease liabilities$406 
v3.25.0.1
STOCKHOLDERS' EQUITY (Tables)
 12 Months Ended
Dec. 31, 2024
Equity [Abstract]  
Schedule of Reconciliation of Common Stock Activity
The following table provides a reconciliation of DuPont Common Stock activity for the years ended December 31, 2024, 2023 and 2022:
Shares of DuPont Common StockIssuedHeld in Treasury
In thousands
Balance at January 1, 2022511,793 — 
Issued 2,074 — 
Repurchased— 55,743 
Retired(55,743)(55,743)
Balance at December 31, 2022458,124 — 
Issued 1,225 — 
Repurchased
— 29,239 
Retired
(29,239)(29,239)
Balance at December 31, 2023430,110 — 
Issued1,513 — 
Repurchased
— 13,629 
Retired
(13,629)(13,629)
Balance at December 31, 2024417,994 — 
Schedule of Dividends Declared and Paid Dividends declared and paid to common stockholders during the years ended December 31, 2024, 2023 and 2022 are summarized in the following table:
Dividends Declared and Paid202420232022
In millions
Dividends declared to common stockholders$635 $651 $652 
Dividends paid to common stockholders$635 $651 $652 
Schedule of Accumulated Other Comprehensive Loss
The following table summarizes the activity related to each component of accumulated other comprehensive loss ("AOCL") for the years ended December 31, 2024, 2023 and 2022:
Accumulated Other Comprehensive LossCumulative Translation AdjPension and OPEB
Derivative Instruments 1
Total
In millions
2022
Balance at January 1, 2022$(88)$73 $56 $41 
Other comprehensive (loss) income before reclassifications(1,101)44 61 (996)
Amounts reclassified from accumulated other comprehensive income— (3)— (3)
M&M Divestiture reclassification adjustment221 (54)— 167 
Net other comprehensive (loss) income$(880)$(13)$61 $(832)
Balance at December 31, 2022$(968)$60 $117 $(791)
2023
Other comprehensive income (loss) before reclassifications46 (83)(41)(78)
Amounts reclassified from accumulated other comprehensive income— (9)— (9)
Delrin® Divestiture reclassification adjustment
(9)(23)— (32)
Net other comprehensive income (loss)$37 $(115)$(41)$(119)
Balance at December 31, 2023$(931)$(55)$76 $(910)
2024
Other comprehensive (loss) income before reclassifications(562)(59)32 (589)
Amounts reclassified from accumulated other comprehensive income — (1)— (1)
Net other comprehensive (loss) income$(562)$(60)$32 $(590)
Balance at December 31, 2024$(1,493)$(115)$108 $(1,500)
1. Includes cumulative translation adjustment impact associated with derivative instruments.

The tax effects on the net activity related to each component of other comprehensive income (loss) for the years ended December 31, 2024, 2023 and 2022 were as follows:
Tax Benefit (Expense)202420232022
In millions
Pension and other post-employment benefit plans$11 $26 $16 
Derivative instruments(9)12 (15)
Tax benefit from income taxes related to other comprehensive income (loss) items$2 $38 $1 
Schedule of Reclassifications Out of Accumulated Other Comprehensive Loss
A summary of the reclassifications out of AOCL for the years ended December 31, 2024, 2023 and 2022 is provided as follows:
Reclassifications Out of Accumulated Other Comprehensive Loss 202420232022Income Classification
In millions
Cumulative translation adjustments$— $(9)$221 See (1) below
Pension and other post-employment benefit plans(2)(35)(71)See (1) below
Tax expense (benefit) 1 3 14 See (1) below
    Pension and other post-employment benefit plans,
    after tax
(1)(32)(57)
Total reclassifications for the period, after tax$(1)$(41)$164 
1. The activity for the year ended December 31, 2024 is classified within "Sundry income (expense) - net" as part of continuing operations. The activity for the year ended December 31, 2023 is classified almost entirely within "(Loss) income from discontinued operations, net of tax" as part of the Delrin® Divestiture, with a portion classified within "Sundry income (expense) - net" as part of continuing operations. The activity for the year ended December 31, 2022 is classified almost entirely within "(Loss) income discontinued operations, net of tax" as part of the M&M Divestiture, with a portion classified within "Sundry income (expense) - net" as part of continuing operations.
v3.25.0.1
PENSION PLANS AND OTHER POST-EMPLOYMENT BENEFITS (Tables)
 12 Months Ended
Dec. 31, 2024
Retirement Benefits [Abstract]  
Schedule of Weighted-Average Assumptions Used
The weighted-average assumptions used to determine pension plan obligations and net periodic benefit costs for all plans are summarized in the table below:
Weighted-Average Assumptions for Pension Plans Benefit Obligations
 at December 31,		Net Periodic Costs
for the Years Ended
 20242023202420232022
Discount rate3.67 %3.26 %3.46 %3.05 %1.48 %
Interest crediting rate for applicable benefits1.75 %2.00 %2.00 %2.25 %1.25 %
Rate of compensation increase3.41 %3.11 %3.11 %3.25 %3.15 %
Expected return on plan assetsN/AN/A4.43 %3.61 %2.69 %
Schedule of Pension Plans and Other Postretirement Benefits
Summarized information on the Company's pension and other postretirement benefit plans is as follows:
Change in Projected Benefit Obligations of All Plans20242023
In millions
Change in projected benefit obligations:
Benefit obligations at beginning of year$2,704 $2,726 
Service cost17 25 
Interest cost84 99 
Plan participants' contributions9 7 
Actuarial changes in assumptions and experience
(49)132 
Benefits paid(208)(208)
Acquisitions/divestitures/other 1
— (209)
Effect of foreign exchange rates(122)133 
Termination benefits/curtailment cost/settlements— (1)
Benefit obligations at end of year$2,435 $2,704 
1.The year ended 2023 is primarily related to the Delrin® Divestiture.

Change in Plan Assets and Funded Status of All Plans20242023
In millions
Change in plan assets:
Fair value of plan assets at beginning of year$2,424 $2,596 
Actual return on plan assets (14)109 
Employer contributions51 66 
Plan participants' contributions9 7 
Benefits paid(208)(208)
Acquisitions/divestitures/other 1
— (285)
Effect of foreign exchange rates(101)139 
Fair value of plan assets at end of year$2,161 $2,424 
Funded status:
Plans with plan assets$186 $233 
All other plans(460)(513)
Funded status at end of year$(274)$(280)
1.The year ended 2023 is primarily related to the Delrin® Divestiture.

The following tables summarize the amounts recognized in the Consolidated Balance Sheets for all significant plans:
Amounts Recognized in the Consolidated Balance Sheets for All Significant PlansDecember 31, 2024December 31, 2023
In millions
Amounts recognized in the consolidated balance sheets:
Deferred charges and other assets$291 $338 
Accrued and other current liabilities(42)(53)
Pension and other postretirement benefits - noncurrent(523)(565)
Net amount recognized$(274)$(280)
Pretax amounts recognized in accumulated other comprehensive loss (income):
Net loss (gain)$167 $95 
Prior service credit(4)(8)
Pretax balance in accumulated other comprehensive loss at end of year
$163 $87 
Schedule of Accumulated Benefit Obligations in Excess of Plan Assets
Pension Plans with Accumulated Benefit Obligations in Excess of Plan AssetsDecember 31, 2024December 31, 2023
In millions
Accumulated benefit obligations$646 $700 
Fair value of plan assets$134 $138 
Schedule of Pension Plans with Projected Benefit Obligations in Excess of Plan Assets
Pension Plans with Projected Benefit Obligations in Excess of Plan AssetsDecember 31, 2024December 31, 2023
In millions
Projected benefit obligations$683 $743 
Fair value of plan assets$144 $154 
Schedule of Net Periodic Benefit Costs
Net Periodic Benefit Costs for All Significant Plans for the Years Ended December 31,202420232022
In millions
Net Periodic Benefit Costs:
Service cost$17 $25 $43 
Interest cost84 99 55 
Expected return on plan assets(100)(92)(97)
Amortization of prior service credit(3)(3)(5)
Amortization of unrecognized net (gain) loss— (1)1 
Curtailment/settlement1 (3)(4)
Net periodic benefit (credits) costs - Total$(1)$25 $(7)
Less: Net periodic benefit credits - Discontinued operations— (6)(9)
Net periodic benefit (credit) costs - Continuing operations 1
$(1)$31 $2 
Changes in plan assets and benefit obligations recognized in other comprehensive loss (income):
Net loss (gain)$70 $108 $(35)
Amortization of prior service credit3 3 5 
Amortization of unrecognized gain (loss)— 1 (1)
Settlement (loss) gain(1)3 4 
Effect of foreign exchange rates(1)1 5 
Total recognized in other comprehensive loss (income)$71 $116 $(22)
Total recognized in net periodic benefit costs (credits) and other comprehensive loss (income)$70 $147 $(20)
1. Refer to the separate table below for details of Net Periodic Benefit Costs for Plans in Continuing Operations.
Net Periodic Benefit Costs for Plans in Continuing Operations for the Years Ended December 31,202420232022
In millions
Net Periodic Benefit Costs:
Service cost$17 $22 $30 
Interest cost84 93 49 
Expected return on plan assets(100)(78)(73)
Amortization of prior service credit(3)(2)(4)
Amortization of unrecognized net (gain) loss— (1)4 
Curtailment/settlement1 (3)(4)
Net periodic benefit costs - Continuing operations$(1)$31 $2 
Schedule of Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive (Income) Loss
Net Periodic Benefit Costs for All Significant Plans for the Years Ended December 31,202420232022
In millions
Net Periodic Benefit Costs:
Service cost$17 $25 $43 
Interest cost84 99 55 
Expected return on plan assets(100)(92)(97)
Amortization of prior service credit(3)(3)(5)
Amortization of unrecognized net (gain) loss— (1)1 
Curtailment/settlement1 (3)(4)
Net periodic benefit (credits) costs - Total$(1)$25 $(7)
Less: Net periodic benefit credits - Discontinued operations— (6)(9)
Net periodic benefit (credit) costs - Continuing operations 1
$(1)$31 $2 
Changes in plan assets and benefit obligations recognized in other comprehensive loss (income):
Net loss (gain)$70 $108 $(35)
Amortization of prior service credit3 3 5 
Amortization of unrecognized gain (loss)— 1 (1)
Settlement (loss) gain(1)3 4 
Effect of foreign exchange rates(1)1 5 
Total recognized in other comprehensive loss (income)$71 $116 $(22)
Total recognized in net periodic benefit costs (credits) and other comprehensive loss (income)$70 $147 $(20)
1. Refer to the separate table below for details of Net Periodic Benefit Costs for Plans in Continuing Operations.
Net Periodic Benefit Costs for Plans in Continuing Operations for the Years Ended December 31,202420232022
In millions
Net Periodic Benefit Costs:
Service cost$17 $22 $30 
Interest cost84 93 49 
Expected return on plan assets(100)(78)(73)
Amortization of prior service credit(3)(2)(4)
Amortization of unrecognized net (gain) loss— (1)4 
Curtailment/settlement1 (3)(4)
Net periodic benefit costs - Continuing operations$(1)$31 $2 
Schedule of Estimated Future Benefit Payments
The estimated future benefit payments of continuing operations, reflecting expected future service, as appropriate, are presented in the following table:
Estimated Future Benefit Payments at December 31, 2024
In millions
2025$173 
2026171 
2027167 
2028169 
2029174 
Years 2030-2034845 
Total$1,699 
Schedule of Target Allocation for Plan Assets
The weighted-average target allocation for plan assets of DuPont's pension plans is summarized as follows:
Target Allocation for Plan Assets at December 31, 2024DuPont
Asset Category
Equity securities2 %
Fixed income securities9 
Alternative investments24 
Hedge funds26 
Pooled investment vehicles32 
Other investments7 
Total 100 %
The following table summarizes the bases used to measure the Company’s pension plan assets at fair value for the years ended December 31, 2024 and 2023:
Basis of Fair Value MeasurementsDecember 31, 2024December 31, 2023
In millionsTotalLevel 1Level 2Level 3TotalLevel 1Level 2Level 3
Cash and cash equivalents$52 $52 $— $— $55 $55 $— $— 
Equity securities:
U.S. equity securities$20 $20 $— $— $20 $20 $— $— 
Non - U.S. equity securities26 26 — — 29 29 — — 
Total equity securities$46 $46 $— $— $49 $49 $— $— 
Fixed income securities:
Debt - government-issued$34 $— $34 $— $34 $— $34 $— 
Debt - corporate-issued4 — 4 — 5 — 5 — 
Total fixed income securities$38 $— $38 $— $39 $— $39 $— 
Alternative investments:
Real estate$75 $— $— $75 $79 $— $— $79 
   Insurance contracts468 — — 468 524 — — 524 
Derivatives - asset position— — — — 3 — 3 — 
Derivatives - liability position(3)— (3)— — — — — 
Total alternative investments$540 $— $(3)$543 $606 $— $3 $603 
Other Investments:
Pooled Investment Vehicles$685 $685 $— $— $681 $681 $— $— 
Total other investments$685 $685 $— $— $681 $681 $— $— 
Subtotal$1,361 $783 $35 $543 $1,430 $785 $42 $603 
Investments measured at net asset value:
Debt - government-issued$147 $187 
Hedge funds552 667 
Private market securities101 126 
Total investments measured at net asset value
$800 $980 
Items to reconcile to fair value of plan assets:
Pension trust receivables 1
$—    $14    
Pension trust payables 2
—    — 
Total$2,161    $2,424    
1. Primarily receivables for investment securities sold.
2. Primarily payables for investment securities purchased.
Schedule of Fair Value Measurement of Level 3 Plan Assets
The following table summarizes the changes in the fair value of Level 3 pension plan assets for the years ended December 31, 2024 and 2023:
Fair Value Measurement of Level 3 Pension Plan AssetsReal EstateInsurance ContractsTotal
In millions
Balance at Jan 1, 2023$75 $524 $599 
Actual return on assets:
Relating to assets held at Dec 31, 20232 26 28 
Purchases, sales and settlements, net2 (16)(14)
Transfers out of Level 3 1
— (10)(10)
Balance at Dec 31, 2023$79 $524 $603 
Actual return on assets:
Relating to assets held at Dec 31, 2024(6)(56)(62)
Purchases, sales and settlements, net2 (3)(1)
Transfers into Level 3— 3 3 
Balance at Dec 31, 2024$75 $468 $543 
1. Related to the Delrin® Divestiture
v3.25.0.1
STOCK-BASED COMPENSATION (Tables)
 12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Weighted-Average Assumptions The weighted-average assumptions used to calculate total stock-based compensation are included in the following table:
EIP Weighted-Average Assumptions 1
2022
Dividend yield1.8 %
Expected volatility26.4 %
Risk-free interest rate1.9 %
Expected life of stock options granted during period (years)6.0
1. No stock options were granted by the Company out of the EIP plan in 2024 or 2023.
Schedule of Stock Option Activity
The following table summarizes stock option activity for 2024 under the EIP:
EIP Stock OptionsNumber of Shares
 (in thousands)		Weighted Average Exercise Price (per share)Weighted Average Remaining Contractual Term (in years)Aggregate Intrinsic Value (in thousands)
Outstanding at January 1, 2024627 $74.48 
Granted 1
— $— 
Exercised(106)$73.91 
Forfeited/Expired(12)$74.40 
Outstanding at December 31, 2024509 $74.61 6.58$837 
Exercisable at December 31, 2024375 $74.45 6.41$674 
1. No awards were granted by the Company out of the EIP plan in 2024 and 2023.

Additional Information about EIP Stock Options 1
In millions, except per share amounts202420232022
Weighted-average fair value per share of options granted 1
$— $— $17.41 
Total compensation expense for stock options plans 2
$12 $10 $8 
  Related tax benefit 2
$2 $2 $2 
1. No stock options were granted by the Company out of the EIP plan in 2024 and 2023.
2. These amounts represent life to date.
The following table summarizes stock option activity for 2024 under the OIP:
OIP Stock OptionsNumber of Shares
 (in thousands)		Weighted Average Exercise Price (per share)Weighted Average Remaining Contractual Term (in years)Aggregate Intrinsic Value (in thousands)
Outstanding at January 1, 20241,637 $62.58 
Granted— $— 
Exercised(217)$62.55 
Forfeited/Expired(30)$64.16 
Outstanding at December 31, 20241,390 $62.55 5.12$19,041 
Exercisable at December 31, 20241,390 $62.55 5.12$19,041 

Additional Information about OIP Stock Options 1
In millions, except per share amounts202420232022
Total compensation expense for stock options plans 2
$27 $26 $25 
  Related tax benefit 2
$6 $6 $5 
1. No awards were granted by the Company out of the OIP plan in 2024, 2023 or 2022.
2.These amounts represent life to date.
Schedule of Nonvested Awards
Nonvested awards of RSUs and PSUs are shown below:
EIP RSUs and PSUsNumber of Shares
(in thousands)		Weighted Average Grant Date Fair Value
(per share)
Nonvested at January 1, 20241,991 $69.85 
Granted1,212 $70.70 
Vested(880)$72.86 
Forfeited(119)$69.88 
Nonvested at December 31, 20242,204 $69.11 
Nonvested awards of RSUs and PSUs are shown below.
OIP RSUs and PSUsNumber of Shares
(in thousands)		Weighted Average Grant Date Fair Value
(per share)
Nonvested at January 1, 2024163 $68.01 
Granted— $— 
Vested(109)$71.93 
Forfeited(3)$71.42 
Nonvested at December 31, 202451 $59.40 
The following table summarizes stock option activity for 2024:
EIDP Stock OptionsNumber of Shares
(in thousands)		Weighted Average Grant Date Fair Value
(per share)		Weighted Average Remaining Contractual Term (in years)Aggregate Intrinsic Value (in thousands)
Outstanding at January 1, 20242,228 $73.49 
Exercised(205)$70.48 
Forfeited/Expired(21)$76.58 
Outstanding at December 31, 20242,002 $73.77 2.7$8,804 
Exercisable at December 31, 20241,997 $73.78 2.7$8,760 
v3.25.0.1
FINANCIAL INSTRUMENTS (Tables)
 12 Months Ended
Dec. 31, 2024
Investments, All Other Investments [Abstract]  
Schedule of the Fair Value of Financial Instruments
The following table summarizes the fair value of financial instruments at December 31, 2024 and December 31, 2023:
Fair Value of Financial InstrumentsDecember 31, 2024December 31, 2023
In millionsCostGainLossFair ValueCostGainLossFair Value
Cash equivalents$314 $— $— $314 $408 $— $— $408 
Restricted cash equivalents 1
$42 $— $— $42 $411 $— $— $411 
Total cash and restricted cash equivalents$356 $— $— $356 $819 $— $— $819 
Long-term debt including debt due within one year 2
$(7,171)$14 $(57)$(7,214)$(7,859)$70 $(206)$(7,995)
Derivatives relating to:
Net investment hedge 3
— 137 — 137 — 96 — 96 
Foreign currency 4, 5
— 8 (8)— — 26 (23)3 
Interest rate swap agreements 6
— — (206)(206)— — (59)(59)
Total derivatives$— $145 $(214)$(69)$— $122 $(82)$40 
1.Refer to Note 7 and Note 16 for more information on Restricted cash equivalents.
2.At December 31, 2024 the balance included unamortized basis adjustment of $48 million related to the 2022 Swaps, discussed below. At December 31, 2023, the balance included a fair value hedging revaluation related to the 2022 Swaps of $59 million, discussed below. Fair value of long-term debt including debt due within one year is based on quoted market prices for the same or similar issues, or on current rates offered to the company for debt of the same remaining maturities and terms and represents a Level 2 fair value measurement.
3.Classified as "Deferred charges and other assets" in the Consolidated Balance Sheets.
4.Classified as "Prepaid and other current assets" and "Accrued and other current liabilities" in the Consolidated Balance Sheets.
5.Presented net of cash collateral where master netting arrangements allow.
6.The loss on the 2022 and 2024 Swaps are classified as "Other noncurrent obligations" and "Accrued and other current liabilities", respectively, in the Consolidated Balance Sheets.
Schedule of Notional Amounts
The notional amounts of the Company's derivative instruments were as follows:
Notional AmountsDecember 31, 2024December 31, 2023
In millions
Derivatives designated as hedging instruments:
   Net investment hedge$1,000 $1,000 
   Interest rate swap agreements$— $1,000 
Derivatives not designated as hedging instruments:
Foreign currency contracts 1
$(1,176)$(907)
Interest rate swap agreements 2
$4,150 $— 
1.Presented net of contracts bought and sold.
2.Includes notional amounts related to the 2022 Swaps and 2024 Swaps, described further below.
v3.25.0.1
FAIR VALUE MEASUREMENTS (Tables)
 12 Months Ended
Dec. 31, 2024
Fair Value Disclosures [Abstract]  
Schedule of the Fair Value of Assets and Liabilities Measured on a Recurring Basis
The following tables summarize the basis used to measure certain assets and liabilities at fair value on a recurring basis:
Basis of Fair Value Measurements on a Recurring Basis of Significant Other Observable Inputs (Level 2)
December 31, 2024December 31, 2023
In millions
Assets at fair value:
Cash equivalents 1
$314 $364 
Derivatives relating to: 2
Net investment hedge137 96 
Foreign currency contracts 3
23 37 
Total assets at fair value$474 $497 
Liabilities at fair value:
Derivatives relating to: 2
Interest rate swap agreements206 59 
Foreign currency contracts 3
23 34 
Total liabilities at fair value$229 $93 
1.Time deposits included in "Cash and cash equivalents" in the Consolidated Balance Sheets are held at amortized cost, which approximates fair value. "Restricted cash and cash equivalents" and "Restricted cash and cash equivalents - noncurrent" in the Consolidated Balance Sheets at December 31, 2024 included $42 million of money market funds representing Level 1 fair value measurement investments which are held at amortized cost. "Cash and cash equivalents" and "Restricted cash and cash equivalents" in the Consolidated Balance Sheets at December 31, 2023, included $50 million of money market funds and $405 million deposited within a qualified settlement fund consisting of treasury bills, respectively, representing Level 1 fair value measurement investment, also held at amortized cost.
2.See Note 21 for the classification of derivatives in the Consolidated Balance Sheets.
3.Assets and liability derivatives subject to an enforceable master netting arrangement with the same counterparty are presented on a net basis in the Consolidated Balance Sheets. The offsetting counterparty and cash collateral amounts were $15 million and zero, respectively, for both assets and liabilities as of December 31, 2024. The offsetting counterparty and cash collateral amounts were $11 million and zero, respectively, for both assets and liabilities as of December 31, 2023.
Schedule of the Fair Value of Liabilities Measured on a Recurring Basis
Basis of Fair Value Measurements on a Recurring Basis of Significant Unobservable Inputs (Level 3)
December 31, 2024December 31, 2023
In millions
Liabilities at fair value:
Contingent earn-out liabilities
$40 $— 
Total liabilities at fair value$40 $— 
Schedule of the Fair Value of Assets and Liabilities Measured on a Nonrecurring Basis
The following table summarizes the basis used to measure certain assets at fair value on a nonrecurring basis:
Basis of Fair Value Measurements on a Nonrecurring Basis 1
Significant Other Unobservable Inputs (Level 3)Total Losses
In millions
At December 31, 2023
Assets at fair value:
   Goodwill$4,814 $(804)
At December 31, 2022
Assets at fair value:
    Long-lived assets, intangible assets, and other assets$55 $(94)
1.The Company did not incur any losses associated with fair value measurements on a nonrecurring basis for the year ended December 31, 2024.
v3.25.0.1
SEGMENTS AND GEOGRAPHIC REGIONS (Tables)
 12 Months Ended
Dec. 31, 2024
Segment Reporting [Abstract]  
Schedule of Net Trade Revenue and Long-lived Assets by Geographic Region
Net Trade Revenue by Geographic Region202420232022
(In millions) For the years ended December 31,
United States$4,102 $3,914 $4,066 
Canada273 271 293 
EMEA 1
2,146 2,203 2,193 
Asia Pacific 2
5,368 5,191 6,022 
Latin America497 489 443 
Total$12,386 $12,068 $13,017 
1.Europe, Middle East and Africa.
2. Net sales attributed to China/Hong Kong, for the years ended December 31, 2024, 2023 and 2022 were $2,345 million, $2,206 million, and $2,744 million, respectively.

Long-lived Assets by Geographic RegionDecember 31,
In millions202420232022
United States$3,590 $3,559 $3,501 
Canada60 54 49 
EMEA 1
1,259 1,336 1,271 
Asia Pacific823 896 883 
Latin America36 39 27 
Total$5,768 $5,884 $5,731 
1.Europe, Middle East and Africa.
Schedule of Segment Information
Segment Revenue, Significant Segment Expenses and Segment Operating EBITDAFor the years ended December 31,
202420232022
(In millions)Electronics & IndustrialWater & ProtectionElectronics & IndustrialWater & ProtectionElectronics & IndustrialWater & Protection
Segment net sales$5,930 $5,423 $5,337 $5,633 $5,917 $5,957 
Less 1:
Cost of sales$3,420 $3,674 $3,139 $3,879 $3,341 $4,149 
Selling, general and administrative expenses761 574 647 545 632 554 
Research and development expenses366 141 348 138 377 131 
Amortization of intangibles & other segment items 2
341 226 354 225 342 225 
Add:
Equity in earnings of nonconsolidated affiliates$37 $30 $16 $35 $31 $39 
Depreciation and amortization 3
638 522 607 507 580 494 
Segment Operating EBITDA$1,717 $1,360 $1,472 $1,388 $1,836 $1,431 
1.The significant expense categories and amounts align with the segment-level information that is regularly provided to the chief operating decision maker.
2.Other segment items include immaterial other gains or losses and miscellaneous income and expenses.
3.Depreciation is a reconciling item to segment Operating EBITDA as it is included within Cost of sales, Selling, general and administrative expenses and Research and development expenses.
Segment and Corporate & Other InformationElectronics & IndustrialWater & ProtectionCorporate & OtherTotal
In millions
For the Year Ended December 31, 2024
Assets of continuing operations$18,537 $13,098 $5,001 $36,636 
Investment in nonconsolidated affiliates382 278 118 778 
Capital expenditures340 230 49 619 
For the Year Ended December 31, 2023
Assets of continuing operations$18,622 $13,750 $6,180 $38,552 
Investment in nonconsolidated affiliates386 280 122 788 
Capital expenditures306 240 44 590 
For the Year Ended December 31, 2022
Assets of continuing operations$17,110 $14,831 $8,123 $40,064 
Investment in nonconsolidated affiliates396 290 — 686 
Capital expenditures290 289 80 659 
Schedule of Reconciliation of Income (Loss) from Continuing Operations
Reconciliation of Segment Operating EBITDA to Income from continuing operations before income taxesFor the years ended December 31,
(In millions)202420232022
Electronics & Industrial Segment Operating EBITDA$1,717 $1,472 $1,836 
Water & Protection Segment Operating EBITDA1,360 1,388 1,431 
Reportable Segment Operating EBITDA$3,077 $2,860 $3,267 
+Corporate & Other Operating EBITDA$67 $82 $(6)
-Depreciation and amortization1,194 1,147 1,135 
+
Interest income 1
73 155 50 
-
Interest expense 2
364 396 486 
+
Non-operating pension/OPEB benefit costs (credits) 1
18 (9)28 
+
Foreign exchange gains (losses), net 1
3 (73)15 
-Future reimbursable indirect costs— 7 52 
+Significant items charge(488)(961)(233)
Income from continuing operations before income taxes$1,192 $504 $1,448 
1.Included in "Sundry income (expense) - net."
2.The years ended December 31, 2024 and 2022 excludes significant items, refer to details below.
Capital Expenditure Reconciliation to Consolidated Financial Statements202420232022
In millions
Segment and Corporate & Other Totals$619 $590 $659 
Other 1
(40)29 3 
Total$579 $619 $662 
1.Reflects the incremental cash spent or unpaid on capital expenditures; total capital expenditures are presented on a cash basis.
Schedule of Significant Items by Segment
The following tables summarize the pre-tax impact of significant items that are excluded from Operating EBITDA above:
Significant Items for the Year Ended December 31, 2024Electronics & IndustrialWater & ProtectionCorporate & OtherTotal
In millions
Acquisition, integration and separation costs 1
$(12)$— $(156)$(168)
Restructuring and asset related charges - net 2
(5)(50)(32)(87)
Inventory write-offs 3
— (25)— (25)
Inventory step-up amortization 4
(2)— — (2)
Loss on debt extinguishment 5
— — (74)(74)
Interest rate swap items 6
— — (140)(140)
Income tax items 7
— — 8 8 
Total$(19)$(75)$(394)$(488)
1. Acquisition, integration and separation costs related to the Previously Intended Business Separations and the Intended Electronics Separation, and the acquisitions of Spectrum and Donatelle Plastics.
2. Includes restructuring actions and asset related charges. See Note 6 for additional information.
3. Reflects inventory write-offs recorded in “Cost of Sales” in connection with restructuring actions. See Note 6 for additional information.
4. Reflects the amortization of an inventory step-up adjustment related the Donatelle Plastics Acquisition.
5. Reflects the loss on extinguishment of debt related to the partial redemption of an aggregate principal amount of the 2038 Notes. Refer to Note 15 for further details.
6. Includes the non-cash mark-to-market loss related to the 2022 Swaps and 2024 Swaps, net interest settlement loss related to the 2022 Swaps and $2 million of basis amortization on the 2022 Swaps. Refer to Note 21 for further details.
7. Reflects the impact of an indemnified international tax audit.

Significant Items for the Year Ended December 31, 2023Electronics & IndustrialWater & ProtectionCorporate & OtherTotal
In millions
Acquisition, integration and separation costs 1
$(20)$— $— $(20)
Restructuring and asset related charges - net 2
(49)(55)(42)(146)
Goodwill impairment charge 3
— (804)— (804)
Gain on divestiture 4
7 1 1 9 
Total$(62)$(858)$(41)$(961)
1. Acquisition, integration and separation costs related to the Spectrum Acquisition.
2. Includes restructuring actions and asset related charges. See Note 6 for additional information.
3. Reflects a non-cash goodwill impairment charge in the Protection Reporting unit (aggregation of Safety and Shelter businesses). See Note 14 for additional information.
4. Reflected in "Sundry income (expense) - net."

Significant Items for the Year Ended December 31, 2022Electronics & IndustrialWater & ProtectionCorporate & OtherTotal
In millions
Acquisition, integration and separation costs 1
$— $— $(193)$(193)
Restructuring and asset related charges - net 2
(24)(17)(20)(61)
Asset impairment charges 3
(94)— — (94)
Gain on divestiture 4
— 37 32 69 
Terminated Intended Rogers Acquisition financing fees 5
— — (6)(6)
Employee Retention Credit 6
20 20 12 52 
Total$(98)$40 $(175)$(233)
1. Acquisition, integration and separation costs related to strategic initiatives including the sale of the Biomaterials business unit, the acquisition of Laird PM, and the termination fee of $162.5 million associated with the Terminated Intended Rogers Corporation Acquisition.
2. Includes restructuring actions and asset related charges. See Note 6 for additional information.
3. Relates to an impairment of an equity method investment. See Note 6 for additional information.
4. Reflected in "Sundry income (expense) - net." See Note 4 for additional information.
5. Includes acquisition costs associated with the Terminated Intended Rogers Corporation Acquisition related to the financing agreements, specifically the structuring fees and the amortization of the commitment fees reflected in "Interest Expense."
6. Employee Retention Credit pursuant to the Coronavirus Aid, Relief, and Economic Security (“CARES”) Act as enhanced by the Consolidated Appropriations Act (“CAA”) and American Rescue Plan Act (“ARPA”) reflected in "Cost of sales," "Research and development expenses" and "Selling, general and administrative expenses."
Schedule of Total Asset Reconciliation
Total Asset Reconciliation at December 31,202420232022
In millions
Assets of continuing operations$36,636 $38,552 $40,064 
Assets of discontinued operations— — 1,291 
Total assets$36,636 $38,552 $41,355 
v3.25.0.1
Schedule II—Valuation and Qualifying Accounts (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Accounts Receivable—Allowance for Doubtful Receivables      
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance at beginning of period $ 40 $ 38 $ 28
Additions charged to expenses 17 12 11
Deductions from reserves (31) (10) (1)
Balance at end of period 26 40 38
Inventory—Obsolescence Reserve      
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance at beginning of period 8 4 6
Additions charged to expenses 41 14 18
Deductions from reserves (14) (10) (20)
Balance at end of period 35 8 4
Deferred Tax Assets—Valuation Allowance      
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance at beginning of period 738 703 700
Additions charged to expenses 122 47 125
Deductions from reserves (88) (12) (122)
Balance at end of period $ 772 $ 738 $ 703
v3.25.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)
$ in Billions
Nov. 01, 2022
Dec. 31, 2024
Minimum    
Finite-Lived Intangible Assets [Line Items]    
Definite-lived intangible assets, useful life   1 year
Maximum    
Finite-Lived Intangible Assets [Line Items]    
Definite-lived intangible assets, useful life   20 years
Mobility And Materials Businesses | Discontinued Operations, Disposed of by Sale    
Finite-Lived Intangible Assets [Line Items]    
Proceeds from divestiture $ 11.0  
v3.25.0.1
ACQUISITIONS - Narrative (Details) - USD ($)
 12 Months Ended
Jul. 28, 2024
Aug. 01, 2023
Nov. 02, 2022
Nov. 01, 2022
Dec. 31, 2022
Dec. 31, 2024
Dec. 31, 2023
Business Acquisition [Line Items]              
Goodwill         $ 16,663,000,000 $ 16,567,000,000 $ 16,720,000,000
Termination fee paid         $ 162,500,000    
Donatelle Plastics              
Business Acquisition [Line Items]              
Net purchase price $ 365,000,000            
Contingent earn-out liability included in purchase price 40,000,000            
Total assets acquired 268,000,000            
Total liabilities assumed 17,000,000            
Goodwill 114,000,000            
Total Consideration 365,000,000            
Other intangible assets 201,000,000            
Property, plant and equipment 36,000,000            
Maximum aggregate of annual contingent earn-out payments 85,000,000            
Contingent earn-out liability 40,000,000         $ 40,000,000  
Donatelle Plastics | Customer-related              
Business Acquisition [Line Items]              
Other intangible assets with definite lives acquired $ 151,000,000            
Useful lives of other intangible assets with definite lives acquired 20 years            
Donatelle Plastics | Developed technology              
Business Acquisition [Line Items]              
Other intangible assets with definite lives acquired $ 47,000,000            
Useful lives of other intangible assets with definite lives acquired 15 years            
Spectrum Plastics Group              
Business Acquisition [Line Items]              
Total assets acquired   $ 1,226,000,000          
Total liabilities assumed   259,000,000          
Goodwill   814,000,000          
Total Consideration   1,781,000,000          
Other intangible assets   916,000,000          
Property, plant and equipment   125,000,000          
Net upward adjustments   43,000,000          
Goodwill expected to be tax deductible   0          
Spectrum Plastics Group | Customer-related              
Business Acquisition [Line Items]              
Other intangible assets with definite lives acquired   $ 772,000,000          
Useful lives of other intangible assets with definite lives acquired   20 years          
Spectrum Plastics Group | Developed technology              
Business Acquisition [Line Items]              
Other intangible assets with definite lives acquired   $ 126,000,000          
Useful lives of other intangible assets with definite lives acquired   15 years          
Spectrum Plastics Group | Trademarks/tradenames              
Business Acquisition [Line Items]              
Other intangible assets with definite lives acquired   $ 18,000,000          
Useful lives of other intangible assets with definite lives acquired   5 years          
Rogers Corporation              
Business Acquisition [Line Items]              
Expected price of acquisition       $ 5,200,000,000      
Termination fee paid     $ 162,500,000        
v3.25.0.1
ACQUISITIONS - Assets Acquired and Liabilities Assumed (Details) - USD ($)
$ in Millions
Dec. 31, 2024
Dec. 31, 2023
Aug. 01, 2023
Dec. 31, 2022
Fair value of liabilities assumed        
Goodwill $ 16,567 $ 16,720   $ 16,663
Spectrum Plastics Group        
Fair value of assets acquired        
Cash and cash equivalents     $ 31  
Accounts and notes receivable     68  
Inventories     52  
Property, plant and equipment     125  
Other intangible assets     916  
Deferred charges and other assets     34  
Total Assets Acquired     1,226  
Fair value of liabilities assumed        
Accounts payable     21  
Income taxes payable     17  
Deferred income tax liabilities     177  
Other noncurrent liabilities     44  
Total Liabilities Assumed     259  
Goodwill     814  
Total Consideration     $ 1,781  
v3.25.0.1
ACQUISITIONS - Acquisition, Integration and Separation Costs (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]      
Acquisition, integration and separation costs $ 168 $ 20 $ 193
v3.25.0.1
DIVESTITURES - Narrative (Details) - USD ($)
$ in Millions
 12 Months Ended
Nov. 01, 2023
Nov. 01, 2022
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
May 31, 2022
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Net proceeds from divestiture     $ 8 $ 1,244 $ 10,951  
(Loss) income from discontinued operations, net of tax     $ (40) (71) 4,856  
Pre tax gain (loss) on disposition       9 69  
Derby            
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Notes receivable $ 350          
Ownership percentage 19.90%          
Equity investment, fair value $ 121          
Note receivable, fair value 224          
Discontinued Operations, Disposed of by Sale | Mobility And Materials Businesses            
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Proceeds from divestiture   $ 11,000        
Cash divested adjustments   500        
Net proceeds from divestiture   $ 10,500        
Gain on sale       480 5,024  
(Loss) income from discontinued operations, net of tax       (57) (69)  
Discontinued Operations, Disposed of by Sale | Delrin Business            
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Proceeds from divestiture 1,280          
Cash divested adjustments 27          
Net proceeds from divestiture 1,250          
Gain on sale $ 419     $ 419    
Discontinued Operations, Disposed of by Sale | Derby            
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Percentage of ownership holds in subsidiaries 80.10%          
Disposal Group, Disposed of by Sale, Not Discontinued Operations | Biomaterials Business Unit            
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Consideration received for divestiture           $ 240
Pre tax gain (loss) on disposition         26  
Gain (loss) on disposition, net of tax         $ 21  
v3.25.0.1
DIVESTITURES - Schedule of Discontinued Operations (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
(Loss) income from discontinued operations, net of tax $ (40) $ (71) $ 4,856
Net (loss) income from discontinued operations attributable to noncontrolling interests $ 0 $ 0 (4)
Discontinued Operation, Gain (Loss) on Disposal, Statement of Income or Comprehensive Income [Extensible Enumeration] (Loss) income from discontinued operations, net of tax (Loss) income from discontinued operations, net of tax  
Mobility And Materials Businesses      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Provision for income taxes on discontinued operations   $ 21 127
Discontinued Operations, Disposed of by Sale | Mobility And Materials Businesses      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Net sales   460 3,532
Cost of sales   295 2,712
Research and development expenses   3 46
Selling, general and administrative expenses   2 127
Amortization of intangibles   0 28
Acquisition, integration and separation costs   195 555
Equity in earnings of nonconsolidated affiliates   0 (9)
Sundry income (expense) - net   9 4
(Loss) income from discontinued operations before income taxes   (26) 59
Provision for income taxes on discontinued operations   31 128
(Loss) income from discontinued operations, net of tax   (57) (69)
Net (loss) income from discontinued operations attributable to noncontrolling interests   0 (4)
Gain on sale, net of tax   480 5,024
Income from discontinued operations attributable to DuPont stockholders, net of tax   $ 423 $ 4,959
v3.25.0.1
DIVESTITURES - Schedule of Other Discontinued Operations Activity (Details) - Discontinued Operations, Disposed of by Sale - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Tax related matters $ 57 $ 0 $ 0
Other (10) (18) (25)
(Loss) income from discontinued operations, net of tax (40) (71) 4,856
Indemnification Agreement      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Indemnification activity - environmental and legal (24) (50) 0
Mobility And Materials Businesses      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
(Loss) income from discontinued operations (27) 423 4,955
MOU Activity      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
(Loss) income from discontinued operations $ (36) $ (426) $ (74)
v3.25.0.1
REVENUE - Schedule of Net Trade Revenue (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Disaggregation of Revenue [Line Items]      
Net sales $ 12,386 $ 12,068 $ 13,017
Corporate & Other      
Disaggregation of Revenue [Line Items]      
Net sales 1,033 1,098 1,143
Corporate & Other | Retained Businesses      
Disaggregation of Revenue [Line Items]      
Net sales 1,033 1,098 1,067
Corporate & Other | Other      
Disaggregation of Revenue [Line Items]      
Net sales 0 0 76
Electronics & Industrial      
Disaggregation of Revenue [Line Items]      
Net sales 5,930 5,337 5,917
Electronics & Industrial | Industrial Solutions      
Disaggregation of Revenue [Line Items]      
Net sales 1,922 1,756 1,633
Electronics & Industrial | Interconnect Solutions      
Disaggregation of Revenue [Line Items]      
Net sales 1,822 1,688 2,045
Electronics & Industrial | Semiconductor Technologies      
Disaggregation of Revenue [Line Items]      
Net sales 2,186 1,893 2,239
Water & Protection      
Disaggregation of Revenue [Line Items]      
Net sales 5,423 5,633 5,957
Water & Protection | Safety Solutions      
Disaggregation of Revenue [Line Items]      
Net sales 2,375 2,519 2,649
Water & Protection | Shelter Solutions      
Disaggregation of Revenue [Line Items]      
Net sales 1,640 1,655 1,815
Water & Protection | Water Solutions      
Disaggregation of Revenue [Line Items]      
Net sales $ 1,408 $ 1,459 $ 1,493
v3.25.0.1
REVENUE - Schedule of Contract Balances (Details) - USD ($)
$ in Millions
Dec. 31, 2024
Dec. 31, 2023
Revenue from Contract with Customer [Abstract]    
Accounts and notes receivable - trade $ 1,561 $ 1,543
Deferred revenue - current 2 1
Deferred revenue - noncurrent $ 36 $ 22
v3.25.0.1
RESTRUCTURING AND ASSET RELATED CHARGES - NET - Narrative (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Restructuring Cost and Reserve [Line Items]      
Charges for restructuring programs and asset related charges $ 87 $ 146 $ 155
Liabilities related to restructuring programs 48 107  
Inventory write-offs 25    
Equity method investment, other than temporary impairment     94
Equity method investment impairment charges, net of tax     $ 65
2023-2024 Restructuring Program      
Restructuring Cost and Reserve [Line Items]      
Liabilities related to restructuring programs 47 79  
Pre-tax restructuring charges from inception-to-date 199    
Inventory write-offs 25    
2023-2024 Restructuring Program | Severance and Related Benefit Cost      
Restructuring Cost and Reserve [Line Items]      
Pre-tax restructuring charges from inception-to-date 114    
2023-2024 Restructuring Program | Asset Related Charges      
Restructuring Cost and Reserve [Line Items]      
Pre-tax restructuring charges from inception-to-date 85    
2022 Restructuring Program      
Restructuring Cost and Reserve [Line Items]      
Liabilities related to restructuring programs 1 27  
Pre-tax restructuring charges from inception-to-date 94    
Pre-tax restructuring charges (benefits) (2) $ 35  
2022 Restructuring Program | Severance and Related Benefit Cost      
Restructuring Cost and Reserve [Line Items]      
Pre-tax restructuring charges from inception-to-date 80    
2022 Restructuring Program | Asset Related Charges      
Restructuring Cost and Reserve [Line Items]      
Pre-tax restructuring charges from inception-to-date $ 14    
v3.25.0.1
RESTRUCTURING AND ASSET RELATED CHARGES - NET - Restructuring Program (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Restructuring Cost and Reserve [Line Items]      
Restructuring charges $ 87 $ 146 $ 61
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration] Restructuring and asset related charges - net Restructuring and asset related charges - net  
Operating Segments | Electronics & Industrial      
Restructuring Cost and Reserve [Line Items]      
Restructuring charges $ 5 $ 49 24
Operating Segments | Water & Protection      
Restructuring Cost and Reserve [Line Items]      
Restructuring charges 50 55 17
Corporate & Other      
Restructuring Cost and Reserve [Line Items]      
Restructuring charges 32 42 20
2023-2024 Restructuring Program      
Restructuring Cost and Reserve [Line Items]      
Restructuring charges 89 110  
2023-2024 Restructuring Program | Operating Segments | Electronics & Industrial      
Restructuring Cost and Reserve [Line Items]      
Restructuring charges 2 21  
2023-2024 Restructuring Program | Operating Segments | Water & Protection      
Restructuring Cost and Reserve [Line Items]      
Restructuring charges 50 57  
2023-2024 Restructuring Program | Corporate & Other      
Restructuring Cost and Reserve [Line Items]      
Restructuring charges 37 32  
2022 Restructuring Program      
Restructuring Cost and Reserve [Line Items]      
Restructuring charges (2) 35 61
2022 Restructuring Program | Operating Segments | Electronics & Industrial      
Restructuring Cost and Reserve [Line Items]      
Restructuring charges 3 29 23
2022 Restructuring Program | Operating Segments | Water & Protection      
Restructuring Cost and Reserve [Line Items]      
Restructuring charges 0 (2) 16
2022 Restructuring Program | Corporate & Other      
Restructuring Cost and Reserve [Line Items]      
Restructuring charges $ (5) $ 8 $ 22
v3.25.0.1
RESTRUCTURING AND ASSET RELATED CHARGES - NET - Schedule of Restructuring Reserve (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Restructuring Reserve [Roll Forward]      
Restructuring charges $ 87 $ 146 $ 61
2023-2024 Restructuring Program      
Restructuring Reserve [Roll Forward]      
Reserve balance at beginning of period 79 0  
Restructuring charges 89 110  
Reductions against the reserve (58) (31)  
Cash payments (63)    
Reserve balance at end of period 47 79 0
2023-2024 Restructuring Program | Severance and Related Benefit Cost      
Restructuring Reserve [Roll Forward]      
Reserve balance at beginning of period 79 0  
Restructuring charges 34 80  
Reductions against the reserve (3) (1)  
Cash payments (63)    
Reserve balance at end of period 47 79 0
2023-2024 Restructuring Program | Asset Related Charges      
Restructuring Reserve [Roll Forward]      
Reserve balance at beginning of period 0 0  
Restructuring charges 55 30  
Reductions against the reserve (55) (30)  
Cash payments 0    
Reserve balance at end of period $ 0 $ 0 $ 0
v3.25.0.1
SUPPLEMENTARY INFORMATION - Schedule of Sundry Income (Expense), Net (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Nov. 01, 2023
Schedule Of Sundry Income (Expense) [Line Items]        
Non-operating pension and other post-employment benefit ("OPEB") credits (costs) $ 18 $ (9) $ 28  
Interest income 73 155 50  
Net gain on divestiture and sales of other assets and investments 20 19 78  
Foreign exchange gains (losses), net 3 (73) 15  
Loss on debt extinguishment (74) 0 0  
Interest rate swap mark-to-market loss (138) 0 0  
Miscellaneous income (expenses) - net 22 10 20  
Sundry income (expense) - net (76) 102 191  
Water & Protection        
Schedule Of Sundry Income (Expense) [Line Items]        
Net gain on divestiture and sales of other assets and investments     37  
Disposal Group, Held-for-sale, Not Discontinued Operations | Biomaterials Business Unit        
Schedule Of Sundry Income (Expense) [Line Items]        
Net gain on divestiture and sales of other assets and investments     26  
Derby        
Schedule Of Sundry Income (Expense) [Line Items]        
Non-cash interest income on notes receivable 26 4    
Related party notes receivable       $ 350
Interest Rate Swap        
Schedule Of Sundry Income (Expense) [Line Items]        
Interest rate swap mark-to-market loss $ (138) $ 0 $ 0  
v3.25.0.1
SUPPLEMENTARY INFORMATION - Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended
Jun. 30, 2024
Sep. 30, 2023
Dec. 31, 2024
Dec. 31, 2023
Supplementary Information        
Restricted cash and cash equivalents     $ 6 $ 411
Restricted cash and cash equivalents - noncurrent     36 0
Accrued and other current liabilities     1,031 1,269
Accrued payroll     $ 383 250
Water District Settlement Fund        
Supplementary Information        
Litigation settlement payment $ 408 $ 408    
Accrued settlement amount       $ 405
v3.25.0.1
INCOME TAXES - Geographic Allocation of Income (Loss) and Provision for Income Taxes (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
(Loss) income from continuing operations before income taxes      
Domestic $ (505) $ (695) $ (308)
Foreign 1,697 1,199 1,756
Income from continuing operations before income taxes 1,192 504 1,448
Current tax expense      
Federal 148 80 211
State and local 16 9 7
Foreign 389 246 373
Total current tax expense 553 335 591
Deferred tax (benefit) expense      
Federal (141) (24) (191)
State and local (31) (27) (16)
Foreign 33 (313) 3
Total deferred tax benefit (139) (364) (204)
Provision for (benefit from) income taxes on continuing operations 414 (29) 387
Income from continuing operations, net of tax $ 778 $ 533 $ 1,061
v3.25.0.1
INCOME TAXES - Reconciliation to US Statutory Rate (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Income Tax Disclosure [Abstract]      
Statutory U.S. federal income tax rate 21.00% 21.00% 21.00%
Equity earning effect (0.40%) (1.20%) 0.20%
Foreign income taxed at rates other than the statutory U.S. federal income tax rate 2.80% 4.90% (3.90%)
U.S. tax effect of foreign earnings and dividends 4.60% 13.00% 5.00%
Unrecognized tax benefits (0.10%) (0.10%) 1.00%
Acquisitions, divestitures and ownership restructuring activities 9.00% (64.40%) 2.50%
Exchange gains/losses 1.50% (1.10%) 0.40%
State and local income taxes (0.60%) (2.80%) 0.20%
Change in valuation allowance 0.50% 0.00% 0.00%
Goodwill impairments 0.00% 33.50% 0.00%
Stock-based compensation 0.20% (1.00%) (0.20%)
Foreign-derived intangible income (FDII) (1.90%) (6.00%) (2.00%)
Other - net (1.90%) (1.60%) 2.50%
Effective tax rate 34.70% (5.80%) 26.70%
Tax expense (benefit) related to internal entity restructuring $ 103 $ (324)  
v3.25.0.1
INCOME TAXES - Deferred Tax Balances (Details) - USD ($)
$ in Millions
Dec. 31, 2024
Dec. 31, 2023
Deferred tax assets:    
Tax losses and credit carryforwards $ 800 $ 870
Lease liability 98 116
Pension and postretirement benefit obligations 98 46
Other accruals and reserves 124 131
Research and development 268 218
Inventory 7 16
Other – net 254 202
Gross deferred tax assets 1,649 1,599
Valuation allowances (772) (738)
Total deferred tax assets 877 861
Deferred tax liabilities:    
Investments (176) (204)
Unrealized exchange losses, net (36) (17)
Operating lease asset (98) (116)
Property (360) (343)
Intangibles (876) (999)
Total deferred tax liabilities (1,546) (1,679)
Total net deferred tax liability $ (669) $ (818)
v3.25.0.1
INCOME TAXES - Narrative (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Income Tax Contingency [Line Items]      
Deferred tax liability, net $ 669 $ 818  
Undistributed earnings of foreign subsidiaries 7,024    
Tax expense (benefit) related to internal entity restructuring $ 103 (324)  
Mobility And Materials Businesses      
Income Tax Contingency [Line Items]      
Provision for income taxes on discontinued operations   21 $ 127
DuPont Specialty Products USA, LLC      
Income Tax Contingency [Line Items]      
Ownership percentage 100.00%    
DuPont Specialty Products, Partnership      
Income Tax Contingency [Line Items]      
Deferred tax liability, net $ 356 $ 410  
v3.25.0.1
INCOME TAXES - Operating Loss and Tax Credit Carryforwards (Details) - USD ($)
$ in Millions
Dec. 31, 2024
Dec. 31, 2023
Operating Loss Carryforwards [Line Items]    
Operating loss carryforwards $ 622 $ 664
Tax credit carryforwards 178 206
Total Operating Loss and Tax Credit Carryforwards 800 870
Expire within 5 years    
Operating Loss Carryforwards [Line Items]    
Operating loss carryforwards 5 40
Tax credit carryforwards 40 37
Expire after 5 years or indefinite expiration    
Operating Loss Carryforwards [Line Items]    
Operating loss carryforwards 617 624
Tax credit carryforwards $ 138 $ 169
v3.25.0.1
INCOME TAXES - Gross Unrecognized Tax Benefits (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Unrecognized Tax Benefits [Roll Forward]      
Total unrecognized tax benefits at January 1, $ 473 $ 470 $ 351
Decreases related to positions taken on items from prior years (32) (4) (4)
Increases related to positions taken on items from prior years 17 3 4
Increases related to positions taken in the current year 5 18 164
Settlement of uncertain tax positions with tax authorities (21) (10) (10)
Decreases due to expiration of statutes of limitations (5) (9) 0
Exchange gain (9)   (9)
Exchange loss   5  
Total unrecognized tax benefits at December 31, 428 473 470
Total unrecognized tax benefits that, if recognized, would impact the effective tax rate of continuing operations 284 329 338
Total amount of interest and penalties (benefit) recognized in "Provision for (benefit from) income taxes on continuing operations" 7 8 3
Total accrual for interest and penalties associated with unrecognized tax benefits 43 28 16
Unrecognized tax benefits related to discontinued operations 140 141 128
Mobility And Materials Businesses      
Unrecognized Tax Benefits [Roll Forward]      
Divestiture $ 0 $ 0 $ (26)
v3.25.0.1
EARNINGS PER SHARE CALCULATIONS - Schedule of Net Income for EPS Calculations, Basic and Diluted (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Earnings Per Share [Abstract]      
Income from continuing operations, net of tax $ 778 $ 533 $ 1,061
Net income from continuing operations attributable to noncontrolling interests 35 39 53
Income from continuing operations attributable to common stockholders 743 494 1,008
(Loss) income from discontinued operations, net of tax (40) (71) 4,856
Net loss from discontinued operations attributable to noncontrolling interests 0 0 (4)
(Loss) income from discontinued operations attributable to common stockholders (40) (71) 4,860
Net income available to common stockholders $ 703 $ 423 $ 5,868
v3.25.0.1
EARNINGS PER SHARE CALCULATIONS - Schedule of EPS Calculations, Basic (Details) - $ / shares
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Earnings Per Share [Abstract]      
Earnings from continuing operations attributable to common stockholders (in USD per share) $ 1.77 $ 1.10 $ 2.02
(Loss) earnings from discontinued operations, net of tax - basic (in USD per share) (0.10) (0.16) 9.75
Earnings per common share - basic (in USD per share) $ 1.68 $ 0.94 $ 11.77
v3.25.0.1
EARNINGS PER SHARE CALCULATIONS - Schedule of EPS Calculations, Diluted (Details) - $ / shares
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Earnings Per Share [Abstract]      
Earnings per common share from continuing operations - diluted (in USD per share) $ 1.77 $ 1.09 $ 2.02
(Loss) earnings from discontinued operations, net of tax - diluted (in USD per share) (0.10) (0.16) 9.73
Earnings per common share - diluted (in USD per share) $ 1.67 $ 0.94 $ 11.75
v3.25.0.1
EARNINGS PER SHARE CALCULATIONS - Schedule of Share Count Information (Details) - shares
shares in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Earnings Per Share [Abstract]      
Weighted-average common shares - basic (in shares) 419.2 449.9 498.5
Plus dilutive effect of equity compensation plans (in shares) 1.4 1.3 0.9
Weighted-average common shares outstanding - diluted (in shares) 420.6 451.2 499.4
Stock options, restricted stock units, and performance-based restricted stock units excluded from EPS calculations (in shares) 1.1 2.6 4.1
v3.25.0.1
ACCOUNTS AND NOTES RECEIVABLE - NET (Details) - USD ($)
$ in Millions
Dec. 31, 2024
Dec. 31, 2023
Receivables [Abstract]    
Accounts receivable - trade $ 1,534 $ 1,513
Income tax receivable 81 301
Other 584 556
Total accounts and notes receivable - net 2,199 2,370
Accounts receivables - trade, allowance $ 26 $ 40
v3.25.0.1
INVENTORIES (Details) - USD ($)
$ in Millions
Dec. 31, 2024
Dec. 31, 2023
Inventory Disclosure [Abstract]    
Finished goods $ 1,162 $ 1,184
Work in process 509 487
Raw materials 332 350
Supplies 127 126
Total inventories $ 2,130 $ 2,147
v3.25.0.1
PROPERTY, PLANT AND EQUIPMENT (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Property, Plant and Equipment [Line Items]      
Total property, plant and equipment $ 10,956 $ 10,725  
Total accumulated depreciation 5,188 4,841  
Total property, plant and equipment - net 5,768 5,884  
Depreciation expense 599 547 $ 545
Land and land improvements      
Property, Plant and Equipment [Line Items]      
Total property, plant and equipment 455 449  
Buildings      
Property, Plant and Equipment [Line Items]      
Total property, plant and equipment 2,238 2,121  
Machinery, equipment, and other      
Property, Plant and Equipment [Line Items]      
Total property, plant and equipment 7,657 7,306  
Construction in progress      
Property, Plant and Equipment [Line Items]      
Total property, plant and equipment $ 606 $ 849  
Minimum | Land and land improvements      
Property, Plant and Equipment [Line Items]      
Estimated Useful Lives (Years) 1 year    
Minimum | Buildings      
Property, Plant and Equipment [Line Items]      
Estimated Useful Lives (Years) 1 year    
Minimum | Machinery, equipment, and other      
Property, Plant and Equipment [Line Items]      
Estimated Useful Lives (Years) 1 year    
Maximum | Land and land improvements      
Property, Plant and Equipment [Line Items]      
Estimated Useful Lives (Years) 25 years    
Maximum | Buildings      
Property, Plant and Equipment [Line Items]      
Estimated Useful Lives (Years) 50 years    
Maximum | Machinery, equipment, and other      
Property, Plant and Equipment [Line Items]      
Estimated Useful Lives (Years) 25 years    
v3.25.0.1
NONCONSOLIDATED AFFILIATES - Narrative (Details)
$ in Millions
 12 Months Ended
Dec. 31, 2024
USD ($)
affiliate
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Nov. 01, 2023
Investments in and Advances to Affiliates [Line Items]        
Net investment in nonconsolidated affiliates $ 778 $ 788    
Number of nonconsolidated affiliates | affiliate 7      
Income (loss) in equity in earnings of nonconsolidated affiliates $ 60 51 $ 75  
Carrying values of equity interest $ 778 $ 788 $ 686  
Customer Concentration Risk | Revenue Benchmark | Equity Method Investee        
Investments in and Advances to Affiliates [Line Items]        
Concentration risk, percentage 2.00% 2.00% 2.00%  
Supplier Concentration Risk | Cost of Goods and Service Benchmark | Equity Method Investee        
Investments in and Advances to Affiliates [Line Items]        
Concentration risk, percentage 3.00% 3.00% 4.00%  
Other Nonconsolidated Affilates | Minimum        
Investments in and Advances to Affiliates [Line Items]        
Ownership percentage 19.90%      
Other Nonconsolidated Affilates | Maximum        
Investments in and Advances to Affiliates [Line Items]        
Ownership percentage 50.00%      
Derby        
Investments in and Advances to Affiliates [Line Items]        
Ownership percentage       19.90%
Income (loss) in equity in earnings of nonconsolidated affiliates $ (7)      
Transaction costs and amortization expense from purchase accounting 17      
Carrying values of equity interest 117 $ 121    
Carrying values of note receivable 254 228    
Equity method investment, non-cash interest income on note receivable $ 26 $ 4    
v3.25.0.1
NONCONSOLIDATED AFFILIATES - Schedule of Dividend Received and Equity Earnings (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Equity Method Investments and Joint Ventures [Abstract]      
Dividends from nonconsolidated affiliates $ 73 $ 71 $ 103
v3.25.0.1
GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Goodwill (Details) - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Goodwill [Roll Forward]      
Goodwill, beginning of period $ 16,720,000,000 $ 16,663,000,000  
Goodwill recognized for Specturm/Donatelle Plastics Acquisition 114,000,000 818,000,000  
Goodwill recognized for Spectrum Acquisition, including working capital settlements (4,000,000)    
Currency Translation Adjustment (267,000,000) 43,000,000  
Impairment 0 (804,000,000) $ 0
Other 4,000,000    
Goodwill, end of period 16,567,000,000 16,720,000,000 16,663,000,000
Operating Segments | Electronics & Industrial      
Goodwill [Roll Forward]      
Goodwill, beginning of period 10,205,000,000 9,397,000,000  
Goodwill recognized for Specturm/Donatelle Plastics Acquisition 114,000,000 818,000,000  
Goodwill recognized for Spectrum Acquisition, including working capital settlements (4,000,000)    
Currency Translation Adjustment (113,000,000) (10,000,000)  
Impairment   0  
Other 4,000,000    
Goodwill, end of period 10,206,000,000 10,205,000,000 9,397,000,000
Operating Segments | Water & Protection      
Goodwill [Roll Forward]      
Goodwill, beginning of period 5,900,000,000 6,656,000,000  
Goodwill recognized for Specturm/Donatelle Plastics Acquisition 0 0  
Goodwill recognized for Spectrum Acquisition, including working capital settlements 0    
Currency Translation Adjustment (145,000,000) 48,000,000  
Impairment   (804,000,000)  
Other 0    
Goodwill, end of period 5,755,000,000 5,900,000,000 6,656,000,000
Corporate & Other      
Goodwill [Roll Forward]      
Goodwill, beginning of period 615,000,000 610,000,000  
Goodwill recognized for Specturm/Donatelle Plastics Acquisition 0 0  
Goodwill recognized for Spectrum Acquisition, including working capital settlements 0    
Currency Translation Adjustment (9,000,000) 5,000,000  
Impairment   0  
Other 0    
Goodwill, end of period $ 606,000,000 $ 615,000,000 $ 610,000,000
v3.25.0.1
GOODWILL AND OTHER INTANGIBLE ASSETS - Narrative (Details)
 12 Months Ended
Oct. 01, 2024
USD ($)
reportingUnit
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Finite-Lived Intangible Assets [Line Items]        
Number of reporting unit, qualitative testing | reportingUnit 7      
Number of reporting unit, quantitative testing | reportingUnit 1      
Goodwill impairment charge   $ 0 $ 804,000,000 $ 0
Goodwill   16,567,000,000 16,720,000,000 $ 16,663,000,000
Developed technology        
Finite-Lived Intangible Assets [Line Items]        
Fully amortized intangible assets retired   145,000,000    
Trademarks/tradenames        
Finite-Lived Intangible Assets [Line Items]        
Fully amortized intangible assets retired   $ 27,000,000    
Customer-related        
Finite-Lived Intangible Assets [Line Items]        
Fully amortized intangible assets retired     399,000,000  
Other        
Finite-Lived Intangible Assets [Line Items]        
Fully amortized intangible assets retired     $ 25,000,000  
Water & Protection        
Finite-Lived Intangible Assets [Line Items]        
Estimated fair value percentage that exceeds its carrying value 5.00%      
Goodwill $ 4,800,000,000      
v3.25.0.1
GOODWILL AND OTHER INTANGIBLE ASSETS - Summary of Other Intangible Assets (Details) - USD ($)
$ in Millions
Dec. 31, 2024
Dec. 31, 2023
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount $ 8,771 $ 8,846
Accum Amort (4,205) (3,836)
Net 4,566 5,010
Indefinite-lived Intangible Assets [Line Items]    
Total other intangible assets with indefinite lives 804 804
Gross Carrying Amount 9,575 9,650
Net 5,370 5,814
Trademarks/tradenames    
Indefinite-lived Intangible Assets [Line Items]    
Total other intangible assets with indefinite lives 804 804
Developed technology    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 1,975 2,079
Accum Amort (1,124) (1,092)
Net 851 987
Trademarks/tradenames    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 901 924
Accum Amort (451) (414)
Net 450 510
Customer-related    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 5,868 5,815
Accum Amort (2,623) (2,329)
Net 3,245 3,486
Other    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 27 28
Accum Amort (7) (1)
Net $ 20 $ 27
v3.25.0.1
GOODWILL AND OTHER INTANGIBLE ASSETS - Summary of Intangibles by Segment (Details) - USD ($)
$ in Millions
Dec. 31, 2024
Dec. 31, 2023
Schedule of Intangible Assets [Line Items]    
Other intangible assets $ 5,370 $ 5,814
Operating Segments | Electronics & Industrial    
Schedule of Intangible Assets [Line Items]    
Other intangible assets 3,337 3,521
Operating Segments | Water & Protection    
Schedule of Intangible Assets [Line Items]    
Other intangible assets 1,957 2,206
Corporate & Other    
Schedule of Intangible Assets [Line Items]    
Other intangible assets $ 76 $ 87
v3.25.0.1
GOODWILL AND OTHER INTANGIBLE ASSETS - Amortization (Details)
$ in Millions
Dec. 31, 2024
USD ($)
Estimated Amortization Expense  
2025 $ 555
2026 527
2027 480
2028 427
2029 $ 337
v3.25.0.1
SHORT-TERM BORROWINGS, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES AND OTHER OBLIGATIONS - Short-Term Borrowings and Capital Lease Obligations (Details) - USD ($)
$ in Millions
Dec. 31, 2024
Dec. 31, 2023
Debt Disclosure [Abstract]    
Long-term debt due within one year $ 1,848 $ 0
v3.25.0.1
SHORT-TERM BORROWINGS, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES AND OTHER OBLIGATIONS - Long-Term Debt (Details) - USD ($)
$ in Millions
Dec. 31, 2024
Dec. 31, 2023
Debt Instrument [Line Items]    
Finance lease obligations $ 9 $ 10
Finance lease, liability, noncurrent, statement of financial position [extensible enumeration] Long-Term Debt Long-Term Debt
Less: Unamortized debt discount and issuance costs $ 40 $ 51
Less: Long-term debt due within one year 1,848 0
Long-Term Debt 5,323 7,800
Derivative assets (liabilities), loss 214 82
Interest rate swap agreements    
Debt Instrument [Line Items]    
Unamortized basis adjustment 48  
Derivative assets (liabilities), loss 206 59
Promissory Notes | Final maturity 2025    
Debt Instrument [Line Items]    
Long-term debt, gross $ 1,850 $ 1,850
Weighted Average Rate 4.49% 4.49%
Promissory Notes | Final maturity 2028    
Debt Instrument [Line Items]    
Long-term debt, gross $ 2,250 $ 2,250
Weighted Average Rate 4.73% 4.73%
Promissory Notes | Final maturity 2030 and thereafter    
Debt Instrument [Line Items]    
Long-term debt, gross $ 3,102 $ 3,741
Weighted Average Rate 5.47% 5.46%
v3.25.0.1
SHORT-TERM BORROWINGS, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES AND OTHER OBLIGATIONS - Narrative (Details)
 1 Months Ended 12 Months Ended
Jun. 15, 2024
USD ($)
May 08, 2024
USD ($)
May 07, 2024
USD ($)
Apr. 12, 2022
USD ($)
Nov. 22, 2021
Jul. 31, 2022
USD ($)
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Nov. 30, 2023
USD ($)
Debt Instrument [Line Items]                    
Loss on debt extinguishment             $ 74,000,000 $ 0 $ 0  
Remaining borrowing capacity, uncommitted             650,000,000      
Letters of credit outstanding             $ 124,000,000      
Ratio of indebtedness to net capital (not exceed)             0.60      
Payment timing of supplier finance program             110 days      
Require notice of termination for supplier financing             30 days      
Recurring | Level 2                    
Debt Instrument [Line Items]                    
Long-term debt             $ 5,368,000,000 $ 7,995,000,000    
2022 $1B Revolving Credit Facility | Revolving Credit Facility                    
Debt Instrument [Line Items]                    
Proceeds from line of credit           $ 600,000,000        
Five-Year Revolving Credit Facility | Revolving Credit Facility                    
Debt Instrument [Line Items]                    
Committed Credit       $ 2,500,000,000            
Senior Notes | 2038 Notes                    
Debt Instrument [Line Items]                    
Partial redemption of aggregate principal amount $ 650,000,000                  
Loss on debt extinguishment $ 32,000,000           74,000,000      
Unsecured Debt | Floating Rate Senior Notes                    
Debt Instrument [Line Items]                    
Face amount of debt                   $ 300,000,000
Line of Credit                    
Debt Instrument [Line Items]                    
Committed Credit             3,500,000,000      
Line of Credit | Revolving Credit Facility                    
Debt Instrument [Line Items]                    
Term         5 years          
Line of Credit | 2022 $1B Revolving Credit Facility | Revolving Credit Facility                    
Debt Instrument [Line Items]                    
Committed Credit           $ 1,000,000,000        
Line of Credit | 364-Day Revolving Credit Facility | Revolving Credit Facility                    
Debt Instrument [Line Items]                    
Proceeds from line of credit             0      
Line of Credit | 2024 $1B Revolving Credit Facility | Revolving Credit Facility                    
Debt Instrument [Line Items]                    
Committed Credit   $ 1,000,000,000   $ 1,000,000,000     1,000,000,000      
Term   364 days                
Line of Credit | 2023 364-Day Revolving Credit Facility | Revolving Credit Facility                    
Debt Instrument [Line Items]                    
Committed Credit     $ 1,000,000,000              
Term     364 days              
Line of Credit | Five-Year Revolving Credit Facility | Revolving Credit Facility                    
Debt Instrument [Line Items]                    
Committed Credit             $ 2,500,000,000      
Term       5 years            
v3.25.0.1
SHORT-TERM BORROWINGS, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES AND OTHER OBLIGATIONS - Maturities of Long-Term Debt for Next Five Years (Details)
$ in Millions
Dec. 31, 2024
USD ($)
Debt Disclosure [Abstract]  
2025 $ 1,850
2026 0
2027 0
2028 2,250
2029 $ 0
v3.25.0.1
SHORT-TERM BORROWINGS, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES AND OTHER OBLIGATIONS - Committed and Available Credit Facilities (Details) - USD ($)
May 08, 2024
Apr. 12, 2022
Nov. 22, 2021
Dec. 31, 2024
Revolving Credit Facility | Five-Year Revolving Credit Facility        
Line of Credit Facility [Line Items]        
Committed Credit   $ 2,500,000,000    
Line of Credit        
Line of Credit Facility [Line Items]        
Committed Credit       $ 3,500,000,000
Credit Available       3,484,000,000
Line of Credit | Revolving Credit Facility        
Line of Credit Facility [Line Items]        
Term     5 years  
Line of Credit | Revolving Credit Facility | Five-Year Revolving Credit Facility        
Line of Credit Facility [Line Items]        
Term   5 years    
Committed Credit       2,500,000,000
Credit Available       2,484,000,000
Line of Credit | Revolving Credit Facility | 2024 $1B Revolving Credit Facility        
Line of Credit Facility [Line Items]        
Term 364 days      
Committed Credit $ 1,000,000,000 $ 1,000,000,000   1,000,000,000
Credit Available       $ 1,000,000,000
v3.25.0.1
SHORT-TERM BORROWINGS, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES AND OTHER OBLIGATIONS - Schedule Of Supplier Financing Programs (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Supplier Finance Program, Obligation [Roll Forward]    
Confirmed obligations outstanding as of January 1, 2024 $ 97  
Supplier Finance Program, Obligation, Statement of Financial Position [Extensible Enumeration] Accounts payable Accounts payable
Invoices confirmed to financial institutions $ 421  
Confirmed invoices paid to financial institution (413)  
Foreign currency exchange impact (1)  
Confirmed obligations outstanding as of December 31, 2024 $ 104  
Supplier Finance Program, Obligation, Statement of Financial Position [Extensible Enumeration] Accounts payable Accounts payable
v3.25.0.1
COMMITMENTS AND CONTINGENT LIABILITIES - Narrative (Details)
$ in Millions
 1 Months Ended 3 Months Ended 12 Months Ended
Nov. 13, 2024
USD ($)
payment
case
Jun. 30, 2023
USD ($)
Dec. 31, 2024
USD ($)
case
Nov. 30, 2023
USD ($)
Jul. 31, 2021
USD ($)
Jun. 30, 2024
USD ($)
Sep. 30, 2023
USD ($)
Dec. 31, 2024
USD ($)
case
health_condition
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
case
Dec. 31, 2017
USD ($)
case
plaintiff
Dec. 31, 2012
health_condition
Feb. 06, 2024
entity
Dec. 31, 2023
USD ($)
Jan. 22, 2021
USD ($)
Loss Contingencies [Line Items]                              
Qualified spend - eligible PFAS costs, maximum     $ 1,400         $ 1,400             $ 4,000
Payment of qualified spend amount     605         605              
Escrow account balance - required minimum     700         700              
MOU escrow deposits     35         35              
Indemnifiable losses threshold related to PFAS stray liabilities - per party     150         150              
Non-PFAS stray liabilities threshold     200         200              
Indemnifiable losses threshold related to PFAS stray liabilities - total     $ 300         $ 300              
Non-PFAS stray liabilities percent split after threshold     71.00%         71.00%              
Estimated litigation liability     $ 26         $ 26              
Total environmental related liabilities     275         275           $ 300  
Water District Settlement Fund                              
Loss Contingencies [Line Items]                              
MOU escrow deposits                           405  
Litigation settlement payment           $ 408 $ 408                
Litigation expense             400                
Litigation expense payment deposited into MOU escrow             $ 100                
Entities on the list of potential class members who submitted timely requests for exclusion | entity                         900    
Total number of entities on the list of potential class members | entity                         14,167    
Water District Settlement Fund | Discontinued Operations                              
Loss Contingencies [Line Items]                              
Litigation settlement payment               408              
PFOA Multi-District Litigation (MDL)                              
Loss Contingencies [Line Items]                              
Number of cases | case                   70 100        
Number of payments in litigation settlement | payment 2                            
Number of known filed and unfiled cases | case 73                            
State of Delaware                              
Loss Contingencies [Line Items]                              
Amount awarded to other party         $ 50       $ 13            
Estimated litigation liability     $ 9         $ 9              
Personal Injury, PFAS Exposure                              
Loss Contingencies [Line Items]                              
Number of court designated health conditions | health_condition               8              
Term when cases may be re-filed               4 years              
Number of litigation cases | case     5,200         5,200              
Bellwether Personal Injury                              
Loss Contingencies [Line Items]                              
Number of litigation cases | case     25         25              
Tier 2 Plaintiffs                              
Loss Contingencies [Line Items]                              
Number of litigation cases | case     9         9              
DuPont and Corteva                              
Loss Contingencies [Line Items]                              
Percentage split of PFAS liabilities under the separation agreement     50.00%         50.00%              
PFOA Matters | PFOA Multi-District Litigation (MDL)                              
Loss Contingencies [Line Items]                              
Amount awarded to other party                   $ 27          
Percentage of settlement       80.00%                      
Estimated litigation liability     $ 39         $ 39              
Dismissed | PFOA Multi-District Litigation (MDL)                              
Loss Contingencies [Line Items]                              
Litigation settlement payment     11                        
Approximate payments from settlement agreement $ 30                            
Contingent | PFOA Multi-District Litigation (MDL)                              
Loss Contingencies [Line Items]                              
Approximate payments from settlement agreement $ 29                            
Accrued portion of contingent payment     10         10              
Supplemental Settlement | State of Delaware                              
Loss Contingencies [Line Items]                              
Amount awarded to other party         $ 25                    
Chemours, Corteva and DuPont                              
Loss Contingencies [Line Items]                              
MOU escrow deposits     100         100              
Chemours, Corteva and DuPont | Water District Settlement Fund                              
Loss Contingencies [Line Items]                              
Amount awarded to other party   $ 1,185                          
Chemours, Corteva and DuPont | PFOA Matters | PFOA Multi-District Litigation (MDL)                              
Loss Contingencies [Line Items]                              
Amount awarded to other party       $ 110                      
DuPont and Corteva                              
Loss Contingencies [Line Items]                              
Qualified spend - eligible PFAS costs, maximum     $ 2,000         $ 2,000              
Qualified spend - eligible PFAS costs percentage split     50.00%         50.00%              
Future escrow deposit, percentage split     50.00%         50.00%              
DuPont and Corteva | Payments Due September 2021, September 2022                              
Loss Contingencies [Line Items]                              
Future escrow deposit     $ 100         $ 100              
DuPont and Corteva | Payments Due Annually Beginning September 2024                              
Loss Contingencies [Line Items]                              
Future escrow deposit     $ 50         $ 50              
Corteva                              
Loss Contingencies [Line Items]                              
Non-PFAS stray liabilities percent split after threshold     29.00%         29.00%              
Chemours                              
Loss Contingencies [Line Items]                              
Qualified spend - eligible PFAS costs percentage split     50.00%         50.00%              
Future escrow deposit, percentage split     50.00%         50.00%              
Chemours | Payments Due Annually Beginning September 2024                              
Loss Contingencies [Line Items]                              
Future escrow deposit     $ 50         $ 50              
Chemours | PFOA Matters | PFOA Multi-District Litigation (MDL)                              
Loss Contingencies [Line Items]                              
Amount awarded to other party                   $ 29          
EIDP And Chemours | PFOA Multi-District Litigation (MDL)                              
Loss Contingencies [Line Items]                              
Number of pending cases | case                   1          
EIDP And Chemours | PFOA Matters | PFOA Multi-District Litigation (MDL)                              
Loss Contingencies [Line Items]                              
Number of health conditions under personal injury claims | health_condition                       6      
Amount awarded to other party                   $ 83 $ 670        
EIDP | PFOA Matters | PFOA Multi-District Litigation (MDL)                              
Loss Contingencies [Line Items]                              
Number of personal injury lawsuits filed | plaintiff                     3,550        
Dupont And EIDP | PFOA Matters | PFOA Multi-District Litigation (MDL)                              
Loss Contingencies [Line Items]                              
Amount awarded to other party                   $ 27          
Accounts And Notes Receivable, Other                              
Loss Contingencies [Line Items]                              
Indemnification asset     28         28           21  
Deferred Charges And Other Assets                              
Loss Contingencies [Line Items]                              
Indemnification asset     298         298           242  
Accrued and other current liabilities                              
Loss Contingencies [Line Items]                              
Indemnification liabilities     178         178           200  
Other noncurrent obligations                              
Loss Contingencies [Line Items]                              
Indemnification liabilities     $ 237         $ 237           $ 263  
v3.25.0.1
COMMITMENTS AND CONTINGENT LIABILITIES - Schedule of Indemnified Liabilities Related to the MOU (Details) - USD ($)
$ in Millions
Dec. 31, 2024
Dec. 31, 2023
Loss Contingencies [Line Items]    
Total environmental related liabilities $ 275 $ 300
MOU Agreement    
Loss Contingencies [Line Items]    
Current indemnification liabilities 99 87
Long-term indemnification liabilities 123 119
Total indemnified liabilities accrued under the MOU 222 206
Environmental remediation indemnified related liabilities: | Chemours    
Loss Contingencies [Line Items]    
Total environmental related liabilities 146 152
Environmental remediation indemnified related liabilities: | Chemours | Fayetteville    
Loss Contingencies [Line Items]    
Total environmental related liabilities $ 128 $ 139
v3.25.0.1
COMMITMENTS AND CONTINGENT LIABILITIES - Schedule of Environmental Accrued Obligations (Details) - USD ($)
$ in Millions
Dec. 31, 2024
Dec. 31, 2023
Loss Contingencies [Line Items]    
Total environmental related liabilities $ 275 $ 300
Environmental Loss Contingency, Statement of Financial Position [Extensible Enumeration] Accrued and other current liabilities, Other Liabilities, Noncurrent Accrued and other current liabilities, Other Liabilities, Noncurrent
Potential exposure in excess of accrual $ 316  
Environmental remediation liabilities not subject to indemnity    
Loss Contingencies [Line Items]    
Total environmental related liabilities 45 $ 46
Potential exposure in excess of accrual 106  
Environmental remediation indemnified related liabilities: | Dow & Corteva    
Loss Contingencies [Line Items]    
Total environmental related liabilities 83 101
Potential exposure in excess of accrual 177  
Environmental remediation indemnified related liabilities: | MOU    
Loss Contingencies [Line Items]    
Total environmental related liabilities 146 152
Potential exposure in excess of accrual 31  
Environmental remediation indemnified related liabilities: | Other environmental indemnifications    
Loss Contingencies [Line Items]    
Total environmental related liabilities 1 $ 1
Potential exposure in excess of accrual $ 2  
v3.25.0.1
LEASES - Narrative (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Lessee, Lease, Description [Line Items]      
Operating lease, payments $ 120 $ 115 $ 109
Operating lease assets and liabilities 53 160 131
Lease income $ 75 $ 73 $ 58
Operating Lease, Lease Income, Statement of Income or Comprehensive Income [Extensible Enumeration] Selling, general and administrative expenses Selling, general and administrative expenses Selling, general and administrative expenses
Net profits from leases $ 20 $ 18 $ 14
Residual Value Guarantees      
Lessee, Lease, Description [Line Items]      
Future maximum payments for residual value guarantees in operating leases $ 25    
Minimum      
Lessee, Lease, Description [Line Items]      
Operating lease, remaining lease term 1 year    
Contractual lease income for 2025 through 2029 $ 49    
Maximum      
Lessee, Lease, Description [Line Items]      
Operating lease, remaining lease term 30 years    
Contractual lease income for 2025 through 2029 $ 75    
v3.25.0.1
LEASES - Components of Lease Cost (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Leases [Abstract]      
Operating lease cost $ 125 $ 121 $ 113
Short-term lease cost 5 4 4
Variable lease cost 37 39 39
Less: Sublease income 4 4 12
Total lease cost $ 163 $ 160 $ 144
v3.25.0.1
LEASES - Supplemental Balance Sheet Information (Details) - USD ($)
$ in Millions
Dec. 31, 2024
Dec. 31, 2023
Leases [Abstract]    
Operating lease right-of-use assets $ 403 $ 484
Operating lease, right-of-use asset, statement of financial position [extensible enumeration] Other Assets, Noncurrent Other Assets, Noncurrent
Current operating lease liabilities $ 84 $ 97
Operating lease, liability, current, statement of financial position [extensible enumeration] Accrued and other current liabilities Accrued and other current liabilities
Noncurrent operating lease liabilities $ 322 $ 390
Operating lease, liability, noncurrent, statement of financial position [extensible enumeration] Other Liabilities, Noncurrent Other Liabilities, Noncurrent
Total operating lease liabilities $ 406 $ 487
v3.25.0.1
LEASES - Lease Term and Discount Rate (Details)
Dec. 31, 2024
Dec. 31, 2023
Leases [Abstract]    
Weighted-average remaining lease term (years) 7 years 9 months 18 days 8 years 6 months
Weighted-average discount rate 3.78% 3.55%
v3.25.0.1
LEASES - Maturities of Lease Liabilities (Details) - USD ($)
$ in Millions
Dec. 31, 2024
Dec. 31, 2023
Leases [Abstract]    
2025 $ 97  
2026 76  
2027 61  
2028 44  
2029 34  
2030 and thereafter 157  
Total lease payments 469  
Less: Interest 63  
Present value of lease liabilities $ 406 $ 487
v3.25.0.1
STOCKHOLDERS' EQUITY - Narrative (Details)
$ / shares in Units, shares in Millions
 1 Months Ended 3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended 17 Months Ended
Nov. 30, 2023
USD ($)
Nov. 30, 2022
USD ($)
counterparty
shares
Jun. 30, 2024
USD ($)
shares
Mar. 31, 2024
USD ($)
counterparty
shares
Sep. 30, 2023
USD ($)
counterparty
shares
Jun. 30, 2024
$ / shares
shares
Sep. 30, 2023
USD ($)
$ / shares
shares
Sep. 30, 2022
USD ($)
shares
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Mar. 31, 2024
USD ($)
$ / shares
shares
Feb. 28, 2022
USD ($)
Equity, Class of Treasury Stock [Line Items]                          
Purchases of treasury stock                 $ 400,000,000 $ 1,600,000,000 $ 3,725,000,000    
Payments for repurchase of common stock   $ 3,250,000,000                      
Excise tax on purchases of treasury stock                 8,000,000 21,000,000      
Undistributed earnings of nonconsolidated affiliates included in retained earnings                 626,000,000 637,000,000      
2022 Stock Repurchase Programs                          
Equity, Class of Treasury Stock [Line Items]                          
Remaining authorized repurchase amount   250,000,000                      
2022 Share Buyback Program                          
Equity, Class of Treasury Stock [Line Items]                          
Authorized stock repurchase amount                         $ 1,000,000,000.0
Stock repurchased and retired (in shares) | shares               11.9          
Purchases of treasury stock               $ 750,000,000          
$5B Share Buyback Program                          
Equity, Class of Treasury Stock [Line Items]                          
Authorized stock repurchase amount   5,000,000,000                      
Payments for repurchase of common stock $ 3,000,000,000                        
2022 Stock Repurchase Transactions                          
Equity, Class of Treasury Stock [Line Items]                          
Authorized stock repurchase amount   $ 3,250,000,000                      
Stock repurchased and retired (in shares) | shares   38.8     8.0   46.8            
Number of counterparties | counterparty   3                      
Payments for repurchase of common stock   $ 250,000,000                      
Stock retired   $ 2,600,000,000                      
Unsettled forward contract for accelerated share repurchase         $ 613,000,000                
Average price per share (in dollars per share) | $ / shares             $ 69.44            
2023 Stock Repurchase Transactions                          
Equity, Class of Treasury Stock [Line Items]                          
Authorized stock repurchase amount         $ 2,000,000,000   $ 2,000,000,000            
Stock repurchased and retired (in shares) | shares       6.7 21.2             27.9  
Number of counterparties | counterparty       1 3                
Payments for repurchase of common stock         $ 2,000,000,000                
Stock retired         $ 1,600,000,000                
Average price per share (in dollars per share) | $ / shares                       $ 71.67  
2024 Stock Repurchase Transactions                          
Equity, Class of Treasury Stock [Line Items]                          
Authorized stock repurchase amount       $ 1,000,000,000               $ 1,000,000,000  
Stock repurchased and retired (in shares) | shares       6.0                  
Payments for repurchase of common stock       $ 500,000,000                  
Q1 2024 Stock Repurchase Transactions                          
Equity, Class of Treasury Stock [Line Items]                          
Stock repurchased and retired (in shares) | shares     1.0     6.9              
Stock retired     $ 72,000,000 400,000,000                  
Unsettled forward contract for accelerated share repurchase       $ 100,000,000                  
Average price per share (in dollars per share) | $ / shares           $ 71.96              
Share Repurchase Programs                          
Equity, Class of Treasury Stock [Line Items]                          
Excise tax on purchases of treasury stock                 $ 8,000,000 $ 21,000,000      
v3.25.0.1
STOCKHOLDERS' EQUITY - Common Stock Activity (Details) - shares
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Common stock activity      
Balance at the beginning of the year (in shares) 430,110,140    
Balance at the end of the year (in shares) 417,994,343 430,110,140  
Issued      
Common stock activity      
Balance at the beginning of the year (in shares) 430,110,000 458,124,000 511,793,000
Issued (in shares) 1,513,000 1,225,000 2,074,000
Retired (in shares) (13,629,000) (29,239,000) (55,743,000)
Balance at the end of the year (in shares) 417,994,000 430,110,000 458,124,000
Held in Treasury      
Common stock activity      
Balance at beginning of the year (in shares) 0 0 0
Repurchased (in shares) 13,629,000 29,239,000 55,743,000
Retired (in shares) (13,629,000) (29,239,000) (55,743,000)
Balance at the end of the year (in shares) 0 0 0
v3.25.0.1
STOCKHOLDERS' EQUITY - Dividends Declared and Paid (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Equity [Abstract]      
Dividends declared to common stockholders $ 635 $ 651 $ 652
Dividends paid to common stockholders $ 635 $ 651 $ 652
v3.25.0.1
STOCKHOLDERS' EQUITY - Summary of Accumulated Other Comprehensive Loss (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]        
Beginning balance $ 23,793 $ 24,725 $ 27,017 $ 27,050
Other comprehensive (loss) income before reclassifications (589) (78) (996)  
Amounts reclassified from accumulated other comprehensive income (1) (9) (3)  
Split-off and divestiture reclassification adjustment   (32) 167  
Net other comprehensive (loss) income (590) (119) (832)  
Ending balance 23,793 24,725 27,017  
Total        
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]        
Beginning balance (1,500) (910) (791) 41
Ending balance (1,500) (910) (791)  
Cumulative translation adjustments        
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]        
Beginning balance (1,493) (931) (968) (88)
Other comprehensive (loss) income before reclassifications (562) 46 (1,101)  
Amounts reclassified from accumulated other comprehensive income 0 0 0  
Split-off and divestiture reclassification adjustment   (9) 221  
Net other comprehensive (loss) income (562) 37 (880)  
Ending balance (1,493) (931) (968)  
Pension and OPEB        
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]        
Beginning balance (115) (55) 60 73
Other comprehensive (loss) income before reclassifications (59) (83) 44  
Amounts reclassified from accumulated other comprehensive income (1) (9) (3)  
Split-off and divestiture reclassification adjustment   (23) (54)  
Net other comprehensive (loss) income (60) (115) (13)  
Ending balance (115) (55) 60  
Derivative instruments        
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]        
Beginning balance 108 76 117 $ 56
Other comprehensive (loss) income before reclassifications 32 (41) 61  
Amounts reclassified from accumulated other comprehensive income 0 0 0  
Split-off and divestiture reclassification adjustment   0 0  
Net other comprehensive (loss) income 32 (41) 61  
Ending balance $ 108 $ 76 $ 117  
v3.25.0.1
STOCKHOLDERS' EQUITY - Tax Benefit (Expense) (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Tax benefit from income taxes related to other comprehensive income (loss) items $ 2 $ 38 $ 1
Pension and OPEB      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Tax benefit from income taxes related to other comprehensive income (loss) items 11 26 16
Derivative instruments      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Tax benefit from income taxes related to other comprehensive income (loss) items $ (9) $ 12 $ (15)
v3.25.0.1
STOCKHOLDERS' EQUITY - Summary of Reclassifications Out of Accumulated Other Comprehensive Loss (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]      
Net income $ 738 $ 462 $ 5,917
Net income before tax 1,192 504 1,448
Tax expense (benefit) 414 (29) 387
Reclassification out of Accumulated Other Comprehensive Loss      
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]      
Net income (1) (41) 164
Reclassification out of Accumulated Other Comprehensive Loss | Cumulative translation adjustments      
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]      
Net income 0 (9) 221
Reclassification out of Accumulated Other Comprehensive Loss | Pension and other post-employment benefit plans      
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]      
Net income (1) (32) (57)
Net income before tax (2) (35) (71)
Tax expense (benefit) $ 1 $ 3 $ 14
v3.25.0.1
PENSION PLANS AND OTHER POST-EMPLOYMENT BENEFITS - Narrative (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]      
Employer contributions $ 51 $ 66  
Expected contribution for next year 56    
Projected benefit obligation 2,435 2,704 $ 2,726
Accumulated benefit obligation 2,400 2,600  
DuPont plan assets total 2,200    
DuPont U.S. Retirement Savings Plan      
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]      
Employer contributions $ 92 99  
Employer matching contribution, percent of match 100.00%    
Employer matching contribution, percent of employees' gross pay 6.00%    
Employer discretionary contribution, percent 3.00%    
Employers discretionary contribution, vesting period 3 years    
Matching employer contributions $ 60 65  
Nonmatching employer contributions 32 34  
DuPont Other Contribution Plans      
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]      
Employer contributions 32 35  
Other Postretirement Benefits      
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]      
Projected benefit obligation $ 27 $ 29  
Pension Plans      
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]      
Discount rate 3.67% 3.26% 3.71%
v3.25.0.1
PENSION PLANS AND OTHER POST-EMPLOYMENT BENEFITS - Weighted-Average Assumptions (Details) - Pension Plans
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Benefit Obligations      
Discount rate 3.67% 3.26% 3.71%
Interest crediting rate for applicable benefits 1.75% 2.00%  
Rate of compensation increase 3.41% 3.11%  
Net Periodic Costs      
Discount rate 3.46% 3.05% 1.48%
Interest crediting rate for applicable benefits 2.00% 2.25% 1.25%
Rate of compensation increase 3.11% 3.25% 3.15%
Expected return on plan assets 4.43% 3.61% 2.69%
v3.25.0.1
PENSION PLANS AND OTHER POST-EMPLOYMENT BENEFITS - Change in Projected Benefit Obligation and Plan Assets and Funded Status (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Change in projected benefit obligations:      
Benefit obligations at beginning of year $ 2,704 $ 2,726  
Service cost 17 25 $ 43
Interest cost 84 99 55
Plan participants' contributions 9 7  
Actuarial changes in assumptions and experience (49) 132  
Benefits paid (208) (208)  
Acquisitions/divestitures/other 0 (209)  
Effect of foreign exchange rates (122) 133  
Termination benefits/curtailment cost/settlements 0 (1)  
Benefit obligations at end of year 2,435 2,704 2,726
Change in plan assets:      
Fair value of plan assets at beginning of year 2,424 2,596  
Actual return on plan assets (14) 109  
Employer contributions 51 66  
Plan participants' contributions 9 7  
Benefits paid (208) (208)  
Acquisitions/divestitures/other 0 (285)  
Effect of foreign exchange rates (101) 139  
Fair value of plan assets at end of year 2,161 2,424 $ 2,596
Funded status of plan (274) (280)  
Defined Benefit Plan, Funded Plan      
Change in plan assets:      
Funded status of plan 186 233  
Defined Benefit Plan, Unfunded Plan      
Change in plan assets:      
Funded status of plan $ (460) $ (513)  
v3.25.0.1
PENSION PLANS AND OTHER POST-EMPLOYMENT BENEFITS - Amounts Recognized in the Consolidated Balance Sheets (Details) - USD ($)
$ in Millions
Dec. 31, 2024
Dec. 31, 2023
Amounts recognized in the consolidated balance sheets:    
Deferred charges and other assets $ 291 $ 338
Accrued and other current liabilities (42) (53)
Pension and other post-employment benefits - noncurrent (523) (565)
Net amount recognized (274) (280)
Pretax amounts recognized in accumulated other comprehensive loss (income):    
Net loss (gain) 167 95
Prior service credit (4) (8)
Pretax balance in accumulated other comprehensive loss at end of year $ 163 $ 87
v3.25.0.1
PENSION PLANS AND OTHER POST-EMPLOYMENT BENEFITS - ABO and PBO in Excess of Plan Assets (Details) - USD ($)
$ in Millions
Dec. 31, 2024
Dec. 31, 2023
Retirement Benefits [Abstract]    
Accumulated benefit obligations $ 646 $ 700
Fair value of plan assets 134 138
Projected benefit obligations 683 743
Fair value of plan assets $ 144 $ 154
v3.25.0.1
PENSION PLANS AND OTHER POST-EMPLOYMENT BENEFITS - Net Periodic Benefit Costs for All Significant Plans (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Net Periodic Benefit Costs:      
Service cost $ 17 $ 25 $ 43
Interest cost 84 99 55
Expected return on plan assets (100) (92) (97)
Amortization of prior service credit (3) (3) (5)
Amortization of unrecognized net (gain) loss 0 (1) 1
Curtailment/settlement 1 (3) (4)
Non-operating pension and other post-employment benefit (OPEB) credits (1) 25 (7)
Less: Net periodic benefit credits - Discontinued operations      
Net Periodic Benefit Costs:      
Non-operating pension and other post-employment benefit (OPEB) credits 0 (6) (9)
Net periodic benefit costs - Continuing operations      
Net Periodic Benefit Costs:      
Service cost 17 22 30
Interest cost 84 93 49
Expected return on plan assets (100) (78) (73)
Amortization of prior service credit (3) (2) (4)
Amortization of unrecognized net (gain) loss 0 (1) 4
Curtailment/settlement 1 (3) (4)
Non-operating pension and other post-employment benefit (OPEB) credits (1) 31 2
Changes in plan assets and benefit obligations recognized in other comprehensive loss (income):      
Net loss (gain) 70 108 (35)
Amortization of prior service credit 3 3 5
Amortization of unrecognized gain (loss) 0 1 (1)
Settlement (loss) gain (1) 3 4
Effect of foreign exchange rates (1) 1 5
Total recognized in other comprehensive loss (income) 71 116 (22)
Total recognized in net periodic benefit costs (credits) and other comprehensive loss (income) $ 70 $ 147 $ (20)
v3.25.0.1
PENSION PLANS AND OTHER POST-EMPLOYMENT BENEFITS - Estimated Future Benefit Payments (Details)
$ in Millions
Dec. 31, 2024
USD ($)
Retirement Benefits [Abstract]  
2025 $ 173
2026 171
2027 167
2028 169
2029 174
Years 2030-2034 845
Total $ 1,699
v3.25.0.1
PENSION PLANS AND OTHER POST-EMPLOYMENT BENEFITS - Target Allocation for Plan Assets (Details)
Dec. 31, 2024
Defined Benefit Plan Disclosure [Line Items]  
Target allocation for plan assets, percentage 100.00%
Equity securities  
Defined Benefit Plan Disclosure [Line Items]  
Target allocation for plan assets, percentage 2.00%
Fixed income securities  
Defined Benefit Plan Disclosure [Line Items]  
Target allocation for plan assets, percentage 9.00%
Alternative investments  
Defined Benefit Plan Disclosure [Line Items]  
Target allocation for plan assets, percentage 24.00%
Hedge funds  
Defined Benefit Plan Disclosure [Line Items]  
Target allocation for plan assets, percentage 26.00%
Pooled investment vehicles  
Defined Benefit Plan Disclosure [Line Items]  
Target allocation for plan assets, percentage 32.00%
Other investments  
Defined Benefit Plan Disclosure [Line Items]  
Target allocation for plan assets, percentage 7.00%
v3.25.0.1
PENSION PLANS AND OTHER POST-EMPLOYMENT BENEFITS - Fair Value of Plan Assets (Details) - USD ($)
$ in Millions
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets $ 2,161 $ 2,424 $ 2,596
Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 543 603 599
Derivatives - asset position | Level 1, 2 and 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 0 3  
Derivatives - asset position | Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 0 0  
Derivatives - asset position | Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 0 3  
Derivatives - asset position | Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 0 0  
Derivatives - liability position | Level 1, 2 and 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets (3) 0  
Derivatives - liability position | Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 0 0  
Derivatives - liability position | Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets (3) 0  
Derivatives - liability position | Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 0 0  
Defined Benefit Plan, Assets Before Pension Trust | Level 1, 2 and 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 1,361 1,430  
Defined Benefit Plan, Assets Before Pension Trust | Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 783 785  
Defined Benefit Plan, Assets Before Pension Trust | Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 35 42  
Defined Benefit Plan, Assets Before Pension Trust | Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 543 603  
Defined Benefit Plan, Assets Before Pension Trust | Fair Value Measured at Net Asset Value Per Share      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 800 980  
Cash and cash equivalents | Level 1, 2 and 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 52 55  
Cash and cash equivalents | Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 52 55  
Cash and cash equivalents | Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 0 0  
Cash and cash equivalents | Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 0 0  
Equity securities | Level 1, 2 and 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 46 49  
Equity securities | Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 46 49  
Equity securities | Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 0 0  
Equity securities | Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 0 0  
U.S. equity securities | Level 1, 2 and 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 20 20  
U.S. equity securities | Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 20 20  
U.S. equity securities | Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 0 0  
U.S. equity securities | Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 0 0  
Non - U.S. equity securities | Level 1, 2 and 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 26 29  
Non - U.S. equity securities | Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 26 29  
Non - U.S. equity securities | Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 0 0  
Non - U.S. equity securities | Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 0 0  
Fixed income securities | Level 1, 2 and 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 38 39  
Fixed income securities | Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 0 0  
Fixed income securities | Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 38 39  
Fixed income securities | Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 0 0  
Debt - government-issued | Level 1, 2 and 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 34 34  
Debt - government-issued | Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 0 0  
Debt - government-issued | Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 34 34  
Debt - government-issued | Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 0 0  
Debt - government-issued | Fair Value Measured at Net Asset Value Per Share      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 147 187  
Debt - corporate-issued | Level 1, 2 and 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 4 5  
Debt - corporate-issued | Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 0 0  
Debt - corporate-issued | Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 4 5  
Debt - corporate-issued | Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 0 0  
Alternative investments | Level 1, 2 and 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 540 606  
Alternative investments | Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 0 0  
Alternative investments | Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets (3) 3  
Alternative investments | Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 543 603  
Real estate | Level 1, 2 and 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 75 79  
Real estate | Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 0 0  
Real estate | Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 0 0  
Real estate | Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 75 79 75
Insurance contracts | Level 1, 2 and 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 468 524  
Insurance contracts | Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 0 0  
Insurance contracts | Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 0 0  
Insurance contracts | Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 468 524 $ 524
Other investments | Level 1, 2 and 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 685 681  
Other investments | Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 685 681  
Other investments | Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 0 0  
Other investments | Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 0 0  
Pooled investment vehicles | Level 1, 2 and 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 685 681  
Pooled investment vehicles | Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 685 681  
Pooled investment vehicles | Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 0 0  
Pooled investment vehicles | Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 0 0  
Hedge funds | Fair Value Measured at Net Asset Value Per Share      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 552 667  
Private market securities | Fair Value Measured at Net Asset Value Per Share      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 101 126  
Pension Trust Receivables | Level 1, 2 and 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets 0 14  
Pension Trust Payables | Level 1, 2 and 3      
Defined Benefit Plan Disclosure [Line Items]      
Pension plan assets $ 0 $ 0  
v3.25.0.1
PENSION PLANS AND OTHER POST-EMPLOYMENT BENEFITS - Fair Value Measurement of Level 3 Pension Plan Assets (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Defined Benefit Plan, Change in Fair Value of Plan Assets, Level 3 Reconciliation [Roll Forward]    
Fair value of plan assets at beginning of year $ 2,424 $ 2,596
Fair value of plan assets at end of year 2,161 2,424
Significant Other Unobservable Inputs (Level 3)    
Defined Benefit Plan, Change in Fair Value of Plan Assets, Level 3 Reconciliation [Roll Forward]    
Fair value of plan assets at beginning of year 603 599
Relating to assets held (62) 28
Purchases, sales and settlements, net (1) (14)
Transfers out of Level 3   (10)
Transfers into Level 3 3  
Fair value of plan assets at end of year 543 603
Significant Other Unobservable Inputs (Level 3) | Real estate    
Defined Benefit Plan, Change in Fair Value of Plan Assets, Level 3 Reconciliation [Roll Forward]    
Fair value of plan assets at beginning of year 79 75
Relating to assets held (6) 2
Purchases, sales and settlements, net 2 2
Transfers out of Level 3   0
Transfers into Level 3 0  
Fair value of plan assets at end of year 75 79
Significant Other Unobservable Inputs (Level 3) | Insurance contracts    
Defined Benefit Plan, Change in Fair Value of Plan Assets, Level 3 Reconciliation [Roll Forward]    
Fair value of plan assets at beginning of year 524 524
Relating to assets held (56) 26
Purchases, sales and settlements, net (3) (16)
Transfers out of Level 3   (10)
Transfers into Level 3 3  
Fair value of plan assets at end of year $ 468 $ 524
v3.25.0.1
STOCK-BASED COMPENSATION - Narrative (Details)
$ / shares in Units, $ in Millions
 12 Months Ended
Dec. 31, 2024
USD ($)
subplan
$ / shares
shares
Dec. 31, 2023
USD ($)
$ / shares
shares
Dec. 31, 2022
USD ($)
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Compensation expense $ 77.0 $ 74.0 $ 75.0
Income tax benefits 16.0 $ 16.0 16.0
Unrecognized pretax compensation cost, amount $ 0.2    
Stock Options      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Unrecognized pretax compensation cost, period for recognition 1 month 6 days    
RSUs and PSUs      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Unrecognized pretax compensation cost, period for recognition 1 year 9 months 18 days    
Unrecognized pretax compensation cost, excluding options, amount $ 77.0    
Fair value of awards vested $ 78.0    
Weighted-average share price of awards granted (in USD per share) | $ / shares $ 70.70    
RSUs      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award vesting period (in years) 3 years    
Equity award conversion ratio (shares) | shares 1    
DuPont 2020 Equity and Incentive Plan      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Capital shares reserved for future issuance (in shares) | shares 15,000,000    
Options granted (in shares) | shares 0 0  
DuPont 2020 Equity and Incentive Plan | Stock Options      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Compensation expense $ 12.0 $ 10.0 8.0
Income tax benefits $ 2.0 $ 2.0 $ 2.0
Award requisite service period (in months) 12 months    
Weighted-average stock option price (in USD per share) | $ / shares $ 0 $ 0 $ 17.41
DuPont 2020 Equity and Incentive Plan | RSUs and PSUs      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Weighted-average share price of awards granted (in USD per share) | $ / shares $ 70.70    
DuPont 2020 Equity and Incentive and DuPont Omnibus Incentive Plans | Stock Options      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Maximum term (in years) 10 years    
DuPont 2020 Equity and Incentive and DuPont Omnibus Incentive Plans | RSUs and PSUs      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award requisite service period (in months) 6 months    
DuPont 2020 Equity and Incentive and DuPont Omnibus Incentive Plans | RSUs      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award vesting period (in years) 3 years    
Equity award conversion ratio (shares) | shares 1    
DuPont 2020 Equity and Incentive and DuPont Omnibus Incentive Plans | PSUs | Minimum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Percentage of performance target (percent) 0.00%    
DuPont 2020 Equity and Incentive and DuPont Omnibus Incentive Plans | PSUs | Maximum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Percentage of performance target (percent) 200.00%    
DuPont Omnibus Incentive Plan      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of subplans | subplan 2    
Options granted (in shares) | shares 0 0 0
DuPont Omnibus Incentive Plan | Stock Options      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Compensation expense $ 27.0 $ 26.0 $ 25.0
Income tax benefits $ 6.0 $ 6.0 $ 5.0
Award requisite service period (in months) 6 months    
Options granted (in shares) | shares 0 0 0
DuPont Omnibus Incentive Plan | RSUs and PSUs      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Weighted-average share price of awards granted (in USD per share) | $ / shares $ 0    
TDCC Stock Incentive Plan | Stock Options      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Maximum term (in years) 10 years    
Options granted (in shares) | shares 0 0 0
TDCC Stock Incentive Plan | Stock Options | Minimum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award vesting period (in years) 1 year    
TDCC Stock Incentive Plan | Stock Options | Maximum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award vesting period (in years) 3 years    
EIDP Equity Incentive Plan      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Options granted (in shares) | shares 0 0 0
EIDP Equity Incentive Plan | Stock Options      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award requisite service period (in months) 6 months    
Award vesting period (in years) 3 years    
EIDP Equity Incentive Plan | Stock Options | Grants Between 2016 and 2018      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award vesting period (in years) 10 years    
EIDP Equity Incentive Plan | RSUs      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award requisite service period (in months) 6 months    
Award vesting period (in years) 3 years    
EIDP Equity Incentive Plan | RSUs | Minimum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award vesting period (in years) 3 years    
EIDP Equity Incentive Plan | RSUs | Maximum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award vesting period (in years) 5 years    
v3.25.0.1
STOCK-BASED COMPENSATION - Weighted-Average Assumptions (Details) - DuPont 2020 Equity and Incentive Plan - shares
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Granted (in shares) 0 0  
Stock Options      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Dividend yield     1.80%
Expected volatility     26.40%
Risk-free interest rate     1.90%
Expected life of stock options granted during period (years)     6 years
v3.25.0.1
STOCK-BASED COMPENSATION - Stock Option Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Additional Information about Stock Options      
Total compensation expense for stock options plans $ 77,000 $ 74,000 $ 75,000
Related tax benefit $ 16,000 $ 16,000 $ 16,000
DuPont 2020 Equity and Incentive Plan      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]      
Outstanding at the beginning of the period (in shares) 627,000    
Granted (in shares) 0 0  
Exercised (in shares) (106,000)    
Forfeited/Expired (in shares) (12,000)    
Outstanding at the end of the period (in shares) 509,000 627,000  
Weighted Average Exercise Price (per share)      
Outstanding, weighted average exercise price, beginning balance (USD per share) $ 74.48    
Granted, weighted average exercise price (in USD per share) 0    
Exercised, weighted average exercise price (in USD per share) 73.91    
Forfeited/Expired, weighted average exercise price (in USD per share) 74.40    
Outstanding, weighted average exercise price, ending balance (USD per share) $ 74.61 $ 74.48  
Options outstanding, weighted average remaining contractual term 6 years 6 months 29 days    
Options outstanding, aggregate intrinsic value (in USD) $ 837    
Options exercisable, Number of options (in shares) 375,000    
Options exercisable, weighted average exercise price per share (in USD per share) $ 74.45    
Options exercisable, weighted average remaining contractual term 6 years 4 months 28 days    
Options exercisable, aggregate intrinsic value (in USD) $ 674    
DuPont 2020 Equity and Incentive Plan | Stock Options      
Additional Information about Stock Options      
Weighted-average fair value per share of options granted (in USD per share) $ 0 $ 0 $ 17.41
Total compensation expense for stock options plans $ 12,000 $ 10,000 $ 8,000
Related tax benefit $ 2,000 $ 2,000 $ 2,000
DuPont Omnibus Incentive Plan      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]      
Outstanding at the beginning of the period (in shares) 1,637,000    
Granted (in shares) 0 0 0
Exercised (in shares) (217,000)    
Forfeited/Expired (in shares) (30,000)    
Outstanding at the end of the period (in shares) 1,390,000 1,637,000  
Weighted Average Exercise Price (per share)      
Outstanding, weighted average exercise price, beginning balance (USD per share) $ 62.58    
Granted, weighted average exercise price (in USD per share) 0    
Exercised, weighted average exercise price (in USD per share) 62.55    
Forfeited/Expired, weighted average exercise price (in USD per share) 64.16    
Outstanding, weighted average exercise price, ending balance (USD per share) $ 62.55 $ 62.58  
Options outstanding, weighted average remaining contractual term 5 years 1 month 13 days    
Options outstanding, aggregate intrinsic value (in USD) $ 19,041    
Options exercisable, Number of options (in shares) 1,390,000    
Options exercisable, weighted average exercise price per share (in USD per share) $ 62.55    
Options exercisable, weighted average remaining contractual term 5 years 1 month 13 days    
Options exercisable, aggregate intrinsic value (in USD) $ 19,041    
DuPont Omnibus Incentive Plan | Stock Options      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]      
Granted (in shares) 0 0 0
Additional Information about Stock Options      
Total compensation expense for stock options plans $ 27,000 $ 26,000 $ 25,000
Related tax benefit $ 6,000 $ 6,000 $ 5,000
EIDP Equity Incentive Plan      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]      
Outstanding at the beginning of the period (in shares) 2,228,000    
Granted (in shares) 0 0 0
Exercised (in shares) (205,000)    
Forfeited/Expired (in shares) (21,000)    
Outstanding at the end of the period (in shares) 2,002,000 2,228,000  
Weighted Average Exercise Price (per share)      
Outstanding, weighted average exercise price, beginning balance (USD per share) $ 73.49    
Exercised, weighted average exercise price (in USD per share) 70.48    
Forfeited/Expired, weighted average exercise price (in USD per share) 76.58    
Outstanding, weighted average exercise price, ending balance (USD per share) $ 73.77 $ 73.49  
Options outstanding, weighted average remaining contractual term 2 years 8 months 12 days    
Options outstanding, aggregate intrinsic value (in USD) $ 8,804,000    
Options exercisable, Number of options (in shares) 1,997,000    
Options exercisable, weighted average exercise price per share (in USD per share) $ 73.78    
Options exercisable, weighted average remaining contractual term 2 years 8 months 12 days    
Options exercisable, aggregate intrinsic value (in USD) $ 8,760,000    
v3.25.0.1
STOCK-BASED COMPENSATION - Nonvested Award Activity (Details) - RSUs and PSUs
shares in Thousands
 12 Months Ended
Dec. 31, 2024
$ / shares
shares
Weighted Average Grant Date Fair Value [Abstract]  
Granted, grant date fair value (in USD per share) $ 70.70
DuPont 2020 Equity and Incentive Plan  
Number of Shares [Roll Forward]  
Nonvested awards, beginning of the period (in shares) | shares 1,991
Granted (in shares) | shares 1,212
Vested (in shares) | shares (880)
Forfeited (in shares) | shares (119)
Nonvested awards, end of the period (in shares) | shares 2,204
Weighted Average Grant Date Fair Value [Abstract]  
Nonvested awards, grant date fair value, beginning of the period (in USD per share) $ 69.85
Granted, grant date fair value (in USD per share) 70.70
Vested, grant date fair value (in USD per share) 72.86
Forfeited, grant date fair value (in USD per share) 69.88
Nonvested awards, grant date fair value, end of the period (in USD per share) $ 69.11
DuPont Omnibus Incentive Plan  
Number of Shares [Roll Forward]  
Nonvested awards, beginning of the period (in shares) | shares 163
Granted (in shares) | shares 0
Vested (in shares) | shares (109)
Forfeited (in shares) | shares (3)
Nonvested awards, end of the period (in shares) | shares 51
Weighted Average Grant Date Fair Value [Abstract]  
Nonvested awards, grant date fair value, beginning of the period (in USD per share) $ 68.01
Granted, grant date fair value (in USD per share) 0
Vested, grant date fair value (in USD per share) 71.93
Forfeited, grant date fair value (in USD per share) 71.42
Nonvested awards, grant date fair value, end of the period (in USD per share) $ 59.40
v3.25.0.1
FINANCIAL INSTRUMENTS - Schedule of Fair Value of Financial Instruments (Details) - USD ($)
$ in Millions
Dec. 31, 2024
Dec. 31, 2023
Debt Securities, Available-for-sale [Line Items]    
Cash equivalents, Cost $ 314 $ 408
Restricted cash equivalents, Cost 42 411
Total cash and restricted cash equivalents, Cost 356 819
Long-term debt including debt due within one year, Cost (7,171) (7,859)
Long term debt including debt due within one year, Gain 14 70
Long term debt including debt due within one year, Loss (57) (206)
Long term debt including debt due within one year, Fair Value (7,214) (7,995)
Derivatives relating to:    
Cost 0 0
Gain 145 122
Loss (214) (82)
Fair Value (69) 40
Net investment hedge    
Derivatives relating to:    
Cost 0 0
Gain 137 96
Loss 0 0
Fair Value 137 96
Foreign Currency    
Derivatives relating to:    
Cost 0 0
Gain 8 26
Loss (8) (23)
Fair Value 0 3
Interest rate swap agreements    
Derivatives relating to:    
Cost 0 0
Gain 0 0
Loss (206) (59)
Fair Value (206) $ (59)
Unamortized basis adjustment $ 48  
v3.25.0.1
FINANCIAL INSTRUMENTS - Schedule of Notional Amounts (Details) - USD ($)
$ in Millions
Dec. 31, 2024
Dec. 31, 2023
Derivatives designated as hedging instruments: | Net investment hedge    
Derivative [Line Items]    
Notional Amounts $ 1,000 $ 1,000
Derivatives designated as hedging instruments: | Interest rate swap agreements    
Derivative [Line Items]    
Notional Amounts 0 1,000
Derivatives not designated as hedging instruments: | Interest rate swap agreements    
Derivative [Line Items]    
Notional Amounts 4,150 0
Derivatives not designated as hedging instruments: | Foreign Currency    
Derivative [Line Items]    
Notional Amounts $ (1,176) $ (907)
v3.25.0.1
FINANCIAL INSTRUMENTS - Narrative (Details)
€ in Millions, $ in Millions
 12 Months Ended
Jun. 15, 2024
USD ($)
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Jun. 30, 2024
USD ($)
swap
Jun. 30, 2022
USD ($)
Jun. 30, 2021
USD ($)
Jun. 30, 2021
EUR (€)
Derivatives, Fair Value [Line Items]                
Interest rate swap mark-to-market income (loss)   $ (138) $ 0 $ 0        
Loss on partial extinguishment of debt   74 0 0        
Floating Rate Note Due 2038                
Derivatives, Fair Value [Line Items]                
Face amount of debt           $ 1,000    
Fixed Rate Notes Due 2038                
Derivatives, Fair Value [Line Items]                
Face amount of debt         $ 1,000 1,650    
2038 Notes | Long-Term Debt                
Derivatives, Fair Value [Line Items]                
Cumulative fair value basis loss $ 81              
Fixed Rate Note Due 2048                
Derivatives, Fair Value [Line Items]                
Face amount of debt         $ 2,150      
Senior Notes | 2038 Notes                
Derivatives, Fair Value [Line Items]                
Repayments 650              
Loss on partial extinguishment of debt $ 32 74            
Basis adjustment amortization   1            
Interest rate swap agreements                
Derivatives, Fair Value [Line Items]                
Interest rate swap mark-to-market income (loss)   (138) 0 0        
Basis adjustment amortization   2            
Derivatives designated as hedging instruments: | Net investment hedge                
Derivatives, Fair Value [Line Items]                
Derivative, notional amount             $ 1,000 € 819
Derivative, fixed interest rate             4.73% 4.73%
Derivative, average fixed interest rate             3.26% 3.26%
Derivatives not designated as hedging instruments: | Foreign Currency                
Derivatives, Fair Value [Line Items]                
Interest rate swap mark-to-market income (loss)   (32) $ (64) $ (32)        
Derivatives not designated as hedging instruments: | Interest rate swap agreements                
Derivatives, Fair Value [Line Items]                
Derivative, notional amount           $ 1,000    
Number of derivative instruments entered into | swap         2      
Mark-to-market value   $ 116            
Derivatives not designated as hedging instruments: | Interest rate swap agreements | Floating Rate Note Due 2025 Through 2048                
Derivatives, Fair Value [Line Items]                
Number of derivative instruments converted | swap         1      
v3.25.0.1
FAIR VALUE MEASUREMENTS - Schedule of Assets and Liabilities at Fair Value (Details) - USD ($)
$ in Millions
Dec. 31, 2024
Dec. 31, 2023
Liabilities at fair value:    
Offsetting counterparty and cash collateral netting amount for assets $ 15 $ 11
Offsetting counterparty and cash collateral netting amount for liabilities 0 0
Water District Settlement Fund    
Liabilities at fair value:    
Qualified settlement fund deposit   405
Level 1 | Water District Settlement Fund    
Liabilities at fair value:    
Qualified settlement fund deposit   405
Recurring | Level 2    
Assets at fair value:    
Cash equivalents 314 364
Total assets at fair value 474 497
Liabilities at fair value:    
Total liabilities at fair value 229 93
Recurring | Level 2 | Derivatives designated as hedging instruments: | Net investment hedge    
Assets at fair value:    
Derivative assets 137 96
Recurring | Level 2 | Derivatives designated as hedging instruments: | Interest rate swap agreements    
Liabilities at fair value:    
Derivative liabilities 206 59
Recurring | Level 2 | Derivatives designated as hedging instruments: | Foreign currency contracts    
Assets at fair value:    
Derivative assets 23 37
Liabilities at fair value:    
Derivative liabilities 23 34
Recurring | Level 1    
Liabilities at fair value:    
Money market funds 42 50
Recurring | Level 3    
Liabilities at fair value:    
Contingent earn-out liabilities 40 0
Total liabilities at fair value $ 40 $ 0
v3.25.0.1
FAIR VALUE MEASUREMENTS - Narrative (Details)
$ in Millions
Jul. 28, 2024
USD ($)
Donatelle Plastics  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Maximum accumulated earn-out payments $ 85
v3.25.0.1
FAIR VALUE MEASUREMENTS - Fair Value Measurements on a Nonrecurring Basis (Details) - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Goodwill $ 0 $ (804,000,000) $ 0
Total Losses     (94,000,000)
Goodwill      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Goodwill   (804,000,000)  
Long-lived assets, intangible assets, and other assets      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Total Losses     (94,000,000)
Level 3 | Nonrecurring | Goodwill      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Assets at fair value:   $ 4,814,000,000  
Level 3 | Nonrecurring | Long-lived assets, intangible assets, and other assets      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Assets at fair value:     $ 55,000,000
v3.25.0.1
SEGMENTS AND GEOGRAPHIC REGIONS - Narrative (Details)
$ in Millions
 12 Months Ended
Dec. 31, 2024
USD ($)
segment
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Segment Reporting Information [Line Items]      
Number of operating segments | segment 2    
Reportable segment net sales $ 12,386 $ 12,068 $ 13,017
Operating Segments      
Segment Reporting Information [Line Items]      
Reportable segment net sales $ 11,353 $ 10,970 $ 11,874
v3.25.0.1
SEGMENTS AND GEOGRAPHIC REGIONS - Net Trade Revenue and Long-lived Assets by Geographic Region (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Revenues from External Customers and Long-Lived Assets [Line Items]      
Net sales $ 12,386 $ 12,068 $ 13,017
Assets 5,768 5,884 5,731
United States      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Net sales 4,102 3,914 4,066
Assets 3,590 3,559 3,501
Canada      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Net sales 273 271 293
Assets 60 54 49
EMEA      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Net sales 2,146 2,203 2,193
Assets 1,259 1,336 1,271
Asia Pacific      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Net sales 5,368 5,191 6,022
Assets 823 896 883
Latin America      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Net sales 497 489 443
Assets 36 39 27
China/Hong Kong      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Net sales $ 2,345 $ 2,206 $ 2,744
v3.25.0.1
SEGMENTS AND GEOGRAPHIC REGIONS - Segment Revenue, Significant Segment Expenses and Segment Operating EBITDA (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Segment Reporting Information [Line Items]      
Equity in earnings of nonconsolidated affiliates $ 60 $ 51 $ 75
Operating Segments      
Segment Reporting Information [Line Items]      
Segment Operating EBITDA 3,077 2,860 3,267
Operating Segments | Electronics & Industrial      
Segment Reporting Information [Line Items]      
Net sales 5,930 5,337 5,917
Cost of sales 3,420 3,139 3,341
Selling, general and administrative expenses 761 647 632
Research and development expenses 366 348 377
Amortization of intangibles 341 354 342
Equity in earnings of nonconsolidated affiliates 37 16 31
Depreciation and amortization 638 607 580
Segment Operating EBITDA 1,717 1,472 1,836
Operating Segments | Water & Protection      
Segment Reporting Information [Line Items]      
Net sales 5,423 5,633 5,957
Cost of sales 3,674 3,879 4,149
Selling, general and administrative expenses 574 545 554
Research and development expenses 141 138 131
Amortization of intangibles 226 225 225
Equity in earnings of nonconsolidated affiliates 30 35 39
Depreciation and amortization 522 507 494
Segment Operating EBITDA $ 1,360 $ 1,388 $ 1,431
v3.25.0.1
SEGMENTS AND GEOGRAPHIC REGIONS - Reconciliation of Segment Operating EBITDA to Income from Continuing Operations Before Income Taxes (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Segment Reporting Information [Line Items]      
Depreciation and amortization $ 1,194 $ 1,147 $ 1,135
Interest income 73 155 50
Interest expense 364 396 486
Non-operating pension/OPEB Benefit costs (credits) 18 (9) 28
Foreign exchange gains (losses), net 3 (73) 15
Future reimbursable indirect costs 0 7 52
Significant items charge (488) (961) (233)
Income from continuing operations before income taxes 1,192 504 1,448
Operating Segments      
Segment Reporting Information [Line Items]      
Operating EBITDA 3,077 2,860 3,267
Operating Segments | Electronics & Industrial      
Segment Reporting Information [Line Items]      
Operating EBITDA 1,717 1,472 1,836
Significant items charge (19) (62) (98)
Operating Segments | Water & Protection      
Segment Reporting Information [Line Items]      
Operating EBITDA 1,360 1,388 1,431
Significant items charge (75) (858) 40
Corporate & Other      
Segment Reporting Information [Line Items]      
Operating EBITDA 67 82 (6)
Significant items charge $ (394) $ (41) $ (175)
v3.25.0.1
SEGMENTS AND GEOGRAPHIC REGIONS - Summary of Significant Items by Segment (Details) - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Segment Reporting Information [Line Items]      
Acquisition, integration and separation costs $ (168,000,000) $ (20,000,000) $ (193,000,000)
Restructuring and asset related charges - net (87,000,000) (146,000,000) (61,000,000)
Inventory write-offs (25,000,000)    
Inventory step-up amortization (2,000,000)    
Loss on debt extinguishment (74,000,000) 0 0
Goodwill 0 (804,000,000) 0
Asset impairment charges     (94,000,000)
Gain on divestiture   9,000,000 69,000,000
Terminated Intended Rogers Acquisition financing fees     (6,000,000)
Employee Retention Credit     52,000,000
Income tax items 8,000,000    
Total (488,000,000) (961,000,000) (233,000,000)
Termination fee paid     162,500,000
Interest rate swap agreements      
Segment Reporting Information [Line Items]      
Interest rate swap items (140,000,000)    
Basis amortization 2,000,000    
Operating Segments | Electronics & Industrial      
Segment Reporting Information [Line Items]      
Acquisition, integration and separation costs (12,000,000) (20,000,000) 0
Restructuring and asset related charges - net (5,000,000) (49,000,000) (24,000,000)
Inventory write-offs 0    
Inventory step-up amortization (2,000,000)    
Loss on debt extinguishment 0    
Goodwill   0  
Asset impairment charges     (94,000,000)
Gain on divestiture   7,000,000 0
Terminated Intended Rogers Acquisition financing fees     0
Employee Retention Credit     20,000,000
Income tax items 0    
Total (19,000,000) (62,000,000) (98,000,000)
Operating Segments | Electronics & Industrial | Interest rate swap agreements      
Segment Reporting Information [Line Items]      
Interest rate swap items 0    
Operating Segments | Water & Protection      
Segment Reporting Information [Line Items]      
Acquisition, integration and separation costs 0 0 0
Restructuring and asset related charges - net (50,000,000) (55,000,000) (17,000,000)
Inventory write-offs (25,000,000)    
Inventory step-up amortization 0    
Loss on debt extinguishment 0    
Goodwill   (804,000,000)  
Asset impairment charges     0
Gain on divestiture   1,000,000 37,000,000
Terminated Intended Rogers Acquisition financing fees     0
Employee Retention Credit     20,000,000
Income tax items 0    
Total (75,000,000) (858,000,000) 40,000,000
Operating Segments | Water & Protection | Interest rate swap agreements      
Segment Reporting Information [Line Items]      
Interest rate swap items 0    
Corporate & Other      
Segment Reporting Information [Line Items]      
Acquisition, integration and separation costs (156,000,000) 0 (193,000,000)
Restructuring and asset related charges - net (32,000,000) (42,000,000) (20,000,000)
Inventory write-offs 0    
Inventory step-up amortization 0    
Loss on debt extinguishment (74,000,000)    
Goodwill   0  
Asset impairment charges     0
Gain on divestiture   1,000,000 32,000,000
Terminated Intended Rogers Acquisition financing fees     (6,000,000)
Employee Retention Credit     12,000,000
Income tax items 8,000,000    
Total (394,000,000) $ (41,000,000) $ (175,000,000)
Corporate & Other | Interest rate swap agreements      
Segment Reporting Information [Line Items]      
Interest rate swap items $ (140,000,000)    
v3.25.0.1
SEGMENTS AND GEOGRAPHIC REGIONS - Segment Information (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Segment Reporting Information [Line Items]      
Assets of continuing operations $ 36,636 $ 38,552 $ 41,355
Investment in nonconsolidated affiliates 778 788 686
Capital expenditures 619 590 659
Continuing Operations      
Segment Reporting Information [Line Items]      
Assets of continuing operations 36,636 38,552 40,064
Operating Segments | Electronics & Industrial      
Segment Reporting Information [Line Items]      
Investment in nonconsolidated affiliates 382 386 396
Capital expenditures 340 306 290
Operating Segments | Electronics & Industrial | Continuing Operations      
Segment Reporting Information [Line Items]      
Assets of continuing operations 18,537 18,622 17,110
Operating Segments | Water & Protection      
Segment Reporting Information [Line Items]      
Investment in nonconsolidated affiliates 278 280 290
Capital expenditures 230 240 289
Operating Segments | Water & Protection | Continuing Operations      
Segment Reporting Information [Line Items]      
Assets of continuing operations 13,098 13,750 14,831
Corporate & Other      
Segment Reporting Information [Line Items]      
Investment in nonconsolidated affiliates 118 122 0
Capital expenditures 49 44 80
Corporate & Other | Continuing Operations      
Segment Reporting Information [Line Items]      
Assets of continuing operations $ 5,001 $ 6,180 $ 8,123
v3.25.0.1
SEGMENTS AND GEOGRAPHIC REGIONS - Total Asset Reconciliation (Details) - USD ($)
$ in Millions
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Segment Reporting [Abstract]      
Assets of continuing operations $ 36,636 $ 38,552 $ 40,064
Assets of discontinued operations 0 0 1,291
Total Assets $ 36,636 $ 38,552 $ 41,355
v3.25.0.1
SEGMENTS AND GEOGRAPHIC REGIONS - Segment Information Reconciliation (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Segment Reporting [Abstract]      
Segment and Corporate & Other Totals $ 619 $ 590 $ 659
Other (40) 29 3
Total $ 579 $ 619 $ 662